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Brachyspira hyodysenteriae is the causative agent of swine dysentery, a disease 
characterised by bloody diarrhoea. It is endemic to the UK, and if untreated it can 
cause severe economic cost to farmers. Currently, it is treated with antibiotics 
including the pleuromutilin antibiotics tiamulin and valnemulin. B. hyodysenteriae 
has become more resistant to the antibiotics used to treat infections , and increasing 
levels of pleuromutilin resistance has been observed in some countries.  
 
In this study, 84 clinical isolates, from 2004 to 2015, were sequenced on an Illumina 
MiSeq. From this, the population structure of B. hyodysenteriae in the UK was 
constructed. In addition, the phenotypic resistance of 47 sequenced isolates was 
obtained using a commercial broth dilution assay. The use of sequenced isolates 
enabled detection of a recently identified pleuromutilin resistance gene and enabled 
prediction of the resistance phenotype of all sequenced isolates. The use of whole-
genome sequencing has increased our knowledge of B. hyodysenteriae in the UK, 
highlighting potential regional differences and has created a reference database of all 
B. hyodysenteriae isolates from 2004 to 2015. This will improve surveillance and 
increase the power of outbreak analysis.  
 
Direct sequencing from clinical samples could further strengthen outbreak analysis 
and surveillance. This would improve the speed of identification and could provide 
useful information. To explore swine dysentery, positive samples were sequenced on 
an Illumina MiSeq and B. hyodysenteriae reads were extracted. From this, it was 
possible to identify the closest sequenced strains. This study highlights the potential 
uses of whole genome sequencing to analyse B. hyodysenteriae.  
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Chapter 1. Introduction 
 
1.1. The domestic pig and pig farming 
 
1.1.1. Historical overview 
 
Pigs were independently domesticated in Anatolia and the Mekong valley in the 
sixth millennium BCE and pig farming reached Western Europe by the fourth 
millennium BCE [1-3]. Traditionally pigs have been raised in a sty in small holdings 
[4]. This changed during the 19th century with an increased intensity of pig farming 
[4-8]. In the UK, outdoor farming was followed by the development of indoor pig 
farming [4]. Indoor farming increased the efficiency of pig fattening and reduced 
costs, but there were increased rates of diarrhoea [4]. The drive towards increased 
efficiency was in part driven by international competition: for example, by 1960 
approximately 300,000 tonnes of bacon and ham were being imported from 
Denmark [4]. Intensification of pig production has continued leading an increase in 
average herd size in the UK from 70 pigs in 1966 to 600 in 2000 [9]. This is part of a 
global trend especially evident over the last twenty years [5-8]. 
 
1.1.2. World production and trade 
 
The United Nations Food and Agriculture Organization estimates that 1.5 billion 
pigs were slaughtered in 2016 [10]. The largest pig producer is China, followed by 
the EU and the USA [11]. In the EU alone, around 260 million pigs were slaughtered 
in 2016 [12]. In addition to the large volumes produced each year, there is a trend 
towards fewer and larger producers, with the largest five producers responsible for 
30% of pigs slaughtered in the UK in 2015 [13]. These trends are seen in other pig-
producing regions— by 2014, over 80% of herds in the USA contained over 5000 
pigs, while in China the proportion of pig production taking place in backyard farms 
fell from 74% in 2000 to 27% in 2015 [7, 8].  
 
There are several types of pig production. In farrow-to-finish herds, pigs are 
produced from breeding to slaughter. In weaner herds, pigs are bred and kept until 
weaning (at 8 weeks or at 20 kg) and then sold to finisher sites, where pigs are grown 
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to 70 kg before being slaughtered [14-16]. These production systems are used 
worldwide and form the majority farms in the EU, the USA and compose an 
important section of Chinese production [5, 17, 18]. However, there are a number of 
regional differences; for example, many breeding herds in China are run by the state. 
In the EU, the degree of intense production varies—with Italy and Romania having 
far more smaller holdings than countries such as Spain or France [19]. In addition, 
some countries have specialised in a particular aspect of production—for example, in 
2016 Denmark exported 13 million piglets to be fattened elsewhere [5, 17, 20].  
 
In the UK, most pigs are farmed in England, chiefly in Yorkshire and the east of 
England. The size of companies varies between regions: 
 Large companies (defined as having more than 50 farms) predominate in the 
east of England [21].  
 Yorkshire has many more small companies (with fewer than five farms) and 
medium-sized companies (with between five and 50 farms) [21].  
 Other regions, in particular, the South West, have a large number of farms 
per kilometre but these are mostly small farms [22].  
 
Analysis of the UK pig network indicates that most nodes in the network, for 
example, pig farms, markets and slaughterhouses, are not directly connected to each 
other, but have a small number of highly connected nodes; this is consistent with 
analysis of the Danish, Belgian, French, Spanish and Swedish pig industry [19, 23-
26]. These highly connected nodes present key areas of vulnerability through which 
a pathogen could spread rapidly. 
 
1.1.3. Role in UK agricultural economy 
 
Agriculture contributes £8.2 billion to the gross domestic product of the UK and 
accounts for 1.35% of the workforce, employing 466,000 people [27]. The UK pig 
industry encompasses 4.8 million pigs covering over 10,000 hectares of land, and the 
value of pig meat produced in 2016 was £1 billion [27]. 
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1.1.4. Current challenges in pig farming 
 
Currently, there is a severe price pressure on the pig industry in the UK, and the pork 
market is volatile, with long periods where meat prices are very low [28, 29]. 
Between 2012 and 2017 the profit margin varied between a loss per pig of £12 and a 
profit of £23 [29]. For the whole of 2012, 2015 and the first two quarters of 2016 the 
cost of pig production was higher than the value of the slaughtered pig [29]. In 2012, 
this was due to the high price of feed, while in 2015 the value of pig meat fell due to 
oversupply exacerbated by a Russian ban on EU pig meat [30]. 
 
1.1.5. The pig gut microbiota 
 
The gut microbiome is defined as the community of microorganisms that inhabit the 
gut [31]. In the pig gut, the composition of the microbiome varies in response to a 
wide range of factors, including age, breed and antibiotic use [32, 33]. Initially, the 
microbiome is dominated by Bacteroides genus, but after weaning this declines and is 
replaced by Prevotella [34, 35]. Over time there is a decrease in Bacteroidetes and an 
increase in Firmicutes, in particular, Anaerobacter, Streptococcus and Lactobacillus 
[35]. In addition, there are genera present at lower levels that contribute to the health 
of the host. These include butyrate-producing genera such as Roseburia and 
Megasphaera [36]. Butyrate is an important energy source for enterocytes and is 
associated with a healthy gut, while Megasphaera has an extensive metabolic potential 
that includes the production of short chain fatty acids, amino acids and vitamins [37]. 
 
1.1.6. Infectious diseases of pigs 
 
Each quarter, diseases that threaten the UK pig industry are summarised in 
surveillance reports from the Department of Environment, Food and Rural Affairs. 
These include  
 emerging threats, such as African swine fever, a viral infection with a 
mortality rate of 90% [38]. An outbreak of African swine fever originating in 
Georgia has spread as far as the Czech Republic [38].  
 endemic diseases such as porcine reproductive and respiratory syndrome 
(PRRS), which is caused by a viral pathogen and has recently devastated 
herds in China [39]. The endemic population in the UK has a different 
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genotype from that in China, but still remains a serious problem for the pig 
industry [40].  
 septicaemia caused by Klebsiella species, in particular, Klebsiella 
pneumoniae subspecies pneumoniae, and swine dysentery [40]. 
1.2. Swine dysentery  
 
1.2.1. Epidemiology and clinical features 
 
Swine dysentery was first documented in 1921 [41]. The causative agent was 
identified in 1971 as Treponema hyodysenteriae, now classified as Brachyspira 
hyodysenteriae [42-44]. Recently, two novel Brachyspira species have been 
implicated in swine dysentery: B. suanatina and B. hampsonii; however, the majority 
of incidents are caused by B. hyodysenteriae [45, 46]. 
 
B. hyodysenteriae has a global distribution, while the novel species are more local: 
B. suanatina has been isolated in Scandinavia and Germany, while B. hampsonii was 
initially isolated in the USA and Canada, but now appears to now be present in 
Belgium and Germany as well [45, 47-50].  
 
Although swine dysentery is found globally, the incidence is often unknown. In the 
USA, it appears to be increasing, with the number of cases in Iowa rising from three 
in 2005 to 466 in the first nine months of 2010 [51, 52]. Swine dysentery is also a 
problem in South America, with 35.3% of diarrhoeal cases in Brazil attributable to 
swine dysentery [53]. Swine dysentery is also present on large pig holdings in 
Australia and has been detected in commercial pig herds in China [53, 54]. Swine 
dysentery is also found across Europe, although it is not known if the rate is 
increasing. In Poland and in Spain, swine dysentery was responsible for 34.8% and 
38.3% of diarrhoea cases respectively [53]. In the UK, swine dysentery remains a 
persistent problem, although there has been a small reduction in reported cases since 
2015 [40]. 
 
The most significant risk factor for swine dysentery is a previous history of the 
infection on the premises [55]. Introduction of new finisher pigs, or pigs from sale 
yards, also contributes to the risk of swine dysentery [55].  Continuous pig 
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production may be a factor, as the infection cycle is unbroken [56]. Pigs typically 
become infected after ingestion of infected faeces [53], so inadequate 
decontamination (cleaning or disinfection) could trigger an outbreak.   
 
The typical incubation period for swine dysentery is 10 to 14 days [53]. Infected pigs 
have yellow to soft grey faeces and, as diarrhoea develops, faeces become watery 
and contain mucus and blood. On post-mortem, large lesions are evident in the colon 
[53]. Subsequent outbreaks may occur over three to four-week periods due to the 
removal of therapeutic agents. Morbidity of 90% has been reported and, in 
experimental models, mortality can reach 80%, although in clinical cases a mortality 




Brachyspira are anaerobic Gram-negative bacteria belonging to the phylum 
Spirochaetes [58], a diverse taxon, most members of which have long spiral-shaped 
cells. The phylum is also home to Borriela burgdorferi, the causative agent of Lyme 
disease [59]. The genus Brachyspira is composed of both pathogenic and commensal 
species: 
 B. innocens and B. murdochii are considered commensals of pigs, although 
B. murdocchi has infrequently been implicated in disease episodes in pigs 
[60-63].  
 B. intermedia may also be commensal in pigs and causes diarrhoea in 
chickens [62, 64].  
 B. pilosicoli causes porcine intestinal spirochetosis, a milder diarrhoea than 
swine dysentery, in pigs [65].  
 
Species of Brachyspira that produce swine dysentery can be distinguished by their 
high haemolytic activity when grown upon blood agar [45, 49, 53]. B. 
hyodysenteriae is also motile and has a loosely coiled appearance when viewed 
under a microscope [53]. 
 
Although B. hyodysenteriae chiefly colonises the colon of pigs, it has been found in 
other animals. Mallard ducks (Anas platyrhynchos) are asymptomatic carriers and 
have been hypothesised to be a vector species [66, 67]. However, B. hyodysenteriae 
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isolates from mallard ducks were not able to successfully colonise pigs in a 
challenge experiment [66]. In addition, the porcine B. hyodysenteriae reference 
strain B204R was unable to colonise mallard ducks [67]. B. hyodysenteriae can 
potentially colonise other animals typically found on a farm, such as  
 rats and mice—the sequence type ST8 has been recovered from a farm mouse 
[68].  
 chickens—although colonisation is rare, this could represent another animal 
reservoir [69].  
However, B. hyodysenteriae has not been found in other farmed poultry or ruminant 
species. 
 
B. hyodysenteriae can survive in soil for 10 days at 10 °C, so the pathogen could 
perhaps persist in untreated soil before re-infecting a herd. B. hyodysenteriae can 
also survive in pig faeces for 112 days at 10 °C [70]. As production of pigs, 
especially intensive farming, results in large volumes of faeces being flushed into 
large open-storage facilities [71], the resulting lagoons could act as a reservoir for B. 
hyodysenteriae. Pig farmers also produce manure to fertilise their crops, which could 
re-infect pigs [72]. This may explain why isolates of the same sequence type occur 
on the same farm 19 months apart [73].   
 
1.2.3. Pathogenesis  
 
B. hyodysenteriae produces axial flagella, which appear to be important to virulence, 
as mutants unable to produce flagella have an attenuated ability to cause infection 
[74]. The flagella reside within the periplasmic space and are attached to the two 
poles of the cell, which gives Spirochaetes their characteristic spiral shape [75, 76]. 
Like all bacterial flagella, these periplasmic flagella are composed of a filament, a 
hook and a basal-motor complex [77, 78]. However, the motor appears to be larger 
than in the canonical Salmonella system and lacks an L ring [79]. The filament itself 
is composed of a sheaf, FlaA, and at least three core proteins FlaB1, FlaB2 and 
FlaB3 [80]. The flagellar sheaf is a dynamic structure, enabling motility in materials 
of varying viscosity [80]. Flagellar rotation produces helical waves that drive B. 
hyodysenteriae forward in a corkscrew-like motion through linear polymers such as 
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mucin [81]. Chemotaxis enables migrations to the preferred environment, as well as 
to potential sources of energy [74, 82, 83].  
 
B. hyodysenteriae preferentially colonises the mucus above the caecal and colonic 
epithelium [76]. However, it is also able to adhere to the epithelium and invade 
goblet cells [76, 84]. To obtain nutrients, B. hyodysenteriae produces proteolysins 
and haemolysins that cause damage to the epithelium, resulting in the lesions seen in 
swine dysentery [85, 86]. 
 
The composition of mucus in the colon is altered during B. hyodysenteriae infection. 
The mucus in the colon is largely composed of mucins, in particular, mucin 2, which 
forms a gel-like matrix near the epithelium [87]. Mucins may represent an important 
metabolic source of sulfur, and it has been observed that there is a reduction of 
sulfated mucins during swine dysentery [88]. However, B. hyodysenteriae does not 
possess a sulfatase gene and may rely on other bacteria to degrade the mucin [88]. 
This could explain why other bacteria are important for colonisation by B. 
hyodysenteriae [89].  
 
After B. hyodysenteriae colonisation of the colon, there is an increase in mucin 2 and 
de novo production of mucin 5AC [87, 88]. Mucin 5AC may aid in the clearance of 
pathogens. However, the increase in mucin 2 provides more binding sites for B. 
hyodysenteriae, resulting in increased binding of the bacterium to mucin [87, 90, 91]. 
As well as increased production of mucin 2, there is a reduction in mucin 4, a mucin 
important in renewing the epithelium [88]. Degradation of mucin 4 could exacerbate 
the damage caused by haemolysins, enabling migration of luminal bacteria into the 
epithelium and resulting in a severe inflammatory response. The lipooligosaccharide 
(LOS) of B. hyodysenteriae and other bacteria will also contribute to the 
inflammation [92].   
 
It is likely that B. hyodysenteriae is more diverse than previously thought, with some 
strains pathogenic, while other weakly haemolytic strains are asymptomatic. This 
could be an evolving phenotype, or it may be that the techniques used to detect B. 
hyodysenteriae are becoming more sophisticated, and therefore B. hyodysenteriae is 
being detected more often. Crucially, there have been recent reports of B. 
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hyodysenteriae in healthy pigs that do not exhibit any signs of swine dysentery [93-
96]. Bacterial isolates from these cases often carry single nucleotide polymorphisms 
(SNPs) in haemolysin genes, chiefly tylA, haemolysin III and hylA. It has been 
suggested that the associated amino-acid substitutions have inactivated the 
haemolysins, although this has not been proven [95]. SNPs have also been detected 
in the promoter region of some weakly haemolytic isolates [95].  
 
The emergence of weakly haemolytic B. hyodysenteriae presents a problem for 
farmers, as it is not easy to distinguish between pathogenic and commensal forms of 
B. hyodysenteriae. If action is delayed until one can establish the virulence of the 
strain, an outbreak could have already occurred. Also, there could be implications for 
a farmer’s reputation if it is established that a farmer sold pigs colonised with B. 
hyodysenteriae to customers. In a recent case, some farmers decided to stop selling 
live pigs when B. hyodysenteriae was found in their herd [95]. 
 
1.2.4. Immune response 
 
Infection by B. hyodysenteriae results in the activation of T helper cell types 1 and 2 
[97]. Increased levels of IL-17A mRNA have been detected in the colonic epithelium 
[98, 99]. This cytokine results in the production of mucin 5AC in airways and is 
likely to do so in the colon [100]. There is an increase in IL-1B, TNF-α and IL-6. 
Secretion of cytokines such as IL-1B results in the recruitment of neutrophils to the 
site of infection [101] leading to phagocytosis of B. hyodysenteriae and production 
of neutrophil elastase [99]. Neutrophil elastase can result in degradation of bacterial 
virulence factors, direct killing of pathogens and modulation of the inflammatory 
response [102]. Colonisation with B. hyodysenteriae triggers an IgG response to the 





Definitive diagnosis of swine dysentery requires culturing of B. hyodysenteriae from 
clinical samples through serial passage on blood agar under anaerobic conditions 
[53]. Adding antibiotics to the agar enables selection, typically 400 μg/ml of 
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spectinomycin, 25 μg/ml of vancomycin and 25 μg/ml of colistin [53, 103]. Pure 
cultures display a zone of strong haemolysis with a film of growth [53]. Biochemical 
tests are typically used in diagnosis to speciate isolates of Brachyspira. Culture and 
biochemical tests (Table 1.2.5.1) has enabled accurate identification of Brachyspira 
species and detection of novel Brachyspira species [45, 66]. However, purification 
of Brachyspira species is time-consuming and biochemical tests may miss unusual 
isolates, for example, indole-negative B. hyodysenteriae isolates [104]. 
 
Enzyme-linked immunosorbent assays (ELISAs) have been proposed, but none are 
used routinely [53, 94], as some react only with a subset of serotypes, while others 
may not even be specific to a Brachyspira species [105, 106].  
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Table 1.2.5.1: Biochemical tests used to speciate Brachyspira. 
Abbreviations:  
S: Strong, W: Weak, Ind: Indole production, Hip: Hippurate production, ∝-gal: ∝-
galactosidase activity, ∝-gluc: ∝-glucosidase activity, β-gluc: β-glucosidase activity, 
nk: not known. Based on a table by Fellstrom et al, 1995 [107]. 
 
  







S + - - +/- + [107, 
108] 
B. intermedia W + - - + + [107, 
108] 
B. murdochii W - - - - + [107, 
108] 
B. innocens W - - + +/- + [107, 
108] 
B. pilosicoli W - + +/- - - [107, 
108] 
B. hampsonii S - - - - +/- [45] 
B. suanatina S + - - nk nk [66] 
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Table 1.2.5.2: Suggested MIC breakpoints for B. hyodysenteriae.  
Note there are two common MICs for tiamulin * denotes the breakpoint for VetMic 
Brachy plates and the other MIC is for agar dilution.  
 
Antibiotic 
Wild type  
MIC (µg/ml) 







Valnemulin >0.125 [109] na  
Doxycycline <0.5 [109] >4 [111] 
Tylvalosin <1 [109] >16 [110] 
Lincomycin < 1 [109] >16 [110] 




A real-time PCR can distinguish between B. hyodysenteriae, Lawsonia 
intracellularis and B. pilosicoli, while a duplex PCR can distinguish between B. 
hyodysenteriae and B. pilosicoli [112, 113]. Commonly, B. hyodysenteriae is 
identified by sequence analysis of the NADH gene, while other species are identified 
by sequencing of the 16S gene [112, 113]. Although PCR offers a rapid method of 
identification, performance with faecal samples can be problematic, and there is no 
gold standard diagnostic PCR for identification of B. hyodysenteriae [112, 113]. 
 
For B. hyodysenteriae, minimum inhibitory concentration (MIC) testing is done by 
agar dilution or via a commercial broth dilution test, the VetMIC Brachy (SVE, 
Sweden) [114, 115],  which works for six antibiotics: tiamulin, valnemulin, 
doxycycline, tylosin, lincomycin and tylvalosin [114]. There are no universally 
acknowledged clinical resistance breakpoints for B. hyodysenteriae, but a number 
have been suggested (Table 1.2.5.2). In addition, wild-type cut off values have also 
been suggested for B. hyodysenteriae; this enables differentiation between sensitive 
isolates and isolates that are developing tolerance towards antibiotics (Table 1.2.5.2) 
[109]. Isolates below the wild-type breakpoint are classed as susceptible, isolates 
above wild-type and below the clinical resistance breakpoint are classed as 
intermediate, and all isolates with MICs above the clinical resistance breakpoint are 
classed as clinical resistant [109, 110].  
 
MICs provide important epidemiological information and may influence the 
treatment regime. However, MIC testing is slow, and MICs can vary quite 
considerably; in a ring trial for the VetMIC Brachy plates, the manufacturer’s 
recommended quality control strain (B78) varied between three concentrations [116]. 
For agar dilution methods in-house methods make comparison between labs 
difficult, and if MICs are one dilution higher with agar dilution, this could affect the 
treatment given [115]. 
 
Although multiple-locus variable-number-tandem-repeat analysis (MLVA) and 
multilocus enzyme electrophoresis (MLEE) have been used to type isolates of B. 
hyodysenteriae [117, 118], MLST on seven housekeeping genes is the most widely 
used epidemiological typing technique[119], which has shed light on the distribution 
of B. hyodysenteriae strains [120]. MLST has been used to investigate the population 
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structure of B. hyodysenteriae in Australia, Belgium, Germany, Italy, Spain and the 
USA [52, 60, 73, 93-95, 121-125].  
 
Most B. hyodysenteriae STs show a local distribution, restricted to a single country. 
However, there are a few STs that have been found in multiple countries, notably ST 
8 and 52, which are present in several European countries. No STs have a global 
distribution. Although an ST 52 isolate has been identified in Japan, B. 
hyodysenteriae is only infrequently transferred between continents [73].  Weakly 
haemolytic B. hyodysenteriae isolates belong to different STs to strongly haemolytic 
isolates [93, 94]. 
 
1.2.6. Infection control 
 
Carrier pigs represent the most likely source of infection and persistence of B. 
hyodysenteriae on a farm. B. hyodysenteriae is typically transported into finisher 
farms by asymptomatic weaner pigs [118]. However, in farrow-to-finisher farms, 
sows who have survived the disease act as reservoirs [126]. Visitors or trucks from 
B. hyodysenteriae-positive farms can introduce it into a new herd [120, 127], as B. 
hyodysenteriae can be cultured from trucks even after decontamination [128]. It is 
also possible that B. hyodysenteriae could be introduced to farms by unidentified 
animal vectors. 
 
A number of safeguards to prevent B. hyodysenteriae infections have been 
suggested. In all-in-all-out production (AIAO) systems, batches of pigs are grown in 
a succession of pens, with pigs of the same age being kept together [15, 129]. In 
between batches of pigs, occupied pens are left empty for a period of time before 
cleaning and disinfection [129]. Additionally, in multi-site farms, pigs at different 
stages of the production cycle are kept on separate sites [5]. This helps to break the 
infection cycle. 
 
After swine dysentery has been verified, the herd will be treated with antibiotics, 
reduced in size, and in some cases, completely depopulated [53].  The site will be 
thoroughly decontaminated and outside areas used for pig production not be used for 
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several months. After successful decontamination, new pigs will be sourced from 
swine dysentery-free stock [53].  
 
Unfortunately, efforts to develop a vaccine to prevent swine dysentery in pigs have 




In the EU, tylvalosin and the pleuromutilin antibiotics, tiamulin and valnemulin, are 
used for treatment of swine dysentery as well as for prophylaxis and metaphylaxis 
[131-133]. Most commonly tiamulin and valnemulin are used, and the treatment 
lengths are shown in table 1.2.7.  
 
Table 1.2.7: Dosage and treatment length of tiamulin and valnemulin.  
Modified from a table by Zimmermann et al, 2012 [53]. Valnemulin is not 








10 mg/kg body 
weight 
1 to 3 days 
8 mg/kg body 
weight 
5 to 7 days 
100 ppm for 7 to 10 days 
followed by 30 to 40 ppm for 
2 to 4 weeks 
Valnemulin na na  
10 mg/kg body weight 
1 to 4 weeks 
 
1.3. The Challenge of antimicrobial resistance 
 
Overuse of antibiotics has led to the development of antimicrobial resistance, which 
has meant that important antibiotics are becoming less effective. To compound the 
problem, there are few new antibiotics available to replace them, given that no 
significant new classes of antibiotics have hit the market since the late 1980s, [135]. 
Antimicrobial resistance (AMR) has been reviewed extensively, and mechanisms of 
AMR are summarised in table 1.3. [136, 137]. Briefly, resistance can be  
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 intrinsic, resulting from existing genes in the chromosome; for example, 
Pseudomonas  aeruginosa contains an efflux pump, MexAB-OprM, that 
makes its outer membrane only weakly permeable to β-lactams [138].  
 acquired, through SNPs in genes associated with antimicrobial resistance or 
via AMR genes obtained by horizontal gene transfer.  
 
AMR genes can be found on plasmids; for example, the pNDM-CIT plasmid carries 
the metallo β-lactamase gene NDM-1 [139]. In addition, this plasmid carries a gene 
encoding a multi-drug efflux pump [139]. AMR genes can be transferred between 
cells by transposons and temperate bacteriophages: for example, in Streptococcus 
agalactiae, the lincomycin resistance gene lnuC is transferred between strains by the 
transposon MTnSag1 [140], while bacteriophages have been implicated in the 
transfer of bla-CTXM genes to sensitive strains of Escherichia coli [141]. 
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Table 1.3: Mechanisms of antibiotic resistance 
LPS refers to Lipopolysaccharide. 
 
Mechanisms Example Reference 
Alteration of  
target pathway 




by Van genes 
[142] 
Degradation of  
antibiotic 
NDM-1 is a plasmid-born 
β-lactamase that degrades 
cephalosporins 
[143] 
Efflux pumps pump  
antibiotics out of the cell 
The RND/MDR efflux 
pump on the pNDM-CIT 
plasmid enables efflux of 
multiple antibiotics from 
the cell. 
[139] 
Alteration of the targets site 
SNP in the 23S rRNA at 
position 2058 (Escherichia 
coli numbering) results in 
resistance to lincomycin 
and tylosin in B. 
hyodysenteriae. 
[144] 
Reduced Uptake  
Modification of Lipid A of 
LPS results in an alteration 
of the charge across the 
cell membrane reducing 






1.3.1. Antimicrobial use and resistance in human medicine 
 
The WHO has released a list of critically important bacteria that should be priority 
targets for the development of new drugs, while the Public Health Agency Canada 
and the Centers for Disease Control and Prevention have published lists of AMR 
pathogens that are a severe threat to human health [146-148]. It is likely that the 
number of multi-drug resistant pathogens important to human health will increase. 
Indeed, it has been estimated that by 2050, the number of deaths attributable to AMR 
infections will be higher than those attributable to cancer [149]. As the supply of 
new antibiotics is limited, it is essential that currently available antibiotics are well 
stewarded and used only when needed. This focus on stewardship has also become a 
key aspect of government policy towards antibiotic resistance [150, 151]. 
 
1.3.2. Antimicrobial use and resistance in veterinary and agricultural practice 
 
Antibiotics have been used in agriculture for most of the last century. Over this time, 
they have been used to treat bacterial infections, in prophylaxis or in metaphylaxis. 
Antibiotics have been used in subclinical concentrations as growth enhancers since 
the 1940’s [152]. Antibiotic usage in agriculture is changing rapidly due to new 
legislation; such as the 2006 EU ban on antibiotics as growth enhancers and new 
restrictions on antibiotic use in agriculture in the UK [153]. There are also changes 
in industrial practices, such as the establishment of the Targets Task Force to aid in 
reducing antibiotic use in agriculture by the Responsible Use of Medicines in 
Agriculture (RUMA) [154, 155]. 
 
The scale of antibiotics usage in animal health globally is unknown, but it has been 
estimated that the volume of antibiotics used is greater in animal medicine than 
human medicine [156]. In the USA, it has been estimated that 70% more antibiotics 
are sold for animal use than for human medicine [156]. In the UK in 2013, 532 
tonnes of antibiotics were prescribed for human use, and 419 tonnes were sold for 
animal use [157]. RUMA have suggested that the pig industry is associated with the 
highest usage of antibiotics, accounting for 192 tonnes of antibiotics in 2015 [155]. 
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1.3.3. Antimicrobial resistance in B. hyodysenteriae 
 
Resistance to pleuromutilins is most likely to occur by chromosomal SNPs followed 
by clonal expansion of the resistant strain and dissemination by carrier pigs and other 
vectors. Pleuromutilin resistance is thought to develop in a stepwise manner, via a 
series of SNPs in AMR genes [158]. SNPs potentially involved in resistance to 
pleuromutilins have so far only been found in domain V of the 23S ribosomal 
subunit and the L3 50S ribosomal subunit protein [159, 160]. Domain V of the 23S 
ribosomal subunit is the target site of pleuromutilins; a conformational change here 
could prevent binding of the antibiotic. The L3 50S ribosomal subunit protein 
restricts the conformational freedom of domain V of the 23S ribosomal subunit 
[161]. Mutations in the L3 protein result in resistance to tiamulin, but SNPs in the 
23S rRNA are needed for reduced susceptibility to valnemulin [161, 162].  
 
Pringle et al selected for resistance in sensitive isolates in 2004 by repeated 
subculture in sublethal concentration of tiamulin; other studies have identified SNPs 
in clinical isolates of B. hyodysenteriae from Germany, Spain, Italy, Belgium and 
Taiwan (table 1.3.3) [73, 159, 160, 163-166]. Some  candidate SNPs may be 
phenotypically neutral or associated with resistance to other antibiotics, e.g. 
lincomycin, and therefore might have no impact on pleuromutilin sensitivity [144]. 
However, some SNPs appear clearly to be responsible for pleuromutilin resistance. 
For example, a SNP at position 2032 in the 23S rRNA (E. coli numbering) has been 
consistently found only in resistant isolates [159, 164, 167]. There are instances of 
phenotypic resistance not associated with known AMR SNPs in the 23S rRNA and 
the L3 protein; it is possible this could be due to SNPs in as yet unidentified genes in 
B. hyodysenteriae [159]. 
 
Horizontal gene transfer is an important mechanism of disseminating antimicrobial 
resistance within bacteria [168]. However, there are few known mechanisms of 
horizontal gene transfer in B. hyodysenteriae and no evidence that the B. 
hyodysenteriae plasmid is conjugative. The best-studied example in this species is 
the gene transfer agent VSH1 [169, 170]. Gene transfer agents are non-lytic phages 
that have lost the ability to self-replicate but remain able to package and transport 
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DNA for their host bacteria [171]. VHS1 has been shown experimentally to transfer 
coumermycin A(1) resistance, but this has not been implicated in the development of 
AMR in clinical isolates [172].  
 
Recently the transposon MTnSag1 has been identified in an Italian B. hyodysenteriae 
isolate that contains the lincomycin resistance gene lnu(C) [165].  This transposon 
has previously been identified in a B. pilosicoli isolate in Australia and was first 
identified in the S. agalactiae isolate UCN36 [140, 165]. This is an IS-1-like 
transposon that lacks transfer genes and requires the presence of a co-resident 
conjugative element for mobilisation. In S. agalactiae this function is performed by 
Tn916 transposon [173]. This transposase is not present in B. hyodysenteriae, and 





Table 1.3.3: Potential pleuromutilin-resistance SNPs 
SNPs in the 23S rRNA are E. coli (Genbank accession J01695) numbering and SNPs 
in the L3 protein are in B. pilosicoli numbering (Genbank accession AF114845). 
Many SNPs have been identified in pleuromutilin-resistant and pleuromutilin-
sensitive isolates.   
 
Gene 
Present in  
Resistant Isolate 
Present in  
Sensitive Isolate 
A2031T (23S rRNA) ✓[160], ✓[166]   
G2032A (23S rRNA) 
✓[159] , ✓[160], ✓[164], 
✓[166]   
C2055A (23S rRNA) ✓[159]    
G2057A (23S rRNA) ✓[160], ✓[166]    
A2058T (23S rRNA) ✓[160] , ✓[164], ✓[166]  ✓[160] , ✓[164], ✓[166]  
A2058G (23S rRNA) ✓[164]    
A2059G (23S rRNA) ✓[160]    
G2087T (23S rRNA) ✓[160]  ✓[160]  
G2116A (23s rRNA) ✓[164]    
C2146T (23S rRNA) 
✓[160] , ✓[165] 
✓[160]  
G2201C (23S rRNA)   ✓[160], ✓[164]  
G2201T (23S rRNA) ✓[164]    
C2362T (23S rRNA) ✓[160]  ✓[160]  
G2365C (23S rRNA) ✓[160]  ✓[160]  
G2447T (23S rRNA) ✓[159]    
C2449A (23S rRNA) ✓[159]    
T2402C (23S rRNA) ✓[164]    
T2504G (23S rRNA) ✓[159]    
T2528C (23S rRNA) ✓[164]  ✓[164]  
G2535A (23S rRNA) ✓[160] , ✓[164]  ✓[160] , ✓[163] , ✓[164]  
A2572T (23S rRNA) ✓[159]    
C2611T (23S rRNA) ✓[160]    
N148S (L3 protein) 
✓[159] , ✓[160] , ✓[163], 
✓[73], ✓[166]  ✓[160]  
S149I (L3 protein) ✓[159]    
S149T (L3 protein) ✓[159], ✓[160], ✓[166]     
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1.4. New opportunities: whole-genome sequencing 
 
1.4.1. Sequencing technologies 
 
The British scientist Fred Sanger invented the first widely used sequencing approach, 
which exploits chain termination with a known labelled nucleotide base followed by 
gel electrophoresis [174].  Subsequent refinements such as capillary gel 
electrophoresis, shotgun sequencing and use of computers greatly increased the 
utility of sequencing allowing much higher throughput [175, 176]. This led to the 
first whole genome sequencing of a bacterium, Haemophilus influenzae in 1995, and 
the first human genome sequence in 2003 [177, 178].  
 
Early genome projects were time-consuming and expensive; for example, it cost 
$878,450 to sequence the H. influenzae genome [177], far beyond what the average 
lab can afford. In 2004, the National Institutes of Health in the USA launched a $70 
million funding program to develop technologies to sequence human genome for 
$1000, and other funding bodies followed suit [179]. The resulting second-
generation sequencing machines use a variety of techniques. For example, Illumina 
has developed a sequence by synthesis method whereby each of the four nucleotides 
has a different fluorophore attached at the three prime end. After each nucleotide is 
added fluorescence is detected, and the fluorophore is removed. This enables 
identification of the incorporated base. To increase the speed of sequencing the 
genome is cut into multiple small sections, with a maximum size of 700 base pairs, 
and sequenced in parallel [180, 181]. The result of these advancements is the rapid 
sequencing of a whole genome. Many of the more recent sequencing machines, 
including the Illumina MiSeq, are small enough to fit on a laboratory bench, making 
them easy to incorporate into existing laboratories. Recently, there have been new 
developments in the WGS field with the development of two quick long read 
sequencers: the PacBio and the Nanopore [181, 182]. Long read sequencers can 
sequence much longer read lengths than short read sequencers. For example, the 
PacBio can produce sequences of up to 10,000 bases long compared to 700 for the 
MiSeq increasing the simplicity of re-assembling the genome after sequencing and 
downstream analysis [181].These are the first third-generation sequencing machines 
produced, and it is likely that more advanced sequencing machines will be produced 
 22 
in the future. However, the majority of sequencing projects are currently still done 
using second generation sequencing platforms such as the MiSeq due to cost 
implications. 
 
With the development of second-generation sequencing machines, the cost of 
sequencing a genome has decreased substantially. The National Human Genome 
Research Institute has estimated that the cost of sequencing the human genome 
currently stands at $1,121 [183]. It is much cheaper to sequence bacteria due to a 
smaller genome. Furthermore, the speed of sequencing has increased dramatically, 
and it is now possible to sequence the genome of multiple strains of H. influenzae in 
a few days as opposed to the three months it took in 1996 [177]. 
 
1.4.2. Bacterial genome biology, evolution and epidemiology 
 
The reduced cost and speed of second-generation sequencing machines make them 
ideal for the analysis of bacterial species diversity. Typically, this is done by 
comparing SNPs in the core genome, which represents the genes shared by all 
isolates of interest [184, 185]. From this comparison, the relationship between strains 
can be established. In addition, by sequencing the whole genome novel virulence 
factors may be identified.  
 
WGS analysis has been used in the analysis of both bacterial and viral pathogens. 
For example, it identified a 30 amino acid deletion in the non-structural protein 2 in a 
PPRS viral strain responsible for an epidemic in China in 2006 [39]. This protein 
inhibits the innate immune system by blocking activation of NF-κB; a mutation here 
may have increased the virulence of the epidemic strain [186]. WGS has also been 
used to identify the spread of colistin resistance in pigs and humans, to explore the 
relationship between Mycobacterium bovis in five cattle farms and local badgers and 
to distinguish between isolates of livestock-associated methicillin-resistant 
Staphylococcus aureus that had identical STs [168, 187-189]. 
 
A small number of projects have specifically sequenced the genome of B. 
hyodysenteriae [85, 165, 190]. An Australian strain, WA1, was completely 
sequenced using a combination of 454 sequencing and Sanger sequencing [85]. This 
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was the first strain sequenced and increased the understanding of B. hyodysenteriae.  
For example, B. hyodysenteriae has a higher number of genes involved in amino acid 
transport compared to other sequenced Brachyspira species [85]. This may reflect 
adaption to the protein-rich environment of the pig gut. In addition, a 36 kb plasmid 
was also found, containing genes involved in LOS biosynthesis [85]. The importance 
of the plasmid to B. hyodysenteriae is unknown. Initially, it was suggested that this 
plasmid could play a role in virulence, but this plasmid has subsequently been 
identified in non-virulent strains [95, 191]. No other transposon-like elements were 
identified, nor were any pathogenicity islands identified [85]. Subsequent sequencing 
of an Italian clinical isolate revealed a lincomycin resistance gene lnu(C) on a 
transposon [165].  However, the mechanism of transmission is currently unknown, 
and it is likely that horizontal gene transfer only occurs infrequently in B. 
hyodysenteriae.  
 
Draft genome sequences of multiple strains of B. hyodysenteriae isolates have also 
been analysed. Analysis of genomes from across the world identified potentially 
useful vaccine targets and differences between haemolytic and weakly haemolytic B. 
hyodysenteriae isolates [93, 95, 192].  
 
Another study used core genome SNP analysis to investigate the relationship 
between different species of Brachyspira. This was done to investigate the 
relationship between B. suanatina and other Brachyspira species [46]. B. suanatina 
was compared to closely related species including B. hyodysenteriae, and it was 
determined that it was distinct from these species and is most likely a distinct 
species. The genome sizes were also compared, and it was found that B. 
hyodysenteriae had the smallest genome [46]. This could potentially mean that B. 
hyodysenteriae is adapting to the pig gut through reductive evolution through the 






As sequencing has become steadily cheaper over time, it has become economically 
feasible to sequence DNA directly from a sample. The analysis of genetic material 
directly from samples is referred to as metagenomic analysis, a term first used in 
1998 [194]. Initially, this was conducted by analysing the 16S ribosomal gene. The 
16S rRNA subunit provided a molecular barcode allowing rapid identification of the 
species in a metagenomic sample and was first proposed as a typing mechanism by 
Carl Woese [195].  
 
By sequencing total DNA additional genomic information is available, for example, 
AMR gene presence, as well as species presence. This approach is often referred to 
as shotgun metagenomics to distinguish it from the 16S analysis, and it is a rapidly 
developing field driven by improvements in technology. A historical perspective as 
well as more recent developments are summarised below (figure 1.4.3). 
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Figure 1.4.3: Timeline of Metagenomics.  
Edited from Escobar-Zepeda et al 2015 [196]. Squares signify themes in the 
timeline. Red: technological development, purple: theoretical development, Green: 
key publications (in relation to metagenomics in pigs) and orange relates to 
metagenomic studies that involved clinical samples.         
 
16/05/2018 Venngage | Editor
https://infograph.venngage.com/edit/f328571c-859c-4a6b-88c5-9e2ada7c95b5 1/2
Leeuwenhoeck first sees the 
microbiota of a tooth [197]
R. Koch isolates and grows bacteria 
using solid media [198]
1684
1882
C. Woese propose 16S rRNA as a 
taxonomic marker [195]
1977
Sanger et al. develop DNA sequencing 
[174] 1977
K. Mullis developes PCR  [199]1985
First 16S PCR analysis, to investigate 




Handelsman J. et al propose term 
metagenomics [194]
First shotgun metagenomic analysis, 
investigating the Saragossa sea [207] 2004
2005 Release of the Roche 454, the first next 
generation sequencing machine
2007
Human microbiome project released 
[200]
Reference catalogue of the human 
microbiome published [201]
2010
Assembly of outbreak O104:H4 E. coli 
direct from clinical sample [209] 2013
Sequencing Mycobacterium 
tuberculosis and M. africanum direct 
from sputum  [202]
2014
Reference catalogue of the pig 
microbiome published [33] 2016
Ebola genomes sequenced in real-time 
during outbreak [210]2014
Identification of multidrug-resistant 
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filters [203]






















1.4.3.1. Applications in microbial ecology 
  
16S analysis allowed rapid quantification of total species composition in an 
environment of interest. In 1990 and 1991 Giovannonni and Schmidt respectively 
demonstrated the potential of metagenomics to thoroughly interrogate the microbial 
ecology of the Saragossa Sea and the Pacific Ocean [205, 206]. Shotgun 
metagenomic analysis has also been used to investigate microbial ecology with the 
first published analysis occurring in 2004 investigating the Saragossa Sea where a 
number of new species were identified. Additionally, it was also possible to identify 
rhodopsin-like genes, which are important in photosynthesis [207]. 
 
1.4.3.2. Applications in pathogen discovery and detection 
 
16S analysis was initially used to identify pathogens. In the first instance, this was 
done to identify Campylobacter species on chicken products [208]. More recently 
shotgun metagenomics has become more widely used to investigate pathogens. For 
example, it was used to identify and re-assemble the genome of the E. coli O104:H4 
strain responsible for an outbreak of food poisoning in Germany in 2011 [209]. 
Shotgun metagenomics has also been used to track outbreaks. Recently it was used 
to sequence multiple Ebola and Zika genomes during the 2014 Ebola epidemic and 
helped identify cases of co-infection of Zika and Chikungunya during the 2015 Zika 
outbreaks [210, 211]. As well as uses for outbreak analysis, metagenomics has the 
potential to elucidate changes in the microbiome. Shotgun metagenomics has been 
used to investigate the colonisation of bacterial species after a faecal transplant and 
has identified AMR gene carriage in a children’s ward at Cincinnati Children’s 
Hospital Medical Center [212, 213]. 
 
With regard to B. hyodysenteriae infections, there has been little metagenomic 
analysis into the interaction of the microbiome with B. hyodysenteriae. This is 
despite the importance of the microbiota potentially in B. hyodysenteriae infection 
[89]. Terminal restriction fragment length polymorphism analysis established that 
during infection there is disruption of the normal microbiota when pigs are 
challenged with B. hyodysenteriae [214]. A 16S rRNA analysis of the lumen and 
epithelium of pigs challenged with B. hyodysenteriae identified species that are 
enriched compared to control pigs. Linear discriminatory analysis (LDA) identified a 
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number of genera associated with swine dysentery including Brachyspira, 
Campylobacter, Mogibacterium, and Desulfovibrio. Lactobacillus and 
Bifidobacterium genera were associated with healthy pigs, Desulfovibrio species are 
able to bind and degrade sulfated mucin possibly providing an energy source for B. 
hyodysenteriae [215]. Bifidobacterium and Lactobacilli are associated with a healthy 
microbiome and have been suggested as potential probiotics [216]. It is possible that 
B. hyodysenteriae disrupts the microbiota reducing the gut health and leading to an 
environment favourable for colonisation by other pathogenic bacteria. 




Feed given to pigs can also help reduce B. hyodysenteriae infections. A number of 
different additives have been investigated for their ability to protect against B. 
hyodysenteriae infection in pigs (table 1.5.1). Inulin has been shown to protect 
against B. hyodysenteriae infection in multiple trials. It has been hypothesised that 
this protective effect is due to changes in the gut microbiota. Inulin has been 
associated with an increase in the probiotic species Bifidobacterium and 





Table 1.5.1: Summary of additives added to pig diets.  
Pigs were fed the additive and then challenged with B. hyodysenteriae. Abbreviation: 
DDGS refers to Distillers Dried Grains with Solubles.  
 
Additive Effect Conclusion Citation 
Cooked Rice 
No pigs developed  
swine dysentery 
Low levels of non-starch polysaccharide 




All pigs fed  
this diet  
developed swine dysentery 
Highly fermentable  
carbohydrates  
associated with swine dysentery [219] 
Parboiled  
Rice  
90% of pigs still developed 
swine dysentery 
Low levels of  




No significant difference  
between diets 
Low levels  




Lower rate of swine 
dysentery when fed liquid 
feed 
Changes were not due to low levels of 
NSP; it may be due to changes in the 
microbiota. [222] 
Dried Chicory  
Root 
Pigs fed chicory did not 
develop swine dysentery 
Chicory seeds contain inulin which may 
be protective. [223] 
Inulin  
17/20 pigs fed inulin diet 
did not  
develop swine dysentery 
Inulin provides protection  
against swine dysentery [224] 
Inulin  
8/15 pigs were protected 
from swine dysentery 
when fed 80 g/kg 
Inulin needs to be at high concentrations 
(80 g/kg) to be protective. [225] 
DDGS 
Faster onset of swine 
dysentery  
 
Insoluble dietary fibre  






There are a number of probiotic bacteria preparations that could be useful for the 
prevention of B. hyodysenteriae infection. A combination of L. rhamnosus and L. 
farciminis were effective against B. hyodysenteriae in vivo [227].  
 
1.5.3. Phage therapy 
  
Phage have been found to lyse critically important pathogens and have been shown 
to be effective in animal trials against multidrug-resistant pathogens such as P. 
aeruginosa [228-230]. There has also been considerable commercial and 
governmental interest in phage therapy. The first clinical phase one trial of a phage 
therapy occurred in 2009 to treat chronic venous leg ulcers and the EU have 
provided € 3,838,422 to investigate the potential of phage therapy in the treatment of 
burn patients [231, 232].  
 
Due to the strict legal and regulatory processes that need to be completed before a 
product can be sold for human treatment, the sector where phage therapy is likely to 
become more used is in agriculture. There are a small number of treatments that are 
commercially available. This includes AgriPhageTM used to prevent tomato spot 
and speck (Omnilytics, USA). While Listex P100 has been classified by the US Food 
and Drug Administration as “generally recognised as safe” and is used to treat 
animal products before market [233]. Although there is currently no published 
research for phage as a treatment for B. hyodysenteriae infections it has been used to 
deal with a number of other important pathogens that colonise pigs, for example, 
removal of pathogenic Salmonella during slaughter and prevention of diarrhoea in 
pigs [234, 235]. 
 
1.6. Aims and Objectives of this Study 
 
There is a growing body of literature on pleuromutilin resistance within B. 
hyodysenteriae in the UK. However, little is known about the population structure 
within the UK or the mechanisms of pleuromutilin resistance in isolates from the 
UK. Moreover, there has been little WGS based phylogenetic studies conducted on 
 30 
B. hyodysenteriae, and it is unknown whether resistant strains are becoming 
dominant in the UK. In this study we hypothesis 
 
The aim of this study was to characterise the population of B. hyodysenteriae in the 
UK. The objectives of this study were to identify the phylogenetic relationship of 
clinical isolates of B. hyodysenteriae in the UK (chapter 3) and identify resistance 
mechanisms that may have caused pleuromutilin resistance (chapter 4). In addition, 
shotgun metagenomics was used to directly sequence B. hyodysenteriae from faeces 
and investigate the changes in the microbiota associated with swine dysentery 
(chapter 5).  
 
 Establish the population structure of B. hyodysenteriae within the UK 
 Identify genetic determinants associated with pleuromutilin resistance 
 Sequence B. hyodysenteriae directly from faeces 
 Investigate changes in the microbiome in swine dysentery 
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Samples were provided by the Animal and Plant Health Agency (APHA). 
Brachyspira hyodysenteriae isolates were collected from the APHA Bacteriology 
Culture Collection held Bury St Edmunds regional laboratory and stored at -80 C 
until use. Historic faecal samples were sent from the APHA Penrith regional 
laboratory and stored at -20 C until use. Faecal isolates received over the course of 
the study were sent from the APHA Bury St Edmunds regional laboratory and stored 
at -80 C until use. Pig caecal samples collected from healthy pigs at abattoirs as part 
of a separate APHA project (VM0518) were stored at -80 C. All of the samples 
were stored at APHA Weybridge. 
2.2 Media 
 
Media was prepared according to manufacturer’s instructions and sterilised by 
autoclaving at 121 C for 15 minutes at 15 psi (Table 2.3). 
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Table 2.2 Media used in this study  
Media Atmosphere Antibiotics Notes 
Fastidious 
Anaerobic 
Agar + 5% 
Sheep Blood 





Used to store 
B. hyodysenteriae at -80 ℃ 
Brain Heart 
Infusion 
Broth + 10% 
Horse Serum 











Used at Bury Regional Lab to 
isolate B. hyodysenteriae. 
Ref: [236] 
 
2.2.1 Bacterial Media 
 
Fastidious Anaerobic Agar plates, supplemented with 5% horse blood (FABA) made 
at the APHA media department, were used to culture B. hyodysenteriae isolates 
routinely. Brain Heart Infusion (BHI) supplemented with 10% horse serum (v/v) 
(EO Labs) was used for liquid cultures of B. hyodysenteriae. 
 
2.2.2 Bacterial Growth Conditions 
 
B. hyodysenteriae was grown in an anaerobic cabinet (Don Whitley, Shipley, UK) on 
FABA plates for 3 to 5 days at 37 °C. The gas mix was 10% hydrogen, 10% carbon 
dioxide and 80% nitrogen. For broth cultures, B. hyodysenteriae was grown in pre-
reduced BHI with 10% horse serum in an anaerobic cabinet at 37 °C overnight on a 
mini orbital-shaking platform (Stuart, Staffordshire, UK) at 80 rpm.  
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Isolates were subcultured from the initial culture a minimum of two times before being 
used. At this point plates were sub-cultured for 4 days and were used to make either a 
cell pellet, a frozen stock or a broth culture.  
 
The overnight culture was used to perform MIC tests (Chapter 4, section 4.2.3). 
Contaminated B. hyodysenteriae samples were purified by repeat subculturing on 
FABA plates. If this was not sufficient, isolates were purified by repeat subculturing 
from additional frozen stocks on Brachyspira Selective Media, made in-house (Table 
2.3), under anaerobic conditions at 37 °C at the APHA Bury St Edmunds regional 
laboratory.  
 
For cell pellets, a plate was scraped into a McFarland tube containing 2 ml of 
Phosphate-buffered saline (PBS) (APHA media department) and resuspended by 
pipetting. A McFarland reading was obtained using a Den-1 McFarland 
Densitometer (Grant Bio, Cambridge, UK), and the contents were transferred to a 1.5 
ml or 2 ml microcentrifuge tube and centrifuged for 7 minutes at 13,500 rpm. The 
supernatant was removed and the cell pellet stored at -20 °C until the DNA was 
extracted. 
 
For frozen stocks, a plate was scraped into a McFarland tube containing 2 ml of 
Brachyspira Enrichment Media (APHA Newcastle regional laboratory) and re-
suspended by pipetting. A McFarland reading was obtained using a Den-1 McFarland 
Densitometer and 660 l was transferred to three cryovials (ThermoFisher) and stored 
at -80 °C. 
2.3 Isolation of DNA 
 
2.3.1 Extraction of DNA by Blood and Tissue Kit 
 
The DNase Blood and Tissue Kit (Qiagen) was used for isolation of DNA from B. 
hyodysenteriae. Cell pellets were re-suspended in 180 l ATL buffer and 20 l of 
proteinase K was added. This was mixed by vortexing and incubated at 56 °C under 
shaking conditions (80 rpm) in a shaking heating block (Eppendorf, Stevenage, UK) 
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for 1 hour until the tissue was completely lysed. Samples were then vortexed for 15 
seconds and 200 l buffer AL was added and vortexed to mix. To the mixture, 200 
l of ethanol (100%) was added and the sample vortexed. This was added to a 
DNeasy Mini spin column and centrifuged at 6000 x g for 1 minute. The collection 
tube and flow-through were discarded, and the spin column was placed in a new 
collection tube. To the spin column, 500 l of buffer AW1 was added and 
centrifuged at 6000 x g for 1 minute. The collection tube and flow through were 
discarded, and the spin column was added to a new collection tube, and 500 l of 
buffer AW2 added and the column centrifuged for 3 minutes at 20,000 x g. The 
collection tube and flow through were again discarded and the spin column was 
added to a 1.5 ml microcentrifuge tube. Finally, 100 l of buffer AE was added 
directly to the DNeasy membrane and incubated at room temperature for 1 minute 
before centrifugation at 6000 x g for 1 minute. To maximise DNA yield this step was 
repeated by adding another 100 l of buffer AE to the DNeasy membrane and 
centrifuging at 600 x g. The DNA was stored at – 20 °C until needed. 
 
2.3.2 DNA extraction using the MacMAX CORE Nucleic Acid Purification Kit and 
Kingfisher DUO Prime 
 
Buffers were supplied as part of the MagMAX CORE nucleic acid purification kit 
(ThermoFisher). To rows B and C of a 96-deep-well plate, 500 l of wash buffers 1 
and 2 were added respectively. To wells of a separate elution strip 90 l of elution 
buffer was added. A working solution of 350 l of lysis buffer and 350 l of binding 
buffer per sample was prepared. Beads were vortexed for 10 seconds before 20 l of 
beads were then added to 10 l of proteinase K per sample and pipetted into row A. 
Cell pellets were prepared as described previously (Materials and methods, section 
2.2) and then re-suspended in 270 l PBS and added to row A. The 96-deep-well 
plate was then incubated for 2 minutes at room temperature before 700 l of the 
lysis-binding buffer mix was added to row A. A tip comb was then placed in row H 
before the 96-deep-well plat was placed in the Kingfisher Duo Prime and the 
following program was used: MagMax CORE Duo heated script MagMAX CORE 
DUO (ThermoFisher) . 
 
 35 
2.3.3 DNA Quantification by Qubit 2.0 
 
A working solution of 1:200 solution of high sensitivity dye (Life technologies, 
USA) and high sensitivity buffer was made. To individual Qubit tubes, 10 l of each 
high sensitivity standards 1 and 2 or 2 l of sample DNA were added. 190 l of the 
working solution was added to each standard and 198 l of working solution was 
added to the sample DNA. The tubes were then mixed by vortexing for 3 seconds 
and incubated in the dark for 2 minutes at room temperature. They were then 
quantified on the fluorometer and the concentrations recorded. 
 
2.3.4 DNA quantification with Quantifluor  
 
A DNA dilution series of Quantifluor DNA standard (Promega) was made by adding 
1188 l of 10 nM Tris, 1 mM Ethylenediaminetetraacetic acid (TE buffer; Sigma) to 
a 1.7 ml microcentrifuge tube and 600 l to seven other tubes. To the initial tube, 12 
l of DNA standard was added, mixed by vortexing and 600 l was added to the 
next tube. This was repeated for the next five tubes, and the last tube was left as a 
negative control. 1 l of DNA to be quantified was added to wells of a black half-
area clear flat bottom 96-well optical plate (Sigma, Gillingham, UK) with one 
sample per well; 49 l of TE buffer was then added. One column was left for the 
DNA standard and 50 l of the dilution series was added to each well. Picogreen 
(Thermofisher) was diluted 1 in 200 with TE buffer and 50 l was added to each 
well. Fluorescence was detected by a Polarstar Galaxy Plate reader (BMG labtech, 
Aylesbury, UK) with quantifluor test selected and gain adjustment specified. Results 
were analysed in Excel 2013 (Microsoft). If the standard curve was not straight or 
the R2 value was less than 0.95, the test was repeated with the same DNA dilution 
series.  
2.4 DNA Sequencing 
 
2.4.1 Illumina Nextera XT Library Preparation 
 
Except for EB buffer (Qiagen), all buffers were supplied as part of the Nextera XT 
library preparation kit (Illumina). DNA from 2.3.1 was diluted to 0.2 ng/l using EB 
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buffer; from this 5 l of sample DNA was then added to 10 l of TD buffer before 
being centrifuged at 280 x g for 1 minute at room temperature. A microfuge tube of 
the mixture was then placed in a thermocycler with a heated lid and heated for 5 
minutes at 55 °C before being incubated at room temperature for 5 minutes. After 5 
minutes 5 l of NT buffer was mixed by pipetting five times and centrifuged at 280 
x g for 1 minute. 15 l of NPM and 5 l each of an i7 and an i5 adapter was added 
and mixed by pipetting before being centrifuged at 280 x g for 1 minute at room 
temperature. The mixture was then placed in a thermocycler, and the following 
settings were used: 
 
 72 °C for 3 minutes 
 95 °C for 30 seconds 
 15 cycles of: 
o 95 °C for 10 seconds 
o 55 °C for 30 seconds 
o 72 °C for 30 seconds 
 72 °C for 5 minutes 
 Hold at 10 °C 
 
Samples were then cleaned using the AMPure bead method (Materials and methods, 
section 2.4.2), and Qubit 2.0 was used to determine the concentration of DNA 
(Materials and methods, section 2.3.4). Samples sequenced at the APHA followed 
this protocol with the following modifications: samples were diluted in TE buffer; 13 
l instead of 15 l of NPM was used; samples underwent 12 cycles of amplification 
and DNA was quantified using Quantifluor (Materials and methods, section 2.4.4). 
DNA was stored at – 20 °C. 
 
2.4.2 Cleaning of Nextera XT libraries with AMPure Beads 
 
To 50 l of Nextera XT library DNA (Materials and methods, section 2.5.1) 30 l of 
AMPure XP beads were added and incubated at room temperature for 10 minutes 
before being put on a magnetic particle concentrator (MPC). Beads formed a pellet at 
the side of the tube, and the supernatant was discarded. The beads were washed 
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twice with 200 l of 80% ethanol. Ethanol was then removed using a pipette, and the 
samples were left with lids open to dry for 5-10 minutes. Samples were then 
removed from the magnetic stand and 20 l of resuspension buffer (Illumina) was 
added before being vortexed briefly to mix. This was followed by a 2-minute 
incubation before samples were put on the MPC and 18 l was removed and placed 
into a new microcentrifuge tube. The tube was stored at -20 °C until needed. 
 
2.4.3 Preparation of PhiX control 
 
PhiX library (Illumina) was diluted to 4 nM by mixing 2 l of 10 nM PhiX library 
with 10 mM Tris-CL (Sigma), pH 8.5 with 0.1% Tween 20 (Sigma). This solution 
was diluted further by mixing 5 l of 4 nM PhiX library and 5 l of 0.2 N NaOH 
before being vortexed briefly and centrifuged at 280 x g for 1 minute. This was then 
incubated at room temperature for 5 minutes and 990 l of pre-chilled HT1 
(Illumina) was added. This was further diluted to 12.5 pM PhiX by diluting 375 l of 
20 pM PhiX library in 225 l of pre-chilled HT1. Samples sequenced at the APHA 
followed this protocol with the following modifications: PhiX library was diluted to 
12.5 pM by mixing 10 l of the PhiX library with 1590 l of pre-chilled HT1.  
 
2.4.4 Sequencing isolates on a MiSeq 
 
Samples were diluted to 4 nM using EB buffer and 5 l of each sample was pooled. 
From the pooled samples 5 l was then denatured by adding it to 5 l of fresh 0.2 N 
NaOH solution before being vortexed and centrifuged at 280 x g for 1 minute at 
room temperature. After a 5-minute, incubation at room temperature 10 l was 
added to 990 l of pre-chilled HT1 buffer. Pre-chilled HT1 buffer was then used to 
dilute the pool to 12 pM by mixing 360 l of the pool with 234 l of pre-chilled 
buffer. To this, 6 l of PhiX control were added (Materials and methods, section 
2.5.4), and the diluted pool was then sequenced on an Illumina MiSeq using either 
the Illumina Miseq V2 2x250 bp or MiSeq V3 2 x 300 bp paired-end protocols.  
 
Samples sequenced at the APHA followed this protocol with the following 
modifications: samples were diluted to 2 nM in TE buffer instead of being diluted to 
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4 nM; and 7.5 l of the library pool was mixed with 2.5 l of 0.2 N NaOH and 
incubated for 5 minutes before 940 l of pre-chilled HT1 and 50 l of PhiX library 
(Materials and methods, section 2.5.4) was added.  
 
2.4.5 Sequencing isolates on a NextSeq 
 
Samples were diluted to 2 nM using TE buffer and 5 l of each sample was pooled. 
From the pooled samples 6 l was then denatured by adding it to 0.5 l of fresh 2 N 
NaOH solution. To this 994 l of pre-chilled HT1 buffer was added before being 
vortexed and centrifuged at 280 x g for 1 minute at room temperature. An aliquot of 
150 l was made, and 1150 l of pre-chilled HT1 and 2 l of 12.5 pM PhiX library 
(Materials and methods, section 2.4.3) was added. The diluted pool was then 
sequenced on an Illumina NextSeq using the Illumina NextSeq 2x150 bp paired-end 
protocol. 
 
2.5 Bioinformatic analysis 
 
2.5.1 Assembly and annotation 
 
Adapters and low-quality reads were removed using default Illumina software. 
Isolates were assembled using the Nullabor pipeline (version 1.2) [237, 238] with 
SPAdes, (version 3.10.1) specified as the assembly software [238]. In the Nullabor 
pipeline, reads were trimmed with Timmomatic (version 0.36) [239] before 
contaminants were identified with Kraken (version 0.10.5-beta) [240]. Any 
contaminated samples were regrown from frozen stock, purified and re-sequenced. If 
the amount of contaminant was less than 1%, Samtools was used to remove all reads 
that did not map to the WA1 reference using the command samtools view -f4 –bS. 
Bam files were then converted into fastq with bam2fastq [241] and then assembled 
by Nullabor. After samples had been assembled, they were aligned to the WA1 
reference genome using Mauve (version 5.0)  [242] and annotated with prokka 
(version 1.11) [243].  
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2.5.2 Phylogenetic trees 
 
An alignment of SNPs in the core-genome was constructed by Snippy (version 3.1) 
using default settings [244]. SNPs in recombinant sites were removed with Gubbins 
(version 2.2.0) [245] using default settings, and maximum likelihood trees were 
bootstrapped using RAxML (version 8.2.11) [246]. GTRGAMMA was used as the 
nucleotide substitution model, and 1000 bootstraps were conducted. The number of 
SNPs between isolates was obtained using snp-dist (version 0.2) [247], and trees 




Chapter 3. Population structure of B. 




Analysis of the population structure of pathogens can reveal valuable information 
and aid in the development of strategies to limit their impact. The population 
structure of B. hyodysenteriae has been investigated using a variety of techniques, 
including Multilocus enzyme electrophoresis (MLEE) and Multiple-locus variable 
number tandem repeat analysis (MLVA) [117, 118, 249, 250]. MLEE characterises 
isolates based on the electrophoretic mobility of a core set of enzymes, but it is time-
consuming, and for recombinant species, hundreds of electrophoresis gels may be 
required [251]. MLVA is a faster alternative and relies upon the amplification of 
specific repeating sections of the chromosome, the number of varying repeats differs 
between strains and therefore can be used for characterisation [118]. Multi-locus 
sequence typing (MLST) has become the most commonly used technique and has 
been found to be slightly more discriminatory than MLVA [118].To visualise MLST 
data minimum spanning trees are most commonly used; these are simple trees that 
link closely related individuals [252].  It has been used to describe the population 
structure of B. hyodysenteriae in Australia, Belgium, Germany, Italy, Spain and the 
USA [52, 60, 73, 93-95, 121-125]. The dominant STs vary between countries, and 
there is little spread of STs between geographically distant countries such as 
Germany and the USA, probably due to a limited trade in live pigs between these 
countries (in 2018 only 4,024 live pigs were transported between the USA and the 
EU) [52, 73, 253]. In Europe, some STs are shared between countries. This may be 
due to movement of pigs throughout the European pig industry through trade. 
Analysis of SNPs in the core-genome can enhance MLST-based phylogenetic studies 
as it provides higher resolution. It has been used to distinguish between isolates of 
the same ST in pathogens such as S. aureus, P. aeruginosa and has also been used to 
track an outbreak of a ST 258 carbapenem-resistant Klebsiella pneumoniae at the US 
National Institute of Health Clinical Center that resulted in 18 infections [189, 254, 
255]. It has also been used to investigate how the novel species B. suanatina related 
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to seven other Brachyspira species, including B. hyodysenteriae; although the 
population structure of B. hyodysenteriae isolates was not studied [46].   
 
This study was done as part of a larger study investigating B. hyodysenteriae in the 
UK (VM0516) [256]. In a separate part of this project, 39 isolates of B. 
hyodysenteriae were analysed by WGS, and antibiotic sensitivity testing performed 
on these isolates using the VetMic Brachy panel [256]. The remaining ninety-nine B. 
hyodysenteriae isolates held at the APHA were sequenced as part of this study [256]. 
These are the first WGS studies explicitly investigating the population structure of B. 
hyodysenteriae in the UK. 
 
SNP based core-genome analysis provides information on the phylogeny, but other 
techniques are needed to investigate transmission over time. Understanding how B. 
hyodysenteriae has transmitted between regions may highlight areas where 
transmission can be prevented. To investigate transmission Bayesian inference, more 
specifically Metropolis-Hastings Markov chain Monte Carlo (MCMC), was used 
[257]. By using Bayesian inference metadata, such as the date of sampling, can be 
incorporated into analysis, and from this transmission can be inferred. There are a 
variety of programs that have been designed that infer transmission events from 
metadata and can be included in the MCMC.  The most commonly used program is 
the BEAST2 environment; BEAST2 is a development of a customisable BEAST 
program that enables third-party programs to be used [258, 259]. For this study, 
SCOTTI was used to predict the movement of B. hyodysenteriae between different 
regions of England and Wales [260].  SCOTTI is an implementation of an 
approximate structured coalescence framework, developed in the BASTA program, 
to predict transmission events during outbreaks [260, 261]. SCOTTI does not assume 
that all isolates involved in an outbreak have been found, this makes it useful for 
investigating a pathogen able to survive in multiple animal vectors [260]. Each host 
is treated as a different bacterial population, and it is assumed that transmission 
between different hosts is equally likely [260]. These hosts are based upon metadata 
provided, and bacterial lineages are only able to migrate to host that are exposed at a 
similar time (exposure times are also based upon metadata provided) [260].  
Nucleotide mutations are modelled using the HKY substitution model, where 
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nucleotides are present in different amounts, and the rate of transitions and 
transversions differs [262].  
 
3.1.2. Aim of the study 
 
The population structure of B. hyodysenteriae in the UK was investigated in this 
study. This was done using 99 isolates purified from diagnostic samples submitted to 
the APHA Reference Laboratory at Bury St. Edmunds, between 2004 and 2015. 
These isolates were sequenced, then MLST and SNPs in the core-genome were used 
to investigate the population structure of B. hyodysenteriae within the UK. However, 
as there are few sequenced B. hyodysenteriae genomes, core-genome analysis was 
not the best technique to understand the population structure globally. Instead, 
MLST analysis, and comparison to published sequences on pubMLST was used to 
compare more widely outside the UK and provide a global picture of B. 
hyodysenteriae genomics. Such comparisons may identify potential STs moving 
through Europe or structural differences in the UK B. hyodysenteriae population. 
Core-genome analysis was intended to complement this analysis by identifying 
clonal populations in the UK, which was combined with transmission prediction to 
provide information about the persistence of ST and clonal groups in the UK.  
3.2. Methods 
 
Ninety-nine isolates were obtained from the APHA culture collection and cultured as 
specified previously (Table 3.2.1).   
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Table 3.2.1: Information on the location and year of sequenced isolates in this 
study.  
Holdings have been numbered arbitrarily to show where were originally received 
from. Where multiple isolates were received from the same holding at different times 
the same holding number has been given.  
Abbreviations: NUTs refers Nomenclature of Territorial Units for Statistics and 











js03 2013 Yorkshire 3 
js04 2013 South West unknown 










js09 2007 South West 7 
js10 2008 Wales 8 
js11 2010 Yorkshire 9 
js12 2011 Yorkshire 10 
js13 2005 North East 11 
js14 2006 Yorkshire 12 
js15 2007 Yorkshire 13 
js16 2007 Yorkshire 14 
js17 2008 North West 15 
js18 2008 Yorkshire 16 
js19 2008 Yorkshire 17 
js20 2008 Yorkshire 18 
js21 2009 Yorkshire 19 
js22 2009 North East 20 
js23 2009 North East 21 
js24 2010 Yorkshire 22 
js25 2011 Yorkshire 23 
js26 2012 Yorkshire 24 
js27 2012 Yorkshire 25 
js28 2012 Yorkshire 25 










js31 2013 Yorkshire 26 
js32 2013 Yorkshire 27 
js33 2014 North West 28 
js34 2004 North West 29 
js35 2006 North West 30 
js36 2006 North West 31 
js37 2006 North West 32 
js38 2007 North West 33 
js39 2007 North West 34 
js40 2009  North West  35 





js43 2012 South East 38 
js44 2012 South East 38 









js48 2008 South West 42 





js51 2013 Non-UK 45 





js54 2015  Non-UK  48 
js55 2006   Wales 49 
js56 2007   Wales 50 
js57 unknown unknown 51 
js58 unknown    unknown 52 
js59 2011 South West 53 























js66 2005 South West 60 
js67  2007 South West 61 
js68 2009 South West 62 
js69 2009 South West 63 
js70 2010 South West 64 
js71 2010 South West 65 
js72 2011 South West 66 
js73 2014 South West 67 
js74 2015 South West 68 
js75 2005 South West 69 
js76 2006 South West 70 
js77 2008 South West 71 
js78 2008 South West 72 
js79 2008 South West 71 
js80 2008 South West 4 
js81 2008 South West 73 
js82 2008 South West 74 
js83 2009 South West 75 
js84 2009  South West  76 
js85 2010 South West 77 
js86 2011 South West 4 
js87 2011 South West 75 
js88 2012 South West 78 
js89 2012 South West 79 
js90 2004 South East 80 
js91 2005 South East 81 
js92 2006 South West 70 
js93 2007 South East 82 
js94 2011 South East 83 
js95 2010 South East 84 





js98 2015 East of 
England 
88 






SRST2 (version 0.1.5) was used to identify the ST from the fastq files [263]. These 
STs were combined with the 675 MLST profiles published on pubMLST 
(http://pubmlst.org/bhyodysenteriae/) and profiles from previously published studies 
[121] [73]. The fasta of novel ST were extracted using Seqfinder [264] by mapping 
against the B. hyodysenteriae PubMLST allele database 
(http://pubmlst.org/bhyodysenteriae/) and submitted to Tom La for categorisation. 
All STs were then used to make minimum spanning tree using Bionumerics 6.0 with 
1000 bootstraps [265].  
 
3.2.2. Prediction of movement of B. hyodysenteriae between regions of the 
UK 
 
Transmission was predicted for isolates that contained metadata, including a date at 
which the sample was received at the APHA. Snippy identified core-genome SNPs 
in isolates with js90 (the oldest isolate in the study) being used as the reference 
[244]. SNPs in recombinant sites were removed using Gubbins (version 2.2.0) [245].  
SCOTTI (version 1.02) was used to construct a phylogenetic tree and predict 
movement between Nomenclature of Territorial Units for Statistics (NUTS) 1 
regions [266]. NUTS 1 regions are the largest statistical regions within a country and 
enable analysis of movement of B. hyodysenteriae without compromising the 
identity of farmers.  For this analysis the NUTS 1 region of isolate origin, an 
approximate time of infection and the total time of B. hyodysenteriae infection in 
each region were required and provided as csv files. An exact time of infection is 
unknown, so an approximate time of infection was used. Infection was estimated as 
two weeks prior to the APHA receiving the initial clinical sample. This was based on 
an estimated incubation period of 14 days [53, 267]. A maximum of 30 hosts and 






3.3.1 Sequencing of Isolates 
 
Isolates were obtained from the APHA culture collection at Bury St. Edmunds and 
grown at the APHA Weybridge site. It was not possible to purify eight of the 99 
isolates; this was due to overgrowth of contaminants present in the frozen stock. All 
purified isolates were sequenced on an Illumina MiSeq in four MiSeq runs. There 
was variation in the sequence quality with eight sequences being rejected due to low 
quality. Three isolates failed to sequence, three had coverage below 20x and thus 
failed our quality threshold, one was B. pilosicoli, and one appeared to be a mixed 
culture. The remaining 84 isolates were used for the subsequent analysis (Table 3.3). 
Between these isolates, the quality of sequences also varied, with coverage ranging 
between 20x and 226x. The higher coverage for samples js03 to js12 was because 
there were fewer samples on this MiSeq run. The median number of contigs was 
202, but there was a large range in the total number of contigs, with the js20 having 
the fewest contigs (20) and js02 having the most contigs (1309). Contig number may 
not correlate with coverage as some isolates with high coverage, for example, js11 
(140x coverage), had more contigs than isolates with less coverage, for example, 
js01 (28x coverage). It is possible that these genomes contain more repeat regions 
making assembly more difficult. Also, the N50 also varied with the median N50 
being 66839 and js02 having the lowest N50 (4058); while js06 had the highest N50 
(2533390). With lots of small contigs in some isolates, there are likely to be errors in 
the assembly of the genome. This may result in Roary estimating an artificially low 
core-genome. However, Snippy compares the raw fastq file to a reference when 
creating an alignment of SNPs in the core-genome, therefore issues with assembly 
should have little impact on the tree produced. In addition, in silico, MLST was used 
to check for consistency with previously published research. 
 
To identify contaminants, Kraken was used; the percentage of sequences identified 
as B. hyodysenteriae varied between 73.09% and 93.43%. The low similarity 
between strains of the same species is likely to be due to the reference used. The 
MiniKraken database was used for the analysis, and this database uses the Australian 
reference strain B. hyodysenteriae genome WA1. This is a commonly used reference 
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genome as it was the first closed B. hyodysenteriae genome [85]. However, it is 
likely that UK isolates have diverged considerably from this isolate over the decades 
and it is likely in future a complete sequenced UK reference isolate will be needed.  
 
The isolates used for downstream analysis came from 70 individual holdings with 11 
holdings containing multiple isolates. For seven holdings isolates originated in the 
same year and may be multiple isolates taken as part of the same outbreak. There 
were two holdings (4 and 74) that contained isolates that originated in different 
years, with the longest distance between two isolates from the same holding being 
four years (holding 4). It is possible that these represent persistent infections. 
 
Most of these holdings are from England with one Welsh isolate. There was a 
varying number of isolates from each region for this time period with 31 from the 
South West, 18 from Yorkshire and the Humber, six isolates from the East of 
England, seven from the South East, six from the North West, three from the North 
East, seven from the West Midlands, one from the East Midlands. In addition, there 
were three isolates (js04, js57 and js58) from the Scottish Agricultural College that 
may be from Scotland but the origin of these samples is unknown. For the sake of 
continuity, and because some isolates are not English, isolates will continue to be 
called UK isolates, but it must be noted that any conclusions drawn will reflect the 
pig population in England.  
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Table 3.3.1: Information on all sequenced isolates used in the study.  
Note Kraken refers to the percentage identity to the WA1 B. hyodysenteriae 

















js01 373752 29.4 111 504553 112075 28x 85.38 
js02 305230 30.6 1309 31611 4058 25x 90.42 
js03 2318542 28.5 700 1102549 733978 148x 77.79 
js04 1559406 26.9 296 1376438 742677 101x 81.31 
js05 3581236 27 421 2063853 2063853 226x 79.18 
js06 2116200 27.6 264 2533390 2533390 142x 88.9 
js07 2599692 29.3 245 1830524 1830524 175x 85.54 
js08 1377202 26.8 256 1473884 706770 88x 86.66 
js09 2695738 28 93 1095628 742051 168x 81.67 
js11 2325680 28.9 334 335020 130706 140x 73.09 
js12 3161630 28.2 168 808888 359603 206x 84.69 
js13 324316 31 482 49157 11037 28x 91.98 
js14 324842 31 531 68101 10145 23x 88.98 
js15 308588 30.7 514 44160 9714 21x 89.56 
js16 402872 31.2 581 43256 8725 30x 87.46 
js17 520484 30 102 250666 99497 42x 90.69 
js18 370584 31.1 415 41181 15157 27x 82.63 
js19 365860 30.7 266 76419 24565 26x 91.21 
js20 538342 29 35 591358 256675 35x 88.85 
js21 764754 29.7 118 391757 238745 56x 81.92 
js22 361738 31.4 498 47211 10454 25x 90.28 
js23 402382 29.8 199 182316 77444 37x 83.72 
js24 270670 29.8 253 104319 27137 21x 83.14 
js25 542996 30.6 184 115490 43753 29x 88.01 
js26 394442 30.8 388 68957 16189 28x 86.25 
js27 285206 30.8 584 42209 10774 20x 84.32 
js28 319234 31.2 696 35192 8117 23x 86.29 
js29 516624 31.2 366 55765 20067 43x 84.24 

















js31 475520 30 164 131535 37570 29x 80.26 
js32 392526 30.6 326 105253 19587 27x 85.26 
js33 309364 30.4 222 98700 24723 28x 85.32 
js34 985264 29.8 79 431067 263854 67x 86.12 
js35 465962 29 79 486736 207585 34x 90.15 
js37 441568 30.9 304 63116 17210 31x 81.05 
js39 721510 29.9 92 527045 171375 56x 86.62 
js41 673458 30.1 111 592505 159299 51x 88.22 
js42 554310 30.1 168 146060 48488 41x 85.9 
js43 305168 29.9 248 70035 24043 23x 88.02 
js44 289314 29.5 144 118478 42215 22x 88.42 
js46 341496 28.9 204 481915 188391 32x 88.94 
js47 975536 29.2 248 414612 169848 58x 86.06 
js48 372608 29 533 186579 61426 35x 85.68 
js49 466750 29.9 96 499290 97003 35x 83.62 
js50 938502 30 192 346160 112940 64x 89.06 
js51 631868 30.3 123 154426 53882 43x 87.36 
js52 442304 29.6 81 210780 83875 30x 87.35 
js57 323614 30.3 312 96445 22616 24x 85.97 
js59 291520 31.2 443 46757 12485 22x 92.27 
js60 360778 29.4 91 290249 91413 27x 86.53 
js61 340548 29.4 60 524608 95309 27x 91.75 
js62 324226 31.4 944 59447 18118 23x 86.78 
js63 434854 29.8 107 395554 126577 33x 88.6 
js64 573394 29.6 212 383527 167342 42x 92.47 
js65 401064 28.9 57 599968 193903 29x 87.55 
js66 806810 30.9 363 48919 13292 51x 87.38 
js68 906212 29.2 239 636751 359052 58x 80.55 
js69 451504 29.6 149 157415 60673 34x 86.08 
js70 1705804 29.2 76 698386 609582 118x 83.23 
js71 809256 29.8 225 381543 114447 59x 85.75 

















js73 867790 29.8 74 676289 210585 54x 81.36 
js74 396842 29.8 161 126510 41198 30x 85.95 
js75 456774 30.2 196 79848 28020 30x 90.09 
js77 302770 29.7 157 130356 39261 22x 92.61 
js78 763866 29.6 63 612909 364903 56x 91.79 
js79 1073338 29.1 67 792347 507727 69x 81.7 
js80 747816 29.9 63 696639 434402 51x 90.02 
js81 379780 31.8 585 38033 9719 28x 84.09 
js82 309372 31.2 648 33474 7975 23x 85.12 
js83 493586 29.1 41 622043 439225 37x 92.77 
js85 289066 30.5 307 52409 17665 22x 93.00 
js86 1356284 29.5 43 1080869 577440 87x 89.37 
js87 457888 30.5 114 153392 55710 35x 93.42 
js88 380870 30.3 258 71169 24440 28x 84.98 
js90 420878 30.7 208 164859 28855 31x 88.01 
js91 309742 29.1 76 261471 77214 23x 92.06 
js92 581522 29.8 103 421325 117764 44x 86.41 
js93 394280 29.8 137 141341 59374 29x 85.38 
js94 655276 29.9 119 373705 179869 48x 88.31 
js96 407234 30.1 262 127328 57254 31x 86.22 
js97 996098 29.8 54 448580 263047 72x 87.34 




3.3.2 In silico MLST 
 
In silico, MLST identified nine STs (Table 3.3.2.1). Fifteen isolates could not be 
typed and may represent novel STs. The mean depth of coverage across all MLST 
genes for all isolates was above the cut-off of 20-folds, ranging between ~20-fold 
(js02) and ~227-fold (js12). The depth of coverage for untypable isolates ranged 
from 25.9 to 156.8 with the median coverage being 48.63. It is likely that the 
untypable isolates are novel ST with novel alleles of MLST genes. All untypable 
alleles had a coverage above 20. The coverage of each gene was above 20x for all 
isolates except for gdh in js91 which had a coverage of 16x. These fold coverages 
are above the cut-off and may imply that these isolates represent new STs, and, given 
that there are only 675 isolates on the pubMLST database it is unlikely that the total 
diversity of B. hyodysenteriae has been captured in the current database. The fasta 
sequences of MLST genes for all untypable genes were submitted for review to Tom 
La, the curator of the B. hyodysenteriae PubMLST database 
(https://pubmlst.org/brachyspira/), and all but js05 were typed. This was because 
There were two genes in js05 that were too short: glpK (missed the first two 
nucleotides) and thi (the gene ended three nucleotides too early). These genes may 
be shorter in js05, but this could also be an error in the sequencing. To investigate 
further, it would be necessary to conduct MLST using PCR amplification of the 
MLST genes and sequencing of these genes [125]. 
 
There was considerable allelic variation between the MLST genes. For example, 
with adh allele 2 present in all isolates; while glpK contributed the most to the 
variation between STs. The most common ST was 52 and was present in 23 isolates 
in which were from seven regions with 18 isolates originating from the South West. 
These isolates arose from 22 holdings, and were isolated from diagnostic 
submissions made in 2006 to 2015. The least common STs were 89 (this contained 
js26, an isolate from Yorkshire and the Humber), and the new STs 242, 243, 244 and 
245 (which originated from Yorkshire and the Humber, non-UK, South West and the 
South East respectively). There were regional differences, with four of the ST 88 
isolates being found in Yorkshire, and eight of ST 91 isolates were identified in the 
South West. These findings could reflect the pig transportation system in the UK as 
pigs are more likely to be transported a short distance within regions than longer 
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distances between regions.  ST 52 appears to have been able to spread very 
successfully, and the large number of isolates present in the South West may suggest 
a clonal expansion caused by a series of biosecurity breakdowns. 
 
Comparison of STs from this study to previously published STs on PubMLST 
(http://pubmlst.org/bhyodysenteriae/) indicated that a total of five UK STs had 
previously been found in other European countries, and four STs had previously only 
been identified in the UK (Table 3.3.2.2). The most common STs from this study, ST 
52 and ST 8, were both present in multiple European countries. ST 8 occurred 
between 2004 and 2015; while ST 52 occurred between 2006 and 2015. Two UK 
specific STs were also common: ST 88 (eight isolates from Yorkshire and the 
Humber, the West Midlands and the South West), and ST 91 (10 isolates from the 
South West and the West Midlands). These STs were present in the latter years of 
the study. The latest ST 91 isolate (js59) was in 2011, and the latest ST 88 isolate 
(js27) was in 2013; while ST 8 (js97 and js99), and ST 52 (js74) were both present in 
2015. Multiple STs are able to survive in the UK at the same time, with no single ST 
able to dominate completely. This may be due to the survival of isolates with these 
STs in regions where they have been isolated in the environment and/or other vectors 
where they do not have to compete with isolates of different STs. 
 
Of the holdings that had multiple isolates, MLST identified occurrences of potential 
chronic contamination by B. hyodysenteriae at some of these locations. There were 
two holdings that possibly had persistent infections. Analysis of holding 3, with a 
potential persistent infection, indicated that the isolates came from different NUTS 1 
regions. It is likely that this is a company with multiple sites which had sent multiple 
samples to the APHA under one submission. As these isolates could have come from 
farms in different regions, they will be treated as independent infections. On holding 
four there was a succession of STs from ST8 to untypable, this is likely due to 
disease outbreaks caused by independent infections. In the other holdings with 
repeated outbreaks, the ST was the same in subsequent isolates and may indicate 
persistently contaminated holdings. Also, there were two holdings (71 and 72) where 
multiple STs were identified within three months of each other; both STs are likely 
to be co-infecting the pigs.  
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Table 3.3.2.1: MLST profiles of all isolates. 
Isolates that could not be typed were indicated by NF, *indicates mismatches and a 
question mark denotes uncertainty due to low coverage in parts of the MLST genes.  
Information on SNPs and low coverage have been included in Appendix 1.  
 




js01 52 2 13 3 6 8 2 17 35.73 
js02 122 2 11 3 5 9 2 28 20.43 
js03 240 2 11 3 6 43 26 43 156.8 
js04 52 2 13 3 6 8 2 17 77.4 
js05 NF*? 2 11 28 1 15*? 2 19*? 127.37 
js06 239 2 11 33 10 7 3 3 136.50 
js07 8 2 2 3 12 11 1 3 153.65 
js08 122 2 11 3 5 9 2 28 63.61 
js09 52 2 13 3 6 8 2 17 186.55 
js11 87 2 13 3 6 23 2 21 152.88 
js12 8 2 2 3 12 11 1 3 227.11 
js13 240 2 11 3 6 43 26 43 55.47 
js14 122 2 11 3 5 9 2 28 38.66 
js15 242 2 11 33 10 43 3 3 34.82 
js16 122 2 11 3 5 9 2 28 32.12 
js17 239 2 11 33 10 7 3 3 58.55 
js18 167 2 11 3 1 10 2 21 46.11 
js19 239 2 11 33 10 7 3 3 37.48 
js20 239 2 11 33 10 7 3 3 46.62 
js21 87 2 13 3 6 23 2 21 73.22 
js22 239 2 11 33 10 7 3 3 48.15 
js23 87 2 13 3 6 23 2 21 40.66 
js24 87 2 13 3 6 23 2 21 22.59 
js25 8 2 2 3 12 11 1 3 88.94 
js26 89 2 21 3 20 6 1 11 50.76 
js27 88 2 21 3 20 6 11 11 27.7 
js28 88 2 21 3 20 6 11 11 31.22 
js29 88 2 21 3 20 6 11 11 75.88 
js30 240 2 11 3 6 43 26 43 42.66 
js31 52 2 13 3 6 8 2 17 48.08 
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js32 88 2 21 3 20 6 11 11 43.85 
js33 240 2 11 3 6 43 26 43 37.02 
js34 8* 2 2* 3 12 11 1 3 104.04 
js35 122 2 11 3 5 9 2 28 39.33 
js37 52 2 13 3 6 8 2 17 48.69 
js39 52 2 13 3 6 8 2 17 78.98 
js41 8 2 2 3 12 11 1 3 77.2 
js42 52 2 13 3 6 8 2 17 65.84 
js43 8 2 2 3 12 11 1 3 30.02 
js44 8 2 2 3 12 11 1 3 25.69 
js47 239 2 11 33 10 7 3 3 79.16 
js48 167? 2 11 3 1? 10 2 21 32.21 
js49 167 2 11 3 1 10 2 21 50.09 
js50 167 2 11 3 1 10 2 21 100.01 
js51 243 2 11 3 1 9 2 13 64.64 
js52 90 2 11 8 1 8 2 13 36.48 
js57 88 2 21 3 20 6 11 11 21.28 
js59 91? 2 22 5 4? 24 2 6 34 
js60 52 2 13 3 6 8 2 17 21.75 
js61 122? 2 11 3 5? 9 2 28 34.52 
js62 88 2 21 3 20 6 11 11 34.22 
js63 8 2 2 3 12 11 1 3 47.3 
js64 91 2 22 5 4 24 2 6 58.86 
js65 8 2 2 3 12 11 1 3 39.3 
js66 88 2 21 3 20 6 11 11 98.38 
js68 52 2 13 3 6 8 2 17 77.85 
js69 52 2 13 3 6 8 2 17 42.52 
js70 52 2 13 3 6 8 2 17 162.67 
js71 52 2 13 3 6 8 2 17 90.13 
js72 52 2 13 3 6 8 2 17 49.21 
js73 52 2 13 3 6 8 2 17 78.24 
js74 52 2 13 3 6 8 2 17 46.52 
js75 244 2 7 3 6 24 2 3 49.11 
js77 91 2 22 5 4 24 2 6 32.61 
js78 91 2 22 5 4 24 2 6 70.21 
js79 52 2 13 3 6 8 2 17 94.4 
js80 91 2 22 5 4 24 2 6 91.55 
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js81 52 2 13 3 6 8 2 17 52.62 
js82 52 2 13 3 6 8 2 17 38.77 
js83 91 2 22 5 4 24 2 6 44.99 
js85 91 2 22 5 4 24 2 6 35.78 
js86 91 2 22 5 4 24 2 6 136.51 
js87 91 2 22 5 4 24 2 6 48.51 
js88 52 2 13 3 6 8 2 17 45.99 
js90 8 2 2 3 12 11 1 3 52.16 
js91 245 2 31 3 20 4 2 45 25.9 
js92 52 2 13 3 6 8 2 17 66.11 
js93 52 2 13 3 6 8 2 17 25.5 
js94 8 2 2 3 12 11 1 3 73.76 
js96 52 2 13 3 6 8 2 17 44.59 
js97 8 2 2 3 12 11 1 3 101.73 




Table 3.3.2.2: Sequence types of UK isolates and comparison to global isolates. 
ST profiles of isolates from this study compared to global isolates from pubMLST 
(https://pubmlst.org/brachyspira/) and previously published studies [73, 121]. 
Untypable refers to isolates that could not be typed. 
ST 
Isolates  
from this study 
Source of global isolates  
from the same ST 
8 
js07, js12, js25, js34, js41, js43, js44, js63, 
js65, js90, js94, js97, js99 
Belgium, UK, Germany, Italy, Serbia, 
Spain 
52 
js01, js04, js09, js31, js37, js39, js42, js46, 
js60, js68, js69, js70, js71, js72, js73, js74, 
js76, js79, js81, js82, js88, js92, js93, js96 
Austria, Belgium, Germany, Italy, 
Spain 
87  js11, js21, js23, js24 Italy, Belgium 
88 js27, js28, js29, js32, js57, js62, js66 UK 
89 js26 UK 
90 js50, js52 UK 
91 
js59, js64, js77, js78, js80, js83, js85, js86,  
js87 
UK 
122 js02, js08, js14, js16, js35, js61 Germany 
167 js18, js48, js49  Belgium 
239 js06, js17, js19, js20, js22, js47 UK 
240 js03, js13, js30, js33 UK 
242 js15 New 
243 js51 New 
244 js75 New 
245 js91 New 
Untypable  js05  N/A 
 
MLST alleles were used to build a minimum spanning tree using Bionumerics 6 
(Figure 3.3.2.) [265]. In general, different STs were identified in different continents, 
with only three STs present in more than one continent. ST 104 was isolated in the 
USA and Spain; ST 54 has been identified in the USA and Germany, and ST4 was 
isolated in Canada and the UK. The lack of shared STs between distant countries 
may indicate that B. hyodysenteriae STs are diverging rapidly, but there are STs that 
are differentiated by only a few SNPs. This suggests that although there is 
considerable divergence within the population B. hyodysenteriae many STs in 
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different countries are closely related, and there appears to be a clear structure to the 
tree. Therefore B. hyodysenteriae is not completely recombinant and is likely to be 
partly clonal.  
 
There are limits to what can be discerned about the global population structure of B. 
hyodysenteriae due to the biased nature of the pubMLST database. Important pig 
production regions, most specifically China, are absent. However, as much of the 
tree is composed of Australian, European or American isolates, it is possible to infer 
details about the population structure of B. hyodysenteriae in these regions. Each 
region appears to have distinct patterns of STs. In Australia, there were two main 
groups of ST: a group at the centre of the tree and a distinct branch. Some Australian 
STs were similar to global STs; while another group became divergent and is 
evolving independently. This was likely due to the isolation of B. hyodysenteriae in 
Australia, although the majority of Brazilian and North American STs are also on a 
distinct branch. Some STs were dispersed with European STs and dispersed 
throughout the tree. This potentially indicates greater movement of B. 
hyodysenteriae between these continents. However, the movement of B. 
hyodysenteriae between continents does appear limited.  
 
Within Europe, there were similar STs found in different countries. In total ten STs 
were shared between different countries in Europe, but only two STs were present in 
more than two countries: ST 8 and 52. This suggests the movement of B. 
hyodysenteriae across Europe is common; although the relative isolation of Italian 
STs does indicate that it does not apply to all European countries. These results will 
have implications for treatment as it is possible that a multi-drug resistant ST could 
be transported throughout Europe. It should also be noted that the reference strain 
WA1 (ST 32) does appear divergent from European isolates and therefore for future 
analysis of B. hyodysenteriae it would be beneficial to sequence a new European 
reference strain.
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Figure 3.3.2: Minimum Spanning Tree of all MLST isolate on pubMLST with 
(http://pubmlst.org/bhyodysenteriae/) and in silico MLST isolates from this 
study.  
STs are labelled if present in this study or are mentioned in the results or discussion. 
C: Canadian isolates (all other North American isolates are from the USA), T: 
Thailand, J: Japan, K: Korea, Pt: Portugal, D: Denmark (all other Scandinavian 
isolates are from Sweden), P: Poland (all other Central European isolates are 
Austrian). The number of isolates from each country, or region, is also given. 1000 
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3.3.3 Core-genome SNP tree 
 
An alignment of SNPs in the core-genome was constructed and filtered using 
Gubbins to remove recombinant SNPs; this was used to construct a phylogenetic tree 
(Figure 3.3.3.). There were 116649 SNPs from 1337 genes (53.16% of the genome), 
and the average number of SNPs per genome was 1090. When compared to MLST 
there were three discrepancies; ST 88 and ST 89 isolates form the same clade, the 
Australian isolate, WA100, was very similar to a Canadian isolate, FMV88.9330, 
and one ST 240 isolate (js13) clustered with ST 239 isolates. The ST for WA100 and 
FMV88.9330 is not provided on NCBI, but there are isolates on PubMLST with the 
same name, and these are likely to be the same strains. Comparison of STs indicated 
that WA100 (ST 130) and FMV88.9330 (ST 4) were separated by nine SNPs in thi; 
while ST 88 and ST 89 were separated by two SNPs in pgm. ST 239 and 240 share 6 
alleles, and are separated by 6 SNPs in glpK. These discrepancies are likely due to 
greater resolution of core-genome analysis and highlights the potential of WGS to 
provide additional, more in-depth information on the population structure of B. 
hyodysenteriae.  
 
The core-genome tree is dominated by UK isolates as there are only 27 B. 
hyodysenteriae genomes published; despite this, it does appear that the phylogeny 
was conserved. As in the MLST tree, there was a distinct group of Australian 
isolates, clade A, and some isolates were present in clades D, and E. Global isolates 
appeared distinct from UK isolates and did not form a defined cluster. These isolates 
have long branches indicating greater diversity here, which will become apparent as 
more global isolates are sequenced. There was only one global isolate, the German 
isolate G21, that clustered with UK isolates. There does not appear to be a single 
dominant clonal group in the UK. Instead, there were multiple clades present in the 
UK; with each clade or subclade aligned with a ST. Each clade contained isolates 
from multiple regions and holdings. However, smaller clades contained isolates that 
were recovered closely together in time. The larger clades contained isolates that 
were isolated over a longer period of time, for example, the ST 8 clade includes js90, 
from South East England which was isolated in 2004 and js97 from the East of 
England which was isolated in 2015. The existence of clades that have been 
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established for years could suggest that there is a reservoir population circulating 
within the UK, or it may also be due to unintentional transport between holdings.   
 
Within each clade, there were groups if isolates with a small number of SNPs (<20) 
which could indicate clonal expansion, in total there were 13 groups of isolates with 
fewer than 20 SNPs between group members. However, as Gubbins removes SNPs 
that are present in recombinant sites, there may have been an overestimation of the 
number of clones [245]. Clonal groups were most common in clade H; this 
corresponds to ST 52. Clonal groups ranged in size from two to eight isolates with 
the mean clonal group being four isolates. Clonal groups were composed of isolates 
from different regions, for example, clonal group 1 (js07, js25, js43, js44, js63, js65, 
js94 and js97) was composed of isolates from the East of England, the South East, 
the West Midlands and Yorkshire and the Humber. In total 51 isolates comprised 14 
clonal groups. It is likely that clonal expansion is an important mechanism for the 
spread of B. hyodysenteriae and  that an outbreak in one holding could lead to the 
rapid spread of swine dysentery to other holdings. Many of these holdings are 
geographically distant from each other; so, the spread would likely have been 






Figure 3.3.3: Maximum likelihood tree of B. hyodysenteriae isolates based on 
SNP in the core-genome.  
Global isolates published on Genbank have been included. STs have been included 
for isolates of this study. 1000 bootstraps were conducted, and bootstrap values 
above 70 are shown. Untypable refers to isolates that could not be typed, new refers 
to STs identified in this study. js90 and js97 have been highlighted in red. Scale bar 
represents 10 nucleotide substitutions per 100 nucleotides. The global isolates, and 
js71 and js51, have been shown with a W. Unknown includes global isolates where 





3.3.4 Transmission analysis of B. hyodysenteriae in England and Wales 
 
As well as determining the population structure in the UK, transmission events 
between regions of the UK were predicted. This was done using metadata available 
for all isolates in combination with the WGS data. In total 79 isolates were used for 
transmission analysis; the other isolates lacked information on the holding of origin. 
Like the core-genome tree, SNPs were filtered by Gubbins before being used to 
construct a phylogenetic tree. However, js90 was used as the reference instead of 
WA1 as the date of isolation is not known for WA1, and, the aim was to investigate 
transmission events in the UK alone. The tree contained 62,738 SNPs, and the 
average number of SNP per isolate was 794 (Figure 3.3.4). Clustering was slightly 
different to the core-genome tree as transmission between regions over time is 
predicted. The use of a different reference may also have had an effect. There were 
two clusters; one cluster composed of ST 167, ST 87, most of ST 240 and js05 
isolates, with all other isolates being in the second cluster.     
 
Large amounts of the tree were predicted to be unsampled as the oldest sample used 
in the study was from 2004; therefore, anything before this date will be classified as 
unsampled. There does appear to be differences between clades found in different 
regions. The tree was dominated by the South West, where the majority of isolates 
come from a small number of clades, principally, STs 52 and 91. These were present 
for a protracted length of time (nine years for ST 52 isolates and three years for ST 
91 isolates). ST 52 was composed of multiple clonal populations; suggesting the 
expansion of ST 52 being due to multiple outbreaks on holdings, followed by the 
spread to multiple holdings. In Yorkshire and the Humber, there were seven STs 
present, but these were detected for a shorter period, for example, ST 88 was only 
present in Yorkshire and the Humber between 2012 and 2013. Clades appeared to 
spread within a region more than between regions. This may implicate local 
transport as an important factor. Also, the clades with few isolates that occurred in 
Yorkshire and the Humber, and the lack of isolates from the East of England, may 
suggest that B. hyodysenteriae spread was more inhibited in these regions. This 
could reflect bias in the APHA collection, but it could also suggest that in these 
regions there were fewer mechanisms available for the spread of B. hyodysenteriae 
between holdings. In part, this could be due to persistently infected holdings acting 
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as reservoirs. It appears that B. hyodysenteriae spreads more readily within some 
regions than in others, and the spread may be increased by the presence of 
persistently infected holdings.  
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Figure 3.3.4 Transmission event predicted by SCOTTI.  
Holdings with multiple isolates have been indicated in brackets with the year of 
isolation). Clones are indicated in square brackets in blue. Note there is only one 
isolate of clonal groups 7 and 10 as the other isolates did not have sufficient 
metadata. ST are indicated next to the tree. Scale bar represents 20 years. 


















In this study, the aim was to characterise the population structure of B. 
hyodysenteriae in the UK with the aim of identifying clonal groups across pig 
holdings in England and isolates or STs which may be persistent. It was possible to 
identify the population structure by MLST and core-genome SNP based analysis, 
and generally there was an agreement between MLST and SNP based core-genome 
alignment. A prediction of transmission between regions was also intended and was 
possible for all isolates where metadata was available. However, it must be noted 
that submission of isolates to the APHA is voluntary; therefore there will be biases 
in the data/isolate collection, so caution is needed when drawing conclusions. Also, 
most of the samples originated were in England, as this is the main pig producing 
country in the UK; but the lack of samples from other Scotland and Wales means 
conclusions on the population structure in Scotland and Wales cannot be made [269]. 
However, there were trends that were of interest and likely reflect important factors 
affecting the population structure of B. hyodysenteriae. 
 
Analysis of in silico MLST suggested that B. hyodysenteriae is potentially 
recombinant. Recombination of B. hyodysenteriae STs has been seen previously, and 
analysis of historic European isolates from the 1970s did not identify current 
common STs such as 8 and 52 [125]. A similar situation has been found in the USA 
and Australia where there has been divergence of current STs from historic STs. The 
nature of B. hyodysenteriae, whether it is clonal or recombinant, has been debated 
previously. MLEE analysis indicated B. hyodysenteriae was recombinant [117]. 
However, subsequent analysis by MLST and WGS indicated B. hyodysenteriae was 
clonal [121, 125]. From this work, there is evidence that B. hyodysenteriae can be 
clonal, although it appears to mutate relatively quickly. Therefore, divergence of STs 
is likely to continue, and likely to lead to a reduction in the current dominance by ST 
52. 
 
It is unlikely that any ST will develop a dominant position globally due to limited 
movement of pigs between continents. This can be seen in the minimum spanning 
tree (Figure 3.3.1) where many Australian isolates appear distinct, with no ST shared 
with other countries. This may be due to a ban on pigs being imported into Australia 
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since the 1980s, and therefore the B. hyodysenteriae in Australia has been able to 
evolve in isolation [123]. A similar situation was seen with most of the Brazilian and 
North American isolates, which were distinct, with few STs shared with other 
countries. Again, this most likely reflects the regional isolation and the limited 
number of pigs transported between America, Oceania and Europe [253].  
 
There were five STs identified in this study that were common in the rest of Europe, 
chiefly ST 8 and ST 52 [60, 73, 93, 95, 121]. No single ST was completely dominant 
in the UK; ST 52 was the most common, but ST 8 and 91 were also common. A 
similar situation has been seen in other phylogenetic studies of B. hyodysenteriae, 
with multiple STs found [52, 60, 73, 93, 121]. The most common STs for the USA 
(ST 93) and Australia (ST 50, 140 and 150) appeared unique to that continent [52, 
123]. However, in some European countries, the dominant ST had a wide 
distribution. For example, Germany had similar dominant STs to the UK, with ST 52 
dominating and ST 8 also being common [73]. ST 8 was also the dominant ST in 
Spain, and both ST 8 and ST 52 have been found in other European countries 
including Belgium and Italy [60, 124]. However, not all common STs have been 
found throughout Europe; in Germany, 25.9% of isolates were ST 122, a German 
specific ST [73]. In Spain ST 71 was also common, and in Italy, the dominant ST 
(ST 77) was unique to Italy [73, 121, 122]. In Europe there appeared to be a mix of 
country-specific STs and STs that have developed a more widespread distribution. 
As both local and more widespread STs were more common it is unlikely that one 
ST is significantly fitter than other STs, rather spread of STs may be due to the 
chance spread of certain STs by a variety of vectors, for example, animal species or 
biosecurity breakdowns.  
 
The production of pigs is an intensive industry and transport of pigs to slaughter and 
between farms is a key part of this industry. The transport of pigs between countries 
could contribute to the circulation of STs. In the EU there is a large amount of 
movement of pigs between member states. In 2016 9,944,000 pigs were traded for 
slaughter,  22,451,000 pigs were traded for production and 1,030,000 pigs were 
traded for breeding [270]. Potentially trucks that have transported B. hyodysenteriae 
positive pigs and have not been adequately cleaned and disinfected could be a source 
of contamination and a reservoir for B. hyodysenteriae. B. hyodysenteriae can remain 
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viable after decontamination, with the risk of B. hyodysenteriae survival increasing 
with increasing numbers of times pigs were transported by a specific truck [128]. 
Given the large volume of pigs transported across Europe, it is likely that some 
trucks will be used for multiple trips and could be a vector for B. hyodysenteriae. 
 
Also, wild animals could also influence the spread of STs. Migrating birds could 
spread B. hyodysenteriae as they have a wide distribution and migrate across 
multiple countries [66, 67, 271]. The bird species most often associated with B. 
hyodysenteriae is mallard ducks (Anas platyrhynchos) [66, 67]. Reports of ringed 
mallards recovered by EURING (a European organisation monitoring bird 
movement by attaching small rings to birds), indicated  a high concentration of 
mallard ducks on both sides of the English Channel between April and August [271]. 
Mallard ducks migrating across the channel could bring B. hyodysenteriae strains 
with them. Also weakly haemolytic Brachyspira species have been identified in a 
range of other wild birds including Coots (Rallidae fulica) [272]. These also have a 
migratory path that would result in them migrating from the UK to continental 
Europe and vice-versa [271].  After carriage by birds, B. hyodysenteriae could 
colonise rodents through contact with infected faeces; rodents could act as a 
reservoir enabling persistence and transmission of B. hyodysenteriae in the local 
area, including pig farms [68, 273]. Our MLST data suggested B. hyodysenteriae 
movement throughout Europe, with some STs dominant in multiple countries. 
However, the addition of new STs to a region via transport systems or animal vectors 
is likely to lead to a change in the dominant STs over time. To further analyse the 
population structure of B. hyodysenteriae it is necessary to investigate variation 
within STs; in this study, this was done using WGS. 
 
The phylogenetic tree produced was dominated by UK isolates due to the small 
number of isolates currently publically available through Genbank [274]. There are 
small differences between MLST and core-genome analysis, with some isolates 
appearing more closely related than would have been suggested by their STs. Which 
included close similarity between two global isolates WA100 and FMV88.9330; this 
has been found previously by comparison of the che gene [192]. It is possible that 
some clades may be present globally, but this is unlikely to be common. 
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Like MLST data most global isolates appeared distinct from the UK isolates. This is 
consistent with results from MLST studies where the US and Australian isolates 
appeared different from European isolates [52, 125]. Most of the European isolates 
do not cluster with UK isolates. This may reflect local dominance by B. 
hyodysenteriae clades that have not spread, for example, ST 77 in Italy [122]. 
Although the ST of the Genbank isolate, G21 is not stated it is likely it is the ST 8 
G21 isolate on pubMLST (http://pubmlst.org/bhyodysenteriae/). This is a ST 8 
isolate from Germany, which clustered closely with the UK isolates from this panel. 
G21 appeared on a different branch to UK ST 8 isolates, suggesting some divergence 
between ST 8 isolates in the UK and STs from continental Europe. It appeared to 
have been isolated in Hesse in 2004 [275]. Given that there are several STs that are 
shared among European countries, it is likely that as more B. hyodysenteriae isolates 
are sequenced there will be greater clustering of UK and European isolates, in 
particular isolates that belong to the ST 8 and ST 52 groups.   
 
WGS enabled analysis of variation within STs. This led to the identification of 13 
clonal groups which aligned with different STs. These were composed of isolates 
from different regions. This could reflect the spread of B. hyodysenteriae from an 
initial biosecurity failure via pig transport trucks or animal vectors. This spread 
could occur before a diagnosis of swine dysentery has been made, due to the slow 
diagnostic time. Potential clonal expansion of B. hyodysenteriae has been seen in 
Sweden where an outbreak of swine dysentery on one farm led to the spread of 
swine dysentery to four other farms [276]. Three farms had purchased live pigs, and 
transport trucks were implicated in the spread to the fourth farm [276]. It is likely 
that there are multiple mechanisms behind the clonal expansion of B. 
hyodysenteriae, prediction of transmission events may help indicate potentially 
important mechanisms of dissemination of B. hyodysenteriae.  
  
Transmission prediction was performed using SCOTTI in the BEAST 2 
environment. Although BEAST 2 is a useful tool there are limitations; these relate to 
the timescale prediction of BEAST2 where it is possible to generate significantly 
different timescales using the same dataset [260, 277]. Moreover, important inputs 
such as mutation rates are not known for B. hyodysenteriae. Therefore, the timescale 
generated by SCOTTI must be treated with caution. However, the aim of using 
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SCOTTI was not to predict a timescale of B. hyodysenteriae infections in the UK, 
but rather the focus was on predicting potential transmission of B. hyodysenteriae 
between regions of the UK. This has not been done previously for B. hyodysenteriae 
and could provide useful information about dissemination of B. hyodysenteriae in 
pig herds in the UK. 
 
The tree of transmission events predicted by SCOTTI suggests that the population 
structure appears to differ between regions of the UK. The South West appeared to 
have a reasonably stable population composed of ST 52 and ST 91. It also appeared 
to be the primary location of ST 52. The situation was different in Yorkshire and the 
Humber, with many clades present within Yorkshire and the Humber in the 
timeframe covered by this study. This is one of the main pig producing regions of 
the UK and the other main pig producing region of the UK is the East of England 
which also had a diverse range of isolates present [278]. It is likely that a greater 
number of clades can survive as they are present in more reservoirs. These reservoirs 
are likely to include wild animals, trucks and may also include persistently infected 
farms. The variation between regions may also reflect structural differences between 
the pig industry in different regions of the UK. 
 
Pig production in the UK is concentrated in a few areas (Introduction, section 1.1.2). 
With larger producers in the East of England, followed by Yorkshire and the 
Humber; while a large number of small producers are located in the South West 
(Figure 3.4.1) [21, 22]. The East of England is primarily dominated by large 
companies, with 72.1% of producers being classed as large companies (companies 
with >50 farms). This size has an impact on the way pigs are transported. Large 
companies have integrated systems where 89% of the movements of pigs happens 
within their company, i.e. pigs are moved from one company site to another 
company site, compared to 75.6% and 5.3% of pig movement for medium and small 
companies, respectively [21]. Small companies also use fewer hauliers and abattoirs 
than other producers, with medium companies using a greater range of hauliers and 
abattoirs than large companies, and small companies using the greatest range [21]. In 
a region dominated by large companies, there could be fewer biosecurity 
vulnerabilities, and it will be easier to coordinate an eradication program, such as the 
program that occurred in the East of England in 2009  [279]. This may be a 
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contributing factor to the relatively low number of B. hyodysenteriae isolates 
obtained in the East of England.  
 
A slightly different situation is seen in Yorkshire and the Humber. Of the pig 
producing companies in Yorkshire and the Humber, 20.7%  were large companies, 
24.3% were medium companies (companies with 6 to 50 farms), but, crucially 55% 
of farms were small producers [21]. These small farmers mostly transport pigs 
outside of the company and rely on a greater number of hauliers [21]. These 
introduce biosecurity factors outside of the control of the small farmer and may 
result in biosecurity breakdowns. In addition, there were multiple trade communities 
present within Yorkshire and the Humber that were connected to holdings in other 
regions [280]. This could result in the introduction of ST from other regions into 
Yorkshire.  
 
The South West has the highest number of small companies, and, appears to be 
somewhat isolated from other regions and appears to form different trade 
communities [21, 280]. This may be due to the limited distance pigs are typically 
transported, the average distance pigs are transported in the South West is relatively 
small at 30 to 31 km, and only 14% of movements were over 100 km [21, 269]. This 
has continued in recent years with 95% of movements less than 65 km  [280]. The 
spread of ST in the South West could be facilitated by multiple independent hauliers 
transporting pigs for multiple companies. This could result in the spread of a novel 




Figure 3.4.1: A map of the density of pig farms and the proportion of producers 
of different types in each county in England.  
Modified from figure produced by D. Marques and the Scottish agricultural college, 
2008 [269]. Large producers: >1000 pigs moved per year, medium: 1000 – 35 and 







Figure 5 – English pig farm density (number of pig farms - choropleth map) and proportion of pig 
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Figure 5 – English pig farm density (number of pig farms - choropleth map) and proportion of pig 
producers (large/medium/small - colour bar chart) by English county for the year 2008 
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This was one of the first studies to investigate the population structure of B. 
hyodysenteriae in the UK. MLST analysis indicated that there were some pan-
European STs that have a significant presence in the UK. It was also evident that 
there were regional differences between regions of the UK. This could be impacted 
by the biased nature of the sample, but it may also reflect regional differences in pig 
production in the UK. It is notable that the regions with larger and more integrated 
systems had less B. hyodysenteriae. The pig industry is currently becoming more 
industrialised with fewer, larger companies; this could result in better control of B. 
hyodysenteriae in the future [13]. 
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Antibiotic resistance is a major problem for both human and animal health. With the 
development of multi-drug resistant pathogens, there are fewer antibiotics available 
to treat important pathogens [281]. Antibiotics are essential for the treatment of 
veterinary pathogens including SD. In the EU the number of antibiotics that can be 
used to treat swine dysentery is becoming more restricted, in part due to the 
development of resistance to antibiotics such as tylosin [282]. Currently tiamulin, 
valnemulin and tylvalosin are recommended for use [131-133]. However, in the UK 
if no authorised antibiotics are suitable for a specific case, other antibiotics can be 
used as part of the cascade system [283]. The pleuromutilin antibiotics have been 
classified by the World Organisation for Animal Health as critically important for 
the treatment of swine dysentery and for respiratory infections in pigs and poultry 
[284].  
 
The level of resistance to pleuromutilins has been investigated in some of the main 
pig producing countries, including the USA, Germany, Spain, Brazil, and smaller 
producers such as Japan and five other European countries [73, 109, 122, 167, 285-
290]. [115]. Both a wild-type breakpoint and a clinical resistance breakpoint have 
been suggested for tiamulin for both agar dilution and broth dilution MIC methods 
(Table 1.2.5.1) [109, 110]. Analysis of pleuromutilin resistance does indicate 
tiamulin resistant isolates will also have decreased sensitivity to valnemulin [122, 
160, 288, 289], and a wild-type breakpoint has been suggested for valnemulin (Table 
1.2.5.1) [109]. Isolates with a MIC below the wild-type are classed as sensitive, 
isolates with a MIC above the wild-type breakpoint and below clinical resistance are 
classified as intermediate, and isolates with a MIC higher than the clinical resistance 
breakpoint are classed as resistant. Tiamulin resistance has been observed across the 
EU with the lowest levels of antibiotic resistance seen in Sweden [276] and the 
highest levels seen in Germany and Italy where more than 50% of isolates have a 
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tiamulin intermediate or resistant phenotype [73, 122]. In the UK, tiamulin resistance 
was first identified in 1998 and has increased over time, but most current isolates are 
not clinically resistant [291, 292].  
 
SNPs in the 23S rRNA and the 50S rRNA L3 protein (rplC) have been implicated in 
tiamulin resistance; with a SNP at G2032A (E. coli numbering) commonly identified 
in resistant isolates [160, 164]. Other SNPs identified are less clear and have been 
found in both sensitive and resistant isolates [160, 163-165]. There can be a 
disagreement between the resistance phenotype (identified by MIC testing) and 
SNPs identified in the 23S rRNA and rplC [160, 163-165]. Also, there have been 
resistant isolates that do not contain known SNPs in the 23S RNA or rplC [159, 
167]. Although SNPs in the L2 ribosomal proteins have not previously been 
associated with tiamulin resistance, a SNP at T50N in the L2 protein has recently 
been identified that may play a role in tiamulin resistance [163, 293].  
 
Recently two novel antibiotic resistance genes have been identified in B. 
hyodysenteriae. The lincomycin resistance gene lnu(C) was identified in on a 
transposon in an Italian B. hyodysenteriae isolate [165]. This is the first potential 
horizontally transferred gene associated with a stepwise decrease in pleuromutilin 
sensitivity that has been identified in B. hyodysenteriae [165]. In addition, a gene 
associated with pleuromutilin resistance has recently been identified in B. 
hyodysenteriae. This gene, tva(A), is an F-type ATPase [293], which are ABC 
proteins that do not contain intermembrane domains but contain two nucleotide 
binding domains, connected by a linker region [294]. They have been implicated in 
tiamulin resistance in Staphylococcus aureus, S. haemolyticus, and Enterococcus 
faecalis [295-297]. F-type ATPases have activity against antibiotic classes that target 
the ribosome, and it is likely that they bind to the ribosome and can displace the 
antibiotic from the ribosome [294, 298]. The tva(A) gene was identified in B. 
hyodysenteriae isolates with a pleuromutilin intermediate or resistant phenotype 
[293]. It is possible that the tva(A) gene raises tiamulin tolerance slightly, to a similar 
degree as vga(A) does for lincomycin resistance in S. aureus, enabling growth of B. 
hyodysenteriae in the presence of pleuromutilins [299]. It is possible that there may 
be tiamulin resistance genes in B. hyodysenteriae strains that have not been 
identified. WGS could potentially be used in combination with antibiotic 
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susceptibility testing of clinical isolates to identify other genes in the accessory 
genome that have caused pleuromutilin resistance.  
 
4.1.1. Study aims 
 
This study builds upon previous work at the APHA where analysis of B. 
hyodysenteriae isolates identified novel SNPs and the tva(A) gene, both associated 
with pleuromutilin resistance [165]. However, in the previous study 34 B. 
hyodysenteriae isolates were analysed. This study aimed to verify these results on a 
larger set of isolates that had been previously sequenced (Chapter 3) and identify 
other mechanisms of antibiotic resistance. MIC results of clinical isolates of B. 
hyodysenteriae were also investigated using survival curves; this has not previously 
been done for UK isolates. In addition, the ability to induce resistance was 
investigated for tiamulin and valnemulin. 
4.2 Methods 
 
4.2.1 Sample Selection for MIC testing 
 
The same isolates that were used previously (Chapter 3) were used in this study. A 
rational selection of 49 isolates for MIC testing was conducted. Samples were 
initially chosen from the North East of England and Yorkshire as this is the main pig 
producing region of the UK. Isolates were then chosen to ensure selection of isolates 
from across England, and that a range of pleuromutilin resistance genotypes were 
included.  
 
4.2.2 Identification of SNPs in the 23S rRNA and rplC of sequenced B. 
hyodysenteriae isolates 
 
After genomes had been annotated, the 23S rRNA gene and rplC of each isolate 
were isolated using the find function in TextWrangler (Bare Bones Software, USA). 
These genes were compared to the E. coli 23S rRNA (J01685) and the B. pilosicoli 
rplC (AF114845) reference genes, previously used in published literature, to identify 
SNPs (90, 92, 93). This was done using NUCmer (version 3.1) [300].  
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4.2.3 Analysis of the accessory genome of sequenced B. hyodysenteriae 
isolates 
 
To identify genes of interest, Roary (version 3.8.2) was used to identify genes 
present in the accessory genome and absent from closely related strains [301]. These 
genes were then converted into a fasta file of genes of interest, which were screened 
against sequenced fasta files using LS-BSR (version last modified 2/9/2016) [302]. 
LS-BSR preforms reciprocal blast search of all genes in all isolates, and it was used 
to search the presence of genes in all isolates. Snippy was used to identify SNPs, and 
domains in genes of interest were analysed using Interpro [303]. To compare two 
genes nucleotide BLAST was used [304]. 
 
4.2.4 MIC testing by broth dilution  
 
VetMIC Brachy plates were used for MIC testing by broth dilution. B. 
hyodysenteriae was grown overnight in pre-reduced 5 ml BHI (10%) in an anaerobic 
cabinet at 37 C. This was then diluted to a MacFarland standard of 1.5-2 using pre-
reduced BHI (10%) and added to 27 ml pre-reduced BHI (10%) and inverted to mix. 
To this 0.5 ml of this culture was added to each well of a VetMIC Brachy plate 
(SVA), and it was incubated at 37 C under anaerobic conditions with shaking (80 
rpm) for four days. Also, the 30 ml culture was used to make a dilution series by 
performing 1:10 serial dilutions in pre-reduced BHI (10% serum). From this dilution 
series 100 l aliquots of the 1:100, the 1:1000 dilutions and the neat culture were 
plated out on FABA plates. The plates were then incubated for four days. After four 
days, MICs were obtained, and isolates were categorised into sensitive, intermediate 
or resistant (Table 4.2.3). Isolates below the wild type breakpoint were classified as 
sensitive, isolates above the clinical resistance breakpoint were classified as resistant, 
and all isolates between these two breakpoints were classified as sensitive. Also, 
colonies on the 1:100 and 1:1000 plates were counted to estimate the bacterial 
CFU/ml present in the 30 ml culture; while the plate from the 30 ml culture was used 
to check for any contamination. Plates were classified as contaminated if clear 
colonies were observed, or if the growth observed was not an off-white colour. If 
contamination was observed the broth dilution MIC was repeated. In addition, there 
were three controls that were used each time a series of isolates were tested: an 
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isolate with a known MIC was tested, there had to be 1x106 CFU/ml cells tested in 
the VetMIC Brachy plate (the recommended minimum), and growth in the negative 
control well of each plate (containing only distilled water). The B78T type strain was 
tested, as this strain has been used previously; for broth dilution MICs to be accepted 
the B78T the MICs for tiamulin, valnemulin, doxycycline, lincomycin and tylosin 
had to be within the range previously established (tiamulin MIC: 0.063 (g/ml), 
valnemulin MIC: 0.031 (g/ml),  tylosin MIC: 2 to 16 (g/ml), Lincomycin MIC: 1 
(g/ml), and doxycycline 0.125 to 0.5 (g/ml)) [116]. For a test to be accepted the 
MICs for B78T had to be within range, growth had to be observed in the negative 
control well, and the CFU/ml calculated from the dilution series had to be 
approximately 1x106 CFU/ml. If these controls failed, the broth dilution MIC was 
repeated. 
 79 
Table 4.2.3: Breakpoints used in this study 
 
Antibiotic 
Wild type  
MIC (mg/L) 
Clinical resistance 
breakpoint   
MIC (mg/L) 
Tiamulin >0.25 [109] >2  [109] 
Valnemulin >0.125 [109] N/A  
Doxycycline >0.5 [109] >4 [111] 
Tylvalosin >1 [109] >16 [110] 
Lincomycin > 1 [109] >16 [110] 
Tylosin > 16 [109] >16 [110, 276] 
 
4.2.5 Making tiamulin and valnemulin disks 
 
Tiamulin and valnemulin disks were made in-house as commercial disks are not 
produced. Tiamulin fumarate and valnemulin hydrochloride were obtained from 
Sigma. These were dissolved in sterile water to a concentration of 50 g/ml. To 
make lower concentrations the stock solution was further diluted to 10 g/ml. When 
the desired stock concentration had been achieved the stock was filter sterilised with 
a 0.2-micron filter. A working solution was made with a concentration range from 
1.6 – 150 g/l (table 4.2.5). From the working solution 20 /l was then added to 
blank disks (5mm disks: Fisher Scientific), (l0mm disks: Sigma) and left to air dry in 
a class II MSC for 20 minutes. 
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Table 4.2.5: Concentrations used to produce tiamulin and valnemulin disks. 
















32 1.6 10 3.2 16.8 5 
64 3.2 10 6.4 13.6 5 
128 6.4 10 12.8 7.2 5 
256 12.8 50 5.12 14.88 5 
512 25.6 50 10.24 9.76 5 
1000 50 50 20 0 5 
2000 100 50 40 0 10 
3000 150 50 60 0 10 
 
 
4.2.6 Mutant selection  
 
Mutant selection in isolates was based on the technique used by Card. et al. [293]. 
Three isolates were grown from frozen stock as previously described (Materials and 
methods, section 2.3.2) and subcultured at least twice before being used. Isolates 
were selected based upon MIC and the absence of SNPs associated with 
pleuromutilin resistance. At this point 200 l of pre-reduced BHI (10%) was 
aliquoted into a sterile Eppendorf. A loopful of bacteria was scraped from the plate, 
added to the BHI (10%) and mixed by pipetting. Of this 100 l was plated onto two 
new FABA plates. To one plate an antibiotic disk with an initial disk concentration 
of 32 g of valnemulin per disk was added. For isolates grown in tiamulin, MIC 
strips (Liofilchem) were initially used. The plate containing antibiotics will be 
referred to as the antibiotic supplemented plate. The other plate to which an 
antibiotic disc was not added will be referred to as the growth plate. Isolates were 
incubated for three to four days at 38 °C in anaerobic conditions. After incubation, 
the growth plate was inspected for visible growth and contamination. For the 
antibiotic supplemented plate the zone of bacterial growth inhibition was measured 
from the edge of the disk to the edge of the zone of inhibition of growth.  Bacteria 
were scraped from the edge of the zone of inhibition and suspended into 200 l BHI 
(10%), and 100 l plated onto antibiotic supplemented and antibiotic-free plates. If 
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the zone of inhibition was <10mm then bacteria recovered from the plates were 
replated and grown in the presence of discs containing double the concentration of 
antibiotic. After every fifth subculture of bacteria from the antibiotic-free plate a cell 
pellet and a frozen stock was prepared (Materials and methods, section 2.3.3). After 
the 20th subculture, isolates on the growth plate were sequenced at the APHA using 
an Illumina NextSeq. Sequences were assembled as described previously (Materials 
and methods, section 2.6.1) with the following exceptions: sequences were not 
aligned to the WA1 reference genome, also sequences were compared with the 
isogenic parent using Snippy (version 3.1) [244]. Subculturing to induce resistance 
was performed over three months. 
 
4.2.7 Statistical analysis 
 
MIC results were used to construct Kaplan-Meier survival curves, for each antibiotic 
tested. For isolates with a MIC greater or less than the maximum or minimum 
dilution value of the VetMIC Brachy plate, the MIC was converted to the largest or 
smallest MIC respectively. MICs were then multiplied by 32, except for valnemulin 
MICs which was multiplied by 33, and converted into positive log2 values as 
previously done by Hidalgo et al. [167, 305].  Isolates were multiplied by 32, or 33 
to ensure positive log2 values were obtained. This was done using SPSS version 22.0 
(IBM), and a log-rank test was used for statistical analysis. Isolates were split into 
two groups: a 2004 to 2009 and 2010 to 2015 group.  Significance was determined 
as a P value of less than 0.05. Specificity and sensitivity were calculated as a two by 
two table [306].  
4.3 Results 
 
Antibiotic susceptibility testing was performed for 47 isolates using the broth 
dilution method previously described. All isolates that were tested had also been 
sequenced (Chapter 3). The isolates included in our panel were from 2004 to 2015 
and selected from all regions of England. 
 
4.3.1 Antibiotic resistance in B. hyodysenteriae 
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Sensitivities to six antibiotics were tested by broth dilution on the panel of 47 
isolates (Table 4.3.1.1). The MIC results were used to construct survival curves 
(Figure 4.3.1.1). The isolates were split into two group for the analysis: a 2004 to 
2009 group with 24 isolates; and a 2010 to 2015 group with 23 isolates. This split 
was chosen as 2010 which was the end of a British pig executive swine dysentery 
eradication project which started in 2009 in the East of England; therefore this was a 
date when industrial attitudes to swine dysentery appeared to have changed [279].  
 
To visualise, and statistically analyse, the susceptibility data survival curves were 
constructed. The survival curves obtained using MIC data from doxycycline and 
tylvalosin testing showed there was little difference between the susceptibility of 
isolates in the two groups. For tylosin and lincomycin, there was a reduction in 
sensitivity in the 2009 to 2015 group from the 2004 to 2009 group, but this was not 
statistically significant difference. However, there were significant differences for 
tiamulin (P value = 0.024) and valnemulin (P value = 0.002), between isolates from 
the two groups (Figure 4.3.1.1). For tylosin the difference was due to an increase in 
clinical resistance; this indicates that tylosin resistance is common, with more than 
50% of isolates clinically resistant. The percentage of clinical tylosin resistance 
suggest that this antibiotic is no longer a useful method of treating B. hyodysenteriae 
infections in the UK. For tiamulin and valnemulin, the difference between the two 
groups was due to an increase in the number of intermediate isolates in the 2010 to 
2015 group, which was linked with a decline in sensitive isolates. These results 
indicate a long-term trend towards decreased susceptibility of UK isolates to 




Table 4.3.1.1: Tiamulin and valnemulin, doxycycline, tylvalosin, lincomycin and tylosin MICs obtained by broth dilution and 
SNPs associated with resistance.  






















23S rRNA SNPs 




Range 0.25 to 4 0.24 to 8 0.5 to 64 2 to 128 
0.063 to 
8 
0.031 to 4         
MIC 50 0.5 0.5 0.5 4 0.25 0.5         
MIC 90 2 32 16 128 1 1         
js08 2 16 32 >128 ≤0.063 ≤0.031 
A205
8T 
      
G2535
A 
    
G1058
C 
js13 0.5 8 16 >128 ≤0.063 ≤0.032 
A205
8T 
            
G1058
T 
js14 4 8 32 8 ≤0.063 ≤0.031 
A205
8T 
      
G2535
A 
      
js15 4 16 64 8 ≤0.063 ≤0.031 
A205
8T 
              
js16 0.5 8 ≤0.5 4 ≤0.063 ≤0.031 
A205
8T 
      
G2535
A 
    
G1058
C 
js17 0.5 0.5 0.5 4 ≤0.063 0.031               
G1058
C 
js29 0.25 16 32 8 ≤0.063 ≤0.031 
A205
8T 
        
N148
S 
    
js60 ≤0.125 2 8 >128 ≤0.063 ≤0.031 
A205
8T 
            
G1058
C 
js61 2 16 32 >128 ≤0.063 ≤0.031 
A205
8T 
      
G2535
A 
























23S rRNA SNPs 




js66 1 2 16 8 ≤0.063 ≤0.031 
A205
8T 
              
js77 0.25 0.25 0.5 2 ≤0.063 ≤0.031               
G1058
C 
js90 ≤0.125 ≤0.25 ≤0.5 ≤2 ≤0.063 ≤0.031               
G1058
C 
js92 ≤0.25 1 4 >128 ≤0.063 ≤0.031 
A205
8T 
            
G1058
C 
js02 1 8 16 8 ≤0.063 0.063 
A205
8T 
      
G2535
A 
      
js05 ≤0.125 16 32 8 ≤0.063 0.063 
A205
8T 
              
js06 ≤0.125 32 16 16 ≤0.063 0.063 
A205
8T 
              
js19 0.25 16 32 16 0.063 0.063 
A205
8T 
              
js20 0.5 16 32 16 0.063 0.063 
A205
8T 
              
js22 0.5 32 64 16 0.063 0.031 
A205
8T 
            
G1058
C 
js27 1 1 16 64 0.063 0.25 
A205
8T 
      
G2535
A 
  tva(A) 
G1058
C 
js37 ≤0.125 2 16 >128 0.063 0.031 
A205
8T 
            
G1058
C 
js11 2 2 32 >128 0.125 ≤0.031 
A205
8T 








js07 0.5 2 8 64 0.25 0.5 
A205
8T 





  tva(A) 
G1058
C 
js18 2 0.5 0.5 4 0.25 0.5             tva(A) 
G1058
C 
js26 1 2 16 64 0.25 0.5 
A205
8T 
























23S rRNA SNPs 




js28 1 2 32 16 0.25 0.25 
A205
8T 
          tva(A) 
G1058
T 
js09 ≤0.125 2 16 >128 0.5 2 
A205
8T 
          tva(A)   
js12 2 4 32 128 0.5 2 
A205
8T 
      
G2535
A 
  tva(A) 
G1058
C 
js43 2 8 32 >128 0.5 1 
A205
8T 





  tva(A)   
js46 0.5 0.5 2 4 0.5 0.5             tva(A) 
G1058
C 
js69 0.5 2 8 128 0.5 1 
A205
8T 
          tva(A) 
G1058
C 
js71 ≤0.125 4 16 >128 0.5 1 
A205
8T 
          tva(A)   
js97 1 4 32 128 0.5 1 
A205
8T 
      
G2535
A 
  tva(A)   
js99 2 4 16 128 0.5 1 
A205
8T 
      
G2535
A 
  tva(A)   










  tva(A)   
js25 0.5 0.5 8 16 1 2         
G2535
A 
  tva(A) 
G1058
C 














js44 4 8 32 >128 1 2 
A205
8T 





  tva(A)   
js72 ≤0.125 2 16 >128 1 1 
A205
8T 
          tva(A)   
js73 2 8 16 >128 1 1 
A205
8T 
          tva(A)   





























23S rRNA SNPs 




js31 0.25 8 32 >128 2 2 
A205
8T 
          tva(A)   
js49 0.25 1 2 4 4 1         
G2535
A 
  tva(A)   
js23 2 2 32 128 8 4 
A205
8T 





tva(A)   
js24 1 2 16 16 8 4         
G2535
A 
  tva(A)   









  tva(A) 
G1058
C 
js48 0.25 0.5 2 4 8 1         
G2535
A 







Figure 4.3.1.1: Survival curves of MICs obtained by broth dilution.  
The 2004 to 2009 group is the blue line, and 2010 to 2015 is the green line. The Red 
dashed line is the clinical resistance breakpoints used in this study, and the green dashed 
line is the wild-type breakpoint. Note tylosin only has a red dashed line as the wild type 
breakpoint, and clinical resistance breakpoints are the same [109, 276]. 
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To identify an antibiotic resistance genotype for all isolates that were MIC tested the 
sequence for each isolate was compared to previously published SNPs that have been 
associated with antibiotic resistance for each antibiotic tested by broth dilution. SNPs 
previously associated with antibiotic resistance were identified in the 23s rRNA and 
rplC to give a predicted resistance genotype (Table 4.3.1.1). This was compared to the 
resistance phenotype obtained from the MIC. The phenotype was taken to be the gold 
standard and was compared to the genotype. A true positive was taken to be where both 
phenotype and genotype matched; where the results didn’t match they were classified as 
false positive or negatives; this was then used to calculate the specificity, sensitivity, 
positive predicted value, and negative predictive value [165].  
 
The sensitivity and specificity varied between antibiotics (Table 4.3.1.1). For three 
antibiotics (tylvalosin, tylosin and lincomycin) resistance was caused by a single SNP in 
the 23S rRNA: A2058T [144]. This SNP was present in 37 isolates for which MIC data 
was available and was the most common SNP detected. One isolate (js74) had an 
alternative SNP at A2059G that is also likely to confer resistance to macrolides and 
lincomycin. These SNPs were mostly present in isolates with MICs above the wild type 
breakpoint, but, with the exception of tylosin, were also present in sensitive isolates 
(Table 4.3.1.1). These SNPs were used to predict reduced susceptibility (isolates that 
are predicted not to have a sensitive phenotype) based on the presence of the A2058T or 
A2059G SNPs (predicted genotype). The sensitivity and specificity of the correlation 
between phenotype and genotype was high for tylvalosin (sensitivity: 97.37%, 
specificity: 88.89%), and lincomycin (sensitivity: 88.1%, specificity: 80%). There was 
also high sensitivity for tylosin (100%). However, the specificity for tylosin was 
considerably lower (42.86%), and there was a low negative predicted value for 
lincomycin (44.44%). For tylosin the low specificity was due to 11 false negatives; 
while the low negative predicted value was due to the high number of false negatives 
(five false positives compared to four true negatives). In both cases, this is likely due to 
isolates with MICs near to the wild type breakpoint. For tylosin, there were two 
dilutions below the wild type breakpoint; while for lincomycin three out of five false 
negatives were within two dilutions above the wild type breakpoint. This variation is 
within the variation previously observed for B78T [165].  
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Resistance to doxycycline in B. hyodysenteriae has been associated with a G1058C 
SNP in the 16S rRNA [111]. This SNP was present in 23 isolates, and there was also an 
alternative SNP (G1058T) identified in two isolates. A comparison of this doxycycline 
genotypic resistance to the phenotypic resistance showed high correlation with 
sensitivity of 95.45% and specificity of 84%.  
 
For tiamulin and valnemulin, no single SNP was common to all isolates with reduced 
susceptibility to pleuromutilins, and SNPs were found in both susceptible isolates and 
isolates with reduced susceptibility. A comparison of predicted genotypic resistance and 
phenotypic resistance showed low correlation with the sensitivity and specificity for 
tiamulin being 66.67% and 65.38% respectively, and for valnemulin, the sensitivity was 
61.54%, and specificity 66.67%. The poor sensitivity and specificity may be due to the 
inclusion of SNPs that do not contribute to pleuromutilin resistance as the role of many 
SNPs has not yet been clearly established. It may also indicate that other mechanisms 
may be involved in pleuromutilin resistance in B. hyodysenteriae. 
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Table 4.3.1.2: Specificity and sensitivity of prediction of sensitivity to tiamulin, 
valnemulin, doxycycline, tylvalosin, lincomycin and tylosin based on genotype. 
Previously published SNPs were used to predict genotype. Values above 80% have 
been shown in bold. 
 
Within the panel of isolates that were MIC tested there were three isolates that were 
closely related: js11, js23 and js24. Two of these (js23 and js24) were clinically 
resistant to pleuromutilins; while js11 was sensitive. All three isolates had the same 
SNPs in the 23S rRNA and rplC. Analysis of the accessory genome by Roary [301] of 
js23 and js24 identified an ATPase that was absent from js11. The amino acid sequence 
was investigated using Interpro which indicated this gene contained two AAA+ ATPase 
domains, and no membrane-spanning domains were identified. It is therefore unlikely to 
be an efflux pump. Recently a novel pleuromutilin resistance gene tva(A) has been 
identified. BLAST was used to compare the ATPase identified in this study to tva(A) 
(PRJEB24023) and showed 100% coverage and identity. LS-BSR [302] was used to 
identify tva(A) in all sequenced isolates, including all other isolates that had been MIC 
tested (Figure 4.3.1.2a and b). It was present in all isolates with a tiamulin MIC of 0.25 
g/ml or greater but was only present in one isolate (js27) with a MIC below 0.25 g/ml 
(Table 4.3.1.2). In total tva(A) was identified in 55.32% of isolates. The tiamulin and 
valnemulin phenotype and genotype were compared with the presence of tva(A) being 
used to indicate an intermediate or resistant phenotype. As a result, the specificity and 
  
Tiamulin Valnemulin Doxycycline Tylvalosin Lincomycin Tylosin 
SNPs SNPs SNPs SNPs SNPs SNPs 
True 
Positive 14 16 21 37 37 27 
False 
Positive 9 7 4 1 1 11 
True 
negative 17 14 21 8 4 9 
False 
Negative 7 10 1 1 5 0 
Sensitivity 
(%) 66.67 61.54 95.45 100 88.1 100 
Specificity 
(%) 65.38 66.67 84 80 80 42.86 
Positive 
predictive 
value (%) 60.87 69.57 84 94.87 97.37 68.42 
Negative 
predictive 
value (%) 70.83 58.33 95.45 100 44.44 57.14 
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sensitivity for and valnemulin increased from ~60% to 100% and that for tiamulin 
increased to >80% (sensitivity: 80.77%, specificity: 84%)(Table 4.3.1.3).   
 
Table 4.3.1.3: Comparison of specificity and sensitivity of prediction of sensitivity 
to tiamulin and valnemulin based on previously published SNPs and tva(A). 
Previously published SNPs were used to predict genotype. Values above 80% have 
been shown in bold. 
 
To identify the distribution of tva(A), the phylogenetic tree produced previously 
(Chapter 3, section 3.3.3), was annotated with tva(A) presence or absence (Figure 
4.3.1.3). It was absent from most of A and B, and was entirely absent from C and D. 
There were no clades that were composed entirely of isolates containing tva(A).  It was 
present in four clades, and tva(A) has become more common over time, in the 2004 to 
2009 group there were six isolates with tva(A) compared to 20 in the 2010 to 2015 
group. This could suggest tva(A) is becoming more prevalent, this may be due to clonal 
expansion of isolates containing tva(A), but it could also be due to horizontal gene 
transfer. Analysis of all previously sequenced B. hyodysenteriae isolates identified 
tva(A) in other sequenced isolates; in total 30% of all sequenced B. hyodysenteriae 
isolates contained tva(A). This included two global isolates: the Italian isolates BH718 
(with an LS-BSR score of 0.97) and the Australian isolate Q17 (with a score of 0.85). 
Both of these tva(A) genes were compared to tva(A) from js24 using BLASTp for 
BH718 tva(A) had an identity of 99%;while for Q17 the tva(A) gene had an identity of 
95%. BH718 was isolated in 2017 and Q17 was isolated in the 1990’s. It is therefore 
likely that tva(A) has been present in B. hyodysenteriae for decades. Over this time it is 




Valnemulin   
tva(A) SNPs SNPs 
True Positive 14 21 16 26 
False Positive 9 0 7 0 
True negative 17 21 14 21 
False Negative 7 5 10 0 
Sensitivity (%) 66.67 80.77 61.54 100 
Specificity (%) 65.38 100 66.67 100 
Positive predictive 
value (%) 60.87 100 69.57 100 
Negative predictive 
value (%) 70.83 80.77 58.33 100 
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been sequenced globally, but, as more isolates are sequenced, it is likely that tva(A), or 
other AMR genes, will be found more commonly. It is unknown if tva(A) can be 
transferred by horizontal gene transfer; potentially it could be, but there was no 
evidence of transposons in regions flanking tva(A) in sequenced isolates.  
 
Figure 4.3.1.2: Percentage of isolates containing tva(A) based on their 
pleuromutilin resistance phenotype.  
The presence of  tva(A) was identified with LS-BSR [302]. 
Abbreviations: 
a: based on tiamulin resistance phenotype, b: based on valnemulin resistance phenotype. 
Percentage of isolates containing tva(A) is shown above the bars.  
 
















































































Figure 4.3.1.3: Phylogenetic tree of sequenced B. hyodysenteriae isolates (Chapter 
3) and isolates from NCBI annotated with presence or absence of tva(A).  
RAxML was used for bootstrapping, and 1000 bootstraps were conducted. Bootstrap 
support above 70 is shown. The first strip shows Region of origin and the second shows 
the presence or absence of tva(A) identified by LS-BSR. The global isolates, and js71 
and js51, have been shown with a W. 
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As it was possible to predict reduced sensitivity to tiamulin, valnemulin, doxycycline, 
tylvalosin and lincomycin based on genotype with good (higher than 80%) specificity 
and sensitivity a predicted antibiotic sensitivity was made for all 84 sequenced B. 
hyodysenteriae isolates (Table 4.3.1.5.) The predicted sensitivity to tylosin was also 
made, but due to the low specificity (42.86%), caution must be taken when drawing any 
conclusions from this. The most common SNP identified in the isolates was a SNP at 
A2058T in the 23S rRNA (present in 67 isolates), followed by SNP at G1058C in 16S 
rRNA (present in 35 isolates). For tylvalosin, tylosin and lincomycin the majority 
(78.57%) of isolates are predicted to harbour phenotypic resistances above the wild type 
breakpoint (Table 4.3.1.4). All these antibiotics had the same result as a single SNP was 
responsible for the reduced sensitivity to these antibiotics. For doxycycline, tiamulin 
and valnemulin, the levels are lower (41.67%). This was due to a lower number of 
isolates with the G1058C SNP and tva(A) and may suggest these antibiotics would be 
more suitable for swine dysentery in the UK. 
 
Table 4.3.1.4: Predicted resistance phenotype based on previously published SNPs 
and tva(A) present in all 84 sequenced UK isolates. 
 




breakpoint 35 35 35 66 66 66 
Percentage 41.67 41.67 41.67 78.57 78.57 78.57 
 
 
4.3.2 Mutant selection to tiamulin and valnemulin 
 
It is possible that tva(A) may affect tiamulin and valnemulin resistance differently. To 
investigate this three isolates were grown in increasing sub-lethal concentration of 
tiamulin or valnemulin. All these isolates had been previously sequenced and contained 
no SNPs associated with tiamulin resistance. The isolates chosen compromised an 
isolate phenotypically sensitive to tiamulin that lacked tva(A) (js17), a tiamulin 
intermediate isolate with tva(A) (js31) and a tiamulin sensitive isolate js27 with tva(A). 
None of these isolates had any SNPs previously associated with tiamulin resistance. All 
isolates were able to grow on disks with higher concentrations of tiamulin or 
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valnemulin by the end of the experiment. After 20 subcultures, each strain was MIC 
tested (table 4.3.2.1). The dilution series failed for three daughter isolates (js31t20, 
js31v20 and js17v20), and it was not possible to repeat these MICs. Therefore, it was 
not possible to determine if these isolates had developed resistance.  
 
However, MICs were obtained for js17t20 and js27t20 and js27v20. In all these isolates 
there was a reduction in sensitivity to tiamulin and valnemulin. For js27 there was a 
clear difference between the js27 isogenic parent and isolates that had been serially 
subcultured in the presence of tiamulin for 20 passages (js27t20) or valnemulin for 20 
passages (js27v20) with both isolates having reduced sensitivity to tiamulin and 
valnemulin. This was also observed in js17t20, where tiamulin and valnemulin 
susceptibility also decreased with repeated passage in the presence of the antibiotics. 
The greatest change occurred in js27, where both js27t20 and js27v20 became clinically 
resistant to tiamulin from being fully sensitive. This isolate contains the tva(A) gene and 
the greater increase in tiamulin resistance seen in js27 may be due to the presence of 
this gene. Alternatively, there could have been a mutation in a remote site, for example, 
a regulator, that resulted in increased expression of tva(A) resulting in clinical 
resistance. In addition, in 17t20 there was a marked increase in resistance to lincomycin 




Table 4.3.2.1: MICs of isolates grown in increasing sub-lethal concentrations of 
tiamulin or valnemulin and the parent strain.  
Note MICs have not been shown for js31t20, js31v20 and js17v20 as the dilution series 
failed for these isolates. 
Abbreviations: 
t indicated isolates grown in tiamulin while v indicates valnemulin. Tia = tiamulin, Val 
= valnemulin, Dox = doxycycline, Tylv = tylvalosin, Lin = lincomycin and Tyl = 
















js17-0 0.063 0.031 0.5 0.5 0.5 4 
js17t20 1 1 1 2 16 32 
js27-0 0.063 0.25 1 1 16 64 
js27t20 8 4 0.5 4 32 64 
js27v20 4 4 2 4 64 64 
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All daughter isolates (js17t20, js17v20, js27t20, js27v20, js 31t20 and js31v20) were 
sequenced after 20 subcultures on a single NextSeq run at the APHA by the Central 
Sequencing Unit (Table 4.3.2.2). High coverage was obtained for all isolates and is 
likely due to the greater sequencing power of the NextSeq system. Similar percentage 
identity to WA1 was observed as for isolates sequenced on the MiSeq; this again 
highlights the importance of establishing a completely sequenced UK reference strain. 
 
Table 4.3.2.2: Sequencing results of isolates grown in increasing sub-lethal 
concentration of tiamulin or valnemulin.  
Isolates subcultured in the presence of tiamulin are identified with a t, isolates 
subcultured in the presence of valnemulin are signified with a v, and 20 refers to the 

















js17t20 3290782 29.5 113 471244 321698 158x 88.29 
js17v20 4372734 29.3 149 1157885 396753 212x 91.03 
js27t20 7548512 29.8 433 949522 257966 349x 74.73 
js27v20 3847642 29.8 168 732489 187840 186x 77.28 
js31t20 4414172 29.1 279 485817 280296 213x 78.43 
js31v20 4084866 29.2 368 740691 385616 196x 82.24 
 
 
A core-genome tree was produced and isolates clustered with the parent strain 
(Appendix 2). Also, isolates were compared to their isogenic parent strain to identify 
SNPs that could potentially be involved in AMR. Most SNPs identified were in non-
coding regions or were non-synonymous. Of the remaining SNPs, most were unlikely to 
be involved in AMR, for example, SNPs were often identified in variant surface 
proteins. However, in all isolates that had increased resistance to tiamulin and 
valnemulin, there were SNPs identified that may have contributed (Table 4.3.2.3). The 
same potential resistant SNPs were identified in isolates that had been exposed to 
tiamulin or valnemulin. This may be due to the small sample size, or the short length of 
exposure (three months), but it may also suggest that the same SNPs can confer 




Table 4.3.2.3: SNPs identified in isolates when compared to the parent strain. 
B. hyodysenteriae WA1 locus tags have been given for SNPs in novel genes. 
 
  js17t20 js17v20 js27t20 js27v20 js31t20 js31v20 
Total SNPs 237 245 482 411 97 113 
Total non-
synonymous  
SNPs  62 60 133 121 30 37 
SNPs in 23s 
rRNA G2061T G2061T         
SNPs in rplC 
protein           S149T 
SNPs in ABC 
binding protein 
(BHWA1_0019)     N503T N503T     
Non-
synonymous 
















55) (F110L)      
    
Multidrug 
resistance 





protein MdtC  
(BHWA1_005
06) (S700T)     
 
There were a variety of SNPs detected with clear differences between isolates 
originating from js17, js27 and js31. Similar SNPs were detected in both daughter 
lineages. Although js17t20, js27t20 and js27v20 had reduced tolerance to tiamulin, only 
js17v20 and js17t20 contained a SNP in the 23S rRNA. The SNP at G2061T (E. coli 
numbering) in the 23S rRNA was the only potential tiamulin resistant SNP identified in 
js17v20 and js17t20. These isolates also had decreased susceptibility for lincomycin and 
tylvalosin. This SNP, therefore, might also contribute to the increased resistance to 
lincomycin and tylvalosin seen in MIC testing. Js27t20 and js27v20 did not contain any 
new SNPs in the 23SrRNA or rplC compared to the isogenic parent. However, for 
js27t20 and js27v20 there were amino acid substitutions in an ATP binding protein and 
in potential efflux pumps. It is possible that these SNPs could have increased the 
efficiency of the efflux pumps leading to increased binding of tiamulin and increasing 
the efflux out of the cell. There were also SNPs in hypothetical genes, these have not 
been well categorised in B. hyodysenteriae and may include regulatory genes; a 
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mutation in a regulatory gene could also lead to a reduction in tiamulin and valnemulin 
susceptibility.  
 
Although the broth dilution susceptibility test failed for both js31t20 and js31v20, there 
was a SNP identified in js31v20 in rplC that has been previously associated with 
pleuromutilin resistance [159, 167]. To determine if this SNP would have caused an 
increase in resistance to pleuromutilins it would be necessary to repeat the broth dilution 
susceptibility test. It is possible that the SNP would result in js31v20 having a different 
pleuromutilin resistance phenotype compared to js31t20. 
4.4 Discussion 
 
This study aimed to investigate the mechanisms behind antibiotic resistance within B. 
hyodysenteriae in the UK. For macrolides, there was a high level of resistance observed, 
and a high level of reduced susceptibility was predicted from sequenced isolates 
(78.57%). The same was also found for lincomycin. Resistance to these antibiotics is 
caused by a SNP in the 23S rRNA: A2058T [144]. Another SNP was identified in this 
study A2059C; this has been previously identified in Spanish B. hyodysenteriae isolates 
[160].  The high level of resistance observed in this study have been seen in other EU 
countries including Spain [167], and Italy [122]. High levels of resistance are also seen 
globally, for example in Brazil [286], the USA [285] and Japan [287]. This supports the 
decision by the European Medicines Agency to remove tylosin and lincomycin as 
recommended treatments for swine dysentery [282]. It is likely that the A2058T SNP is 
common globally. A SNPs at  A2058G has also been associated with macrolide 
resistance in Mycoplasma smegmatis and in M. smegmatis analysis has suggested that 
the fitness cost of this SNP is not significant (0.4 to 1.4%) per generation, and this was 
not due to compensatory mutations [307]. Although this is a different species to B. 
hyodysenteriae, it is possible that the fitness cost of the A2058T SNP for B. 
hyodysenteriae may also be small. If this is the case macrolide and lincomycin 
resistance in B. hyodysenteriae is likely to continue in the UK, despite the removal of 
tylosin and lincomycin from the recommended list of antibiotics to treat swine 
dysentery [282].   
 
Resistance to doxycycline was lower than for macrolides and lincomycin. However, the 
SNP in 16S G1058C associated with doxycycline resistance in B. hyodysenteriae was 
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common in this study. Also, in two doxycycline resistant isolates (js04 and js30) an 
alternative SNP was detected at G1058T, which has previously been identified in the 
UK [293]. Global resistance to doxycycline varies considerably in B. hyodysenteriae. In 
the USA 50% of isolates were sensitive [285]; while in Brazil [286] and Belgium [60], 
most isolates have reduced sensitivity.  
 
In this study, there were low levels of pleuromutilin resistance with only five isolates 
clinically resistant to tiamulin. This has also been seen in UK surveillance reports, 
where the majority of isolates were not resistant [292]. However, there were many 
intermediate isolates, and more than half of the isolates tested were sensitive to tiamulin 
and valnemulin. When the presence of tva(A) was used to predict the resistance 
phenotype of all sequenced isolates, there was a similar result to resistance detected by 
MIC testing with 41.67% of isolates having reduced sensitivity to tiamulin and 
valnemulin. Similar levels have been seen in Belgium, with 48.28% of isolates below 
the wild type breakpoint when the MIC was obtained by broth dilution (Table 4.4.1) 
[60]. However, most countries appear to fit into two broad groups: there are countries 
with very low levels of resistance and countries with higher levels of clinical resistance. 
The USA [285], Sweden [276] and Switzerland [290] all have low levels of 
pleuromutilin resistance, with most isolates below the wild type breakpoint. There are 
likely to be many factors affecting the level of pleuromutilin resistance observed. The 
low tiamulin resistance seen in the USA could be due to the greater variety of 
antibiotics that can be used to treat swine dysentery [308]. While Switzerland has little 
historic exposure to B. hyodysenteriae [290] and Sweden has a national control program 
to reduce SD, which has resulted in the reduction of swine dysentery [276]. Conversely, 
countries such as Germany [73] and Spain have far higher levels of tiamulin resistance 
[122]. These countries also produce far more pigs than Sweden or Switzerland, which 
may lead to more tiamulin use [309].  
 
Although the level of clinical tiamulin resistant B. hyodysenteriae in the UK appears 
low, there was a statistically significant shift towards an intermediate phenotype after 
2010 as observed in this study. This shift has also been seen in UK surveillance reports, 
where the number of sensitive isolates has reduced over time [292]. This likely indicates 
reduced susceptibility to pleuromutilins in the UK, which potentially could lead to an 
increase in the number of clinically resistant swine dysentery cases in the future. This 
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shift was clearly seen in the survival curves, and a similar shift has been seen in survival 
curves of B. hyodysenteriae isolates from Spain, although in Spain there was also an 
increase in clinical resistance to tiamulin [167].  This shift from tiamulin sensitivity to 
an intermediate or resistant phenotype has been seen in other countries, for example in 
Poland all isolates tested had an intermediate phenotype [289].  A decrease in 
pleuromutilin sensitivity is not restricted to the EU. It has also been observed in 
Australia, and in the USA [51, 123, 285].  
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Table 4.4.1: Comparison of tiamulin MICs from this study to previously published 
data available.  
Only the latest published data for each country was used. Studies have not been 
included if MIC data was not presented, in this case, the most recent study with MIC 
data was used. The MIC data has been re-interpreted using established breakpoints. For 
agar dilution the breakpoints suggested by Rønne, H. and J. Szancer have been used 
while for broth and broth dilution the breakpoints suggested by Pringle et al. have been 
used with one modification: the wild-type breakpoint has been moved to >0.25 g/ml 
(Table 1.2.5.1) [109, 110]. For some studies, data could not be obtained, and this is 
designated with n/a. For Spain raw data was not provided so approximate results were 















dilution 80.95 4.76 14.29 [123] 
Brazil 
Broth 
dilution 9.09 n/a >40 [286] 
Belgium 
Broth 




dilution n/a n/a 24.3 [288] 
Germany 
Broth 
dilution 34.21 20.18 45.61 [73] 
Italy 
Broth 
dilution 13.59 33.01 53.4 [122] 
Japan 
Agar 
dilution 41.14 41.62 17.24 [287] 
Poland 
Broth 
dilution 0 100 0 [289] 
Spain 
Broth 
dilution ~22.5 ~45 ~32 [167] 
Sweden 
Broth 
dilution 95 5 0 [276] 
Switzerland 
Broth 
dilution 100 0 0 [290] 
Taiwan 
Agar 
dilution n/a n/a 29.72 [166] 
USA 
Broth 
dilution 70.27 18.92 10.81 [285] 
UK 
Broth 
dilution 47.92 41.67 10.42 This study 
 
The specificity and sensitivity of phenotypic prediction of tiamulin and valnemulin 
sensitivity based on genotype was poor. The sensitivity was greatly improved when 
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tva(A) was detected in tiamulin intermediate and resistant isolates [293]. This is the 
second time this gene has been detected in B. hyodysenteriae and was detected 
independently on a separate panel of isolates using different techniques. This gene 
appears to be present in multiple distinct clades and may be transferred by horizontal 
gene transfer. In addition, the likely presence of tva(A) in an Australian isolate suggests 
that tva(A) has been present in B. hyodysenteriae for decades as no pigs have been 
imported into Australia since the 1980s [123].  Currently, the best categorised 
horizontal gene transfer agent in B. hyodysenteriae is the gene transfer agent VSH-1 
[169]. This transfers a random segments of approximately 7.5 kb of DNA and has 
previously been shown to transmit resistance to coumermycin A(1) [169, 172]. 
Recently, a transposon (MTnSag1) has been identified in B. hyodysenteriae [165]. 
However, this transposon was first identified in S. agalactiae, and in S. agalactiae this 
transposon requires a co-transposon for transfer between cells [173]. This co-transposon 
was not found in BH718, and no other mechanism of transfer has been identified in B. 
hyodysenteriae [165]. Further work will be needed to show experimentally that tva(A) 
can be transferred between B. hyodysenteriae isolates.  
 
To investigate if tva(A) has a differing impact on tiamulin and valnemulin three isolates 
were repeatedly subcultured in the presence of sublethal concentrations of tiamulin and 
valnemulin. After 20 subcultures there was less sensitivity to tiamulin and valnemulin 
sensitivity for sensitive isolates; with the highest increase in resistance occurring in 
js27. Tiamulin resistance has been selected for previously in B. hyodysenteriae [159, 
293], Mycoplasma gallisepticum [310], M. bovis [311], M. smegmatis [312] and S. 
aureus [313] by serial passage in sub-lethal concentrations of tiamulin. This is the first 
study where B. hyodysenteriae tolerance to valnemulin has also been selected for. The 
development of tiamulin resistance does not commonly lead to the development of 
resistance to other classes of antibiotic, except for valnemulin [293, 313, 314]. In this 
study exposure to tiamulin or valnemulin also led to reduced sensitivity to the other 
pleuromutilin. However, with the exception of M. gallisepticum (where lincomycin 
resistance developed), resistance to other classes of antibiotic resistance did not occur 
[310]. It is likely that most SNPs that result in pleuromutilin resistance do not lead to 
co-resistance with other classes of antibiotics, but some SNPs in the 23S rRNA may 
impair binding of multiple drugs classes due to the closeness of their binding sites.  
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For each isogenic daughter isolate, there was an increase in both tiamulin and 
pleuromutilin resistance. It is therefore likely that treatment of pigs with swine 
dysentery caused by tiamulin resistant isolates would not respond to treatment with 
valnemulin also. It also appears multiple SNPs occurred in the serially passaged strains 
that increased tolerance to tiamulin and valnemulin. The isolates js17t20 and js17v20 
had a SNP at G2061T (E. coli numbering) that was not present in the isogenic parent. 
This has not been associated with tiamulin resistance previously in B. hyodysenteriae, 
but a G2061T has been associated with linezolid resistance in M. tuberculosis and a 
G2061U when M. galisepticum tiamulin resistance was selected for [310, 315]. A SNP 
in the next nucleotide, G2062T, has been linked with tylosin and tiamulin resistance in 
M. bovis [311]. This region of the 23S rRNA is an important binding site for both 
pleuromutilins and macrolides: tiamulin binds to 2062 (E. coli numbering), and 
macrolides bind to 2058 (E. coli numbering) [316, 317]. A SNP could cause a 
conformational change in the peptidyl transferase centre that could affect binding of 
both tiamulin and macrolides.   
 
The G2061T SNP was not present in js27, but there were mutations in efflux pumps and 
in an ATP binding protein. It is possible that these mutations could have increased the 
efficiency of efflux pumps slightly, resulting in increased resistance to tiamulin and 
valnemulin. This would be a method for tiamulin resistance that does not rely upon 
SNPs in the peptidyl transferase centre and may explain the identification of tiamulin 
resistant isolates that do not contain tiamulin resistant SNPs in the 23S rRNA or rplC 
[159, 167]. Also, other mechanisms could have resulted in tiamulin resistance, for 
example, a mutation in a regulator that leads to upregulation of efflux pumps. If this 
regulator was poorly annotated by Prokka, or if the regulator was at a remote site in the 
genome, it may have been missed in the analysis performed in this study. Further work 
with RNAseq could identify transcriptional changes and provide valuable information 
on the role transcription plays in tiamulin resistance. 
 
This study aimed to investigate trends in pleuromutilin sensitivity in the UK and 
identify the mechanisms behind any trend towards reduced sensitivity. A trend towards 
reduced pleuromutilin susceptibility was observed with increasing number of 
pleuromutilin intermediate isolates across the period. Correlation of phenotypic 
resistance to genotypic resistance (based on previously published SNPs) indicated a 
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poor match between pleuromutilin resistance phenotype and genotype. This was 
improved with the identification of a potentially novel tiamulin resistance gene in all 
tiamulin intermediate and resistant isolates. Further research will be necessary to 




Chapter 5. Metagenomic analysis of 
healthy caecum and swine dysentery 




Diagnosis of swine dysentery is a slow process, due to the time taken to obtain a pure B. 
hyodysenteriae isolate, as this is a slow growing organism [53]. It is possible that by the 
time a diagnosis has been made, swine dysentery could have spread to connected 
holdings; this may have occurred in Sweden in 2015 [276]. PCR offers a rapid way of 
identifying B. hyodysenteriae. However, as novel species are becoming more commonly 
identified as the cause of swine dysentery through microbial cultural methodologies, 
these might be missed with species-specific PCRs [45]. WGS offers an alternative 
diagnostic method, and there is increased interest in using WGS for routine surveillance 
and outbreak analysis [318]. This is likely to be done using pure cultures, but for B. 
hyodysenteriae shotgun metagenomic sequencing might be better as no time is lost 
purifying samples. This is potentially a quick way of identifying B. hyodysenteriae, or 
novel Brachyspira species. It may also provide useful information about ST types and 
AMR, which could aid in choosing the appropriate treatment. At present, metagenomic 
sequencing is too expensive for diagnosis; but this could change due to the reduced cost 
of sequencing in the future because of intense competition between sequencing 
companies. 
 
Metagenomic shotgun sequencing also enables analysis of the impact that the gut 
microbiome has upon SD. The pig gut microbiome is composed mainly of Bacteroides 
and Firmicutes with the most common species being Prevotella [35].  As pigs age, the 
relative abundance of Prevotella declines and is replaced by species such as 
Anaerobacter and Lactobacilli species [35]. The microbiome has previously been 
identified as playing an important role in swine dysentery and may be necessary for the 
successful colonisation of the pig gut by B. hyodysenteriae [89]. A number of species, 
such as Campylobacter coli have been associated with swine dysentery [319]. However, 
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analysis of clinical cases from commercial farms in the UK might identify other 
relationships more applicable to the UK pig industrial practices. Although there is 
movement between the UK and Europe this is mostly movement of pigs from the 
Republic of Ireland into Northern Ireland, movement from the rest of the EU into the 
UK was 1673 pigs; this represented 0.00035% of the UK pig herd in 2016 [270]. Within 
the UK, there is little movement of pigs between different regions, and there are distinct 
production systems in different regions, with more intensive production in the East of 
England [21]. In addition, it appears that there is limited travel between regions [21, 
269]. This could result in slightly distinct microbiomes developing in different regions 
of England. It will be necessary to investigate the impact regional production systems 
has on the pig gut microbiome to ensure erroneous conclusions are not drawn about the 
impact swine dysentery has on the pig gut microbiome. 
  
5.1.1. Study aims 
 
This study aimed to identify B. hyodysenteriae directly from sequenced pig faecal 
samples and gain useful clinical information. In addition, differences between the 
microbiome of swine dysentery positive clinical faecal samples, and healthy faecal 
samples were examined. To assess the impact of farming practices and different 
geographical locations of farms, the gut microbiome of healthy pigs was analysed by 
shotgun sequencing faecal samples collected from pigs. Healthy samples are 
infrequently received by the APHA. However, at the time of this study, there was a 
research study (VM0518) running, with the aim of developing molecular techniques to 
rapidly identify AMR present in zoonotic pathogens and indicator species [320]. For 
this study, caecal samples were collected from pigs at slaughter. These pigs can be 
defined as healthy, as they have reached slaughter weight, and were from pig farms 
representing different regions of England and are therefore suitable to use to investigate 





Swine dysentery positive samples came from faecal diagnostic clinical submissions 
made to the APHA reference laboratory; four were from historic clinical submissions 
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that had previously been shown to be B. hyodysenteriae positive by PCR, and two were 
clinical submissions from 2016 that were confirmed to be B. hyodysenteriae positive by 
isolation of B. hyodysenteriae. Where possible, these samples were age-matched by the 
age of pig. However, age information was only available for three swine dysentery 
positive samples: two were 17 weeks, and one was 14 weeks (Table 5.2.1.1). Healthy 
pigs came from a study investigating the presence of mcr-1 in the UK; all faecal 
samples from healthy pigs were taken at 17 weeks [264]. Healthy faecal samples and 
caecal samples were collected by APHA and frozen at – 80 C at Weybridge. Historic 
swine dysentery positive faeces were stored at an APHA regional laboratory before 
being sent to APHA Weybridge and stored at – 20 C. Swine dysentery positive faecal 
samples obtained over the course of this study from the Reference Laboratory at Bury 
St. Edmunds, were stored at – 80 C at Weybridge. 
 
Caecal samples were obtained as part of VM0518. These came from Yorkshire, the 
South West and the Midlands; there were three finisher herds and nine farrow-to-finish 
herds. For this study, a single 0.25 g sample was taken from each farm of interest, 
except for MSG54 (Table 5.2.1.2). This was the first farm investigated, and four 
samples were taken to investigate changes between individuals. The age of the pigs at 
slaughter was not provided, but the pigs are likely to be older than the pigs that 
provided the faecal samples. 
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Table 5.2.1.1: Information on faecal samples used in this study.  
Note Yorkshire refers to Yorkshire and the Humber. nk = not known. The original 
reference for the healthy isolates has been given. 
Sample Region or source Health  Year 
Age 
(weeks) 
14 South West SD 
2015 17 
26 South East SD 2015 14 
123 Yorkshire SD 2010 17 
161 Yorkshire SD 2010 nk 
168 South West SD 2010 nk 
174 Yorkshire SD 
2010 nk 
8 [264] Healthy 2016 17 
69 [264] Healthy 2016 17 
55 [264] Healthy 2016 17 
100 [264] Healthy 2016 17 




Table 5.2.1.2: Information on caecal samples used in this study.  
Note Yorkshire refers to Yorkshire and the Humber. 
Sample Region Type 
MSG20P2 Breeder-Finisher Midlands 
MSG44P2 Breeder-Finisher Midlands 
MSG54P2 Breeder-Finisher Midlands 
MSG54P3 Breeder-Finisher Midlands 
MSG54P4 Breeder-Finisher Midlands 
MSG54P5 Breeder-Finisher Midlands 
MSG07P2 Breeder-Finisher Yorkshire 
MSG16P2 Breeder-Finisher Yorkshire 
MSG22P2 Breeder-Finisher Yorkshire 
MSG11P2 Breeder-Finisher South West 
MSG14P2 Finisher South West 
MSG12P2 Breeder-Finisher South West 
MSG06P2 Finisher South West 
MSG15P2 Breeder-Finisher South West 
MSG38P2 Finisher South West 
 
 
5.2.2. Extraction of DNA from faecal and caecal samples 
 
The PowerSoil Ultra kit (MO Bio) was used for isolation of DNA from caecal and 
faecal samples. Initially, 0.25 g of the sample was added to a PowerBead tube and 
gently vortexed to mix. To this 60 l of Solution C1 was added, and vortexed briefly to 
mix. PowerBead tubes were then securely placed in a bead beater (MO BIO Vortex 
Adapter), and vortexed at maximum speed for 10 minutes before being centrifuged for 
30 seconds at 10,000 x g. 250 l of solution C2 was added and vortexed for 5 seconds 
before being incubated at 4 C for 5 minutes. This was followed by centrifugation at 
10,000 x g for 1 minute. To this 600 l of the supernatant was then transferred to a 2 ml 
collection tube, to which 200 l of solution C3 was added. This was vortexed briefly to 
mix before being incubated at 4 C for 5 minutes. This was then centrifuged at 10,000 x 
g for 1 minute and 750 l of the supernatant were transferred to a new 2 ml collection 
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tube. To this 750 l of Solution C4 was added and vortexed to mix. This was then 
loaded onto a spin filter and centrifuged at 10,000 x g for 1 minute. The supernatant was 
discarded and 500 l of solution C5 was added to the spin filter and centrifuged at 
10,000 x g for 30 seconds. The spin filter was then transferred to a new 2 ml collection 
tube, and the old collection tube and flow through were discarded. To this 100 l of 
solution C6 was added to the spin filter and centrifuged at 10,000 x g for 30 seconds. 
The spin filter was then discarded, and the DNA was stored at –20 C until needed. 
Faecal and caecal samples were then sequenced on an Illumina MiSeq as described 
previously (Materials and methods, section 2.4.1 and 2.4.2). 
 
5.2.3. Identification of antimicrobial resistance genes and plasmids 
 
Fastq files were screened against an in-house AMR database (Seqfinder) [264] using 
SRST2 (version 0.1.5) [263]. Only genes with a depth of coverage of 15x were used for 
subsequent analysis, as SRST2 is highly sensitive at 15x coverage [263]. Results were 
analysed in Excel 2013 (Microsoft) and assembled into a single spreadsheet. AMR 
genes were normalised to parts per million. This was done by dividing reads mapped to 




5.2.4. Speciation with Sigma 
 
Sigma was used to map raw fastq files against the RefSeq database of sequenced 
bacterial reference stains [321]. The RefSeq database 2014 was downloaded from 
NCBI. The 2014 database was used as there was a script to format the database as 
required by Sigma, this script was part of the Kraken program, later versions of the 
RefSeq database are incompatible with this script due to differences in the location of 
the RefSeq database [240]. Relative abundance values were analysed in Excel 2013 
(Microsoft) and assembled into a single spreadsheet. 
 
5.2.5. Further analysis of sequenced samples  
 
R was used to make heatmaps using Bray-Curtis clustering [322]. Clustering was done 
using vegan, and heatmaps were produced using gplots [323, 324]. Principle component 
analysis (PCA) was conducted using FactoMineR, and PCA plots were made using 
factoextra [325, 326]. Lefse, on the Galaxy website, was used to conduct LDA [327]. 
 
5.2.6. Analysis of B. hyodysenteriae directly from sequenced faecal samples 
 
Fastq files were mapped against the B. hyodysenteriae reference WA1 (NC_012225.1) 
using Bowtie2 (version 2.1.0) [328]. Samtools (version 0.1.18) was used to make a 
SAM file of reads mapping to WA1 using the command samtools view -f4 –bS. This 
was then converted to a BAM file with samtools and BAM files were converted into 
fastq files with Bam2Fastq (version 1.1) [241, 329].  
5.3. Results 
 
To analyse the healthy pig gut microbiome of commercial pigs, 12 caecal samples from 
healthy pigs were sequenced. All caecal samples were taken at slaughter as part of 
VM0518. Samples were sequenced on two MiSeq runs. Initially, samples from 
Yorkshire and the Midlands were sequenced on a single MiSeq run, and subsequent 
samples from the South West were sequenced on another MiSeq run.  
 
For caecal samples (Table 5.3) less than 4% of reads were mapped against the RefSeq 
database. The median percentage of reads mapping to the RefSeq database was 0.76%, 
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with the lowest mapping was 0.34% (MSG12P2), and the highest was 3.23% 
(MSG06P2). It is likely that most of the DNA in the sample is pig DNA; this would not 
be detected by the bacteria specific RefSeq database. In addition, low read mapping 
may also be affected by the database used. Some species diversity is not represented in 
the database because of a lack of reference genomes. However, the important genera in 
the pig gut microbiome, for example, Prevotella, are represented in the database so it 
will still be possible to characterise the caecal microbiota.  
 
Table 5.3: Sequencing of caecal samples 
Total sequenced reads and reads mapped to the RefSeq database by Sigma from 
sequenced caecal samples. 
Sample Total Reads Mapped Reads 
MSG20P2 1,137,474 5,066 
MSG44P2 4,935,338 49,436 
MSG54P2 1,623,570 9,724 
MSG54P3 5,157,134 64,372 
MSG54P4 1,321,260 10,888 
MSG54P5 1,137,474 5066 
MSG07P2 4,273,442 25,044 
MSG16P2 4,214,036 31,486 
MSG22P2 2,934,490 11,828 
MSG11P2 2,963,454 36,480 
MSG14P2 2,612,186 42,932 
MSG12P2 3,823,838 29,712 
MSG06P2 3,111,156 100,788 
MSG15P2 3,119,832 23,630 




5.3.1. Speciation of caecal samples  
 
To investigate differences between the microbiome in different regions sequenced 
caecal samples were speciated (Appendix 3), and the relative abundance predicted was 
visualised as a heatmap (Figure 5.3.1.1) and used to conduct PCA (Figures 5.3.1.2a and 
5.3.1.2b). In total 36 species were identified with most abundant species being 
Lactobacillus species and Eubacterium rectale. There also appeared to be a core group 
of species that were present in most isolates; it is likely that these species, for example, 
Faecalibacterium prausnitzii, are present in all samples but are below the detection 
limit. The Lactobacilli species varied between samples and did not show a difference 
based on region, or based on production type. There was also little variation between 
samples from the same farm; this was expected as these pigs were grown at the same 
time and are likely to be fed the same diet. More species were detected in MSG54P3; 
this is likely to be due to a greater sequencing depth. No large differences were 
observed between different regions, and this was indicated by PCA where the majority 
of farms cluster together (Figure 5.3.1.2a). Although there did appear to be some 
variation between the South West and other regions and was more likely to be due to 
differences between finisher farms and farrow-to-finisher farms (Figure 5.3.1.2b). There 
was one outlier MSG15P2; this isolate came from a farm where visitors regularly drove 
onto the farm. It is possible that this could have resulted in the introduction of bacteria 
from other farms, for example via vets, visitors or farm workers. LDA analysis did 
identify species that were differentially abundant in different regions and production 
systems. Eubacterium rectale was associated with the Midlands (with an LDA score of 
5.39), this may be due to higher levels seen in samples from MSG54. In addition, 
Prevotella melaninogenica (LDA score of 4.14) was associated with farrow-to-finish 
farms, and E. siraeum (LDA score of 3.96), C. difficile (LDA score of 4.08), 
Methanobrivibacter smithii (LDA score of 4.5), and Streptococcus suis (LDA score of 
4.14) were associated with finisher herds (Figure 5.3.1.3). However, most of these 
species (M. smithii, C. difficile, E. siraeum, and S. suis) were only identified in one 
sample (MSG06P2), this highlights the need for caution when interpreting results from 
a small sample size. It is likely that these do not reflect significant biological differences 
between production types or region of origin. P. melaninogenica was only found in one 
finisher herd, this could be due to differences in diet, but it may also be due to the small 
number of finisher herds sequenced. To investigate further, it would be necessary to 
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sequence more samples at a greater depth of sequencing. Based on the overlap of 
species identified, and the similarity of the PCA analysis it can be concluded that 
differences between production type or region of origin appear only to have a small 




Figure 5.3.1.1: Heatmap of species identified in caecal samples.  
White indicates that the species was absent. Finisher farms are indicated by *. Samples 
from Yorkshire and shown in green, samples from the South West are in red, and 
samples from the West Midlands are shown in blue. Scale represents percentage 




Figure 5.3.1.2: PCA analysis of the relative abundance of species in caecal samples.  
In both graphs, points are labelled with the name of the sample. Samples are labelled 
with the sample name. In a, samples are coloured by production type. In b, farms are 







Figure 5.3.1.3: LDA analysis of caecal samples based on production type 
Differentially abundant species in caecal samples identified by Lefse when two 
production types are compared. Species associated with farrow-to-finish has been 




5.3.2. Antimicrobial resistance genes in caecal samples 
 
The pig gut microbiome is likely to be a critical area of AMR gene transfer; the 
SeqFinder database and SRST2 was used to explore AMR gene presence. A small 
number of AMR genes were detected in caecal samples; this is likely due to using a cut-
off of 15x coverage (Table 5.3.2). AMR genes were normalised to parts per million to 
ensure higher AMR detection was not merely due to a greater read depth. This was used 
because at lower depths of coverage SRST2 was unable to distinguish between alleles 
of the same gene. However, it was possible to identify multiple AMR genes, therefore 
useful information can still be obtained with this cut-off. AMR genes were normalised 
to parts per million to aid comparisons of samples with different sequencing depths. 
There was little variation detected between the four samples from MSG54, probably due 
to the high cut-off used, although two samples had two more AMR genes detected than 
others. It is likely that if these samples were sequenced at a higher depth more variation 
in AMR gene carriage would be detected. There was more variation between farms, 
with the number of AMR genes detected varying between one and five. Tetracycline 
resistance genes were the most commonly identified AMR genes, with tet(Q) present in 
all samples. Also, tet(Q) was the most common tetracycline resistance gene detected in 
samples from Yorkshire and the Midlands, while tet(W) was more common in samples 






LDA score (log 10)
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from the South East. The least common gene detected was tet(43), present in two 
isolates, one from Yorkshire and the Humber, and one from the South West. In addition, 
MSG20P2 contained an occurrence of tet(Q) genes; this may suggest that multiple 
copies of this gene are present in the sample. Finisher herds had fewer AMR genes 
detected than breeder-finisher (with an average of 6 genes detected in farrow-to-finish 
farms, and 10 genes detected in finisher farms), but it is likely that if more finisher 
samples were sequenced more AMR genes would have been detected. There was no 
clear difference between regions of England, or between production types. It is likely 
that AMR genes detected are affected more by the composition of the microbiome and 




Table 5.3.2: AMR genes detected in caecal samples by SRST2 using the Seqfinder 
database.  
AMR genes have been normalised to parts per million. This was done for all samples 
and was done to ensure higher AMR genes detected was not due to a greater depth of 
sequencing in a sample. Numbers represent the reads per million total reads. Only genes 
with a depth of coverage of 15 or greater have been included. 
 




























































11.86 6.13 25.81 5.26 0 42.81 6.55 
MSG06P2 Finisher South West 0 0 5.16 9.85 6.33 8.91 18.86 
MSG14P2 Finisher South West 0 0 15.34 0 0 24.05 5.67 




5.3.3 Sequencing of metagenomic faecal samples from healthy and swine 
dysentery positive pigs 
 
To identify B. hyodysenteriae directly from faeces, six faecal samples from swine 
dysentery positive pigs were used. In addition, to investigate changes in the microbiome 
in SD, these were compared to healthy faecal samples collected from pigs of a similar 
age. The latter samples were provided by the APHA and came from a study from a 
single farm [264]. All samples were sequenced on a single MiSeq run, as this likely 
reflects the practices that would occur if metagenomics were used for diagnostics. 
 
Like caecal samples (Table 5.3) few reads in the faecal samples were mapped against 
the RefSeq database (Table 5.3.3). The median percentage of faecal samples reads 
mapping to the RefSeq database was 1.33%, the lowest mapping was 103 (0.43%), and 
the highest was 123 (18.41%). This could be due to high amount pig DNA in the 
samples, and it may also reflect the database used. If this analysis were to be repeated 
Sigma would be used with an alternative database, for example, the Kraken database 
[240] or a pig metagenomic catalogue [33]. 
 
Table 5.3.3: Sequencing of faecal samples 
Information on reads mapped to the RefSeq database by Sigma for sequenced faecal 
samples.  
 
Sample Total Reads Mapped Reads 
14 4549728 217842 
26 2908150 60396 
123 4836474 890210 
161 1475026 12270 
168 3029384 155458 
174 5082480 218940 
8 3425410 36760 
69 4275744 56912 
55 4782040 27736 
100 17191830 115614 
103 897996 3880 
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5.3.4. Identification of B. hyodysenteriae directly from faeces. 
 
It was possible to identify B. hyodysenteriae in all swine dysentery positive samples 
using both Sigma and Bowtie2. SRST2 then used to identify the B. hyodysenteriae ST 
type of B. hyodysenteriae in faecal samples. MLST alleles could only be identified in 
sample 14; four alleles were identified: est 3, gdh 12, glpK 11 and thi 36. There were 
three STs that contained these alleles: 8, 69 and 139. To analyse further, B. 
hyodysenteriae reads mapping to the reference strain WA1 from all swine dysentery 
positive samples were extracted using Samtools (Figure 5.3.4.1) [329]. It was not 
possible to identify any AMR genes or SNPs associated with chromosomal genes which 
result in AMR. For one sample, 14, there was enough reads to construct a core-genome 
based phylogenetic tree with previously sequenced samples and samples from NCBI 
(Chapter 3, section 3.3.2) (Figure 5.3.4.2). In the tree, there were 1134 SNPs and 10 
SNPs per isolate on average.  All STs clustered as previously (Chapter 3, section 3.3.2), 
and 14 clustered in the ST 8 clade, and the main difference was the global cluster W 
become 2 smaller clusters. It was also possible to identify two sequenced isolates 14 
was most closely related to (js97 and js99), this could be useful for root cause analysis 
in an outbreak investigation. This is far fewer SNPs than were detected previously 
(Chapter 3, section 3.3.2) and is likely due to the small number of reads in 14. It is, 
therefore, possible to gain epidemiologically useful information (in this case ST, and 
closet related strains) by metagenomic sequencing; but this sample contained a high 
number of reads mapping to WA1 compared to other samples, as 0.95% of total reads 
mapped to WA1 (Figure 5.3.4.1). It is likely that for most samples a higher sequencing 
depth would be required to obtain this information. This would be more expensive but 
the development of new sequencing platforms, for example, the Illumina NextSeq, 




Figure 5.3.4.1: Percentage of total reads extracted from faecal samples after 
mapping to B. hyodysenteriae WA1 by Bowtie2. 
Reads were extracted as described previously (Chapter 5, section 5.2.6). Percentage of 
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Figure 5.3.4.2: Maximum likelihood core-genome tree of sequenced B. 
hyodysenteriae isolates and B. hyodysenteriae genes extracted from faecal sample 
14.  
Reads were extracted as described previously (Chapter 5, section 5.2.6). Sample 14 has 
been circled in red. 1000 bootstraps were conducted with RAxML. Bootstrap support is 
shown when it is above 70. New refers to new ST identified in this study (Chapter 3). 
Unknown includes global isolates where the MLST was not specified or determined by 




5.3.5. Speciation of faeces 
 
There were 54 species identified in faecal samples. This is higher than the amount 
identified in caecal samples. This could imply that there a greater diversity of species in 
the faecal microbiome, and in part may be due to contamination from the ground before 
collection. The median number of species identified in healthy isolates was 15; while 
the median species identified in swine dysentery, positive samples was 17. There was 
some divergence among the healthy faeces; the number of species varied between 7 and 
17 for the healthy faeces collected from the same farm. This likely reflects natural 
variation between individuals and variation in the depth of sequencing between 
samples. Swine dysentery positive and healthy samples were stored at different 
temperatures (healthy faecal samples were stored at –80 C and swine dysentery 
positive samples were stored at -20 C). Some swine dysentery positive samples had 
also been subject to more freeze thawing as they had been used for previous projects 
and transported between sites. The freeze-thawing could damage the DNA and may 
have resulted in poorer sequencing, and fewer species being detected. Therefore the 
diversity of the swine dysentery microbiome is underreported in this study. 
 
In the faecal microbiota, most species were present in both healthy samples and swine 
dysentery positive samples. However, there were three species that were present only in 
swine dysentery positive samples (Appendix 4 and Figure 5.3.5.1). B. hyodysenteriae, 
Campylobacter coli and E. coli were only identified in swine dysentery pigs (Figure 
5.3.5.1). E. coli was identified in all swine dysentery positive samples at a similar 
percentage abundance to B. hyodysenteriae. C. coli was only identified in four swine 
dysentery positive isolates and was present at lower percentage abundance. In addition, 
some unusual species were identified in some samples, in particular, Pshychobacter 
articus and Shigella sonnei. P. articus is most likely a contaminant, potentially from the 
soil the faeces were collected from; it is also possible that it could be identified in error 
due to genes shared with other species, for example, S. sonnei is likely to an E. coli 
strain. Removal of these species arbitrarily could introduce greater error into the study, 
due to research bias, and therefore they were not removed from the analysis. These 
unusual species only composed a small amount of the total species identified, for 
example, S. sonnei, was only identified in one sample at 0.29% of mapped reads and the 
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dominant species in the sample were commonly identified in pig metagenomes. Further 
analysis of the microbiome by PCA appeared to suggest a small difference between the 
swine dysentery positive samples and the samples from healthy pigs (Figure 5.3.5.2).  
 
To identify if there were any statistical differences between the two groups LDA was 
used. This identified five species that were differentially abundant in swine dysentery 
positive and healthy samples. B. hyodysenteriae, Campylobacter coli and E. coli were 
associated with SD, with LDA scores of 4.4, 4.04 and 4.8 respectively; while 
Ruminococcus bromii and Treponema succinifaciens were associated with healthy pigs 
with an LDA score of 4.39 and 4.4 respectively (Figure 5.3.5.3).  C. coli is a known 
pathogen of pigs. To identify if the E. coli was also pathogenic, SRST2 was used to 
screen the raw reads against Enterotoxigenic E. coli (ETEC) specific genes, commonly 
found in pig ETEC strains. The genes used for the screen were the virulence genes estA, 
eltA and Stx2e [330, 331]. These ETEC specific genes were not identified in any 
samples; it is likely that commensal E. coli that have already colonised the swine 
dysentery positive pigs are able to take advantage of the environment that develops in 





Figure 5.3.5.1: Heatmap of species identified in faecal samples.  
Swine dysentery positive samples are labelled in red. E. coli, C. coli and B. 
hyodysenteriae are highlighted in a red box. Numbers in the samples bar represent 







Figure 5.3.5.2: PCA analysis of faecal samples. 
Samples are labelled by sample name and are coloured by their health status. SD refers 
to swine dysentery positive. 
 
 
Figure 5.3.5.2: LDA analysis of faecal samples 
Differentially abundant species in swine dysentery positive and healthy samples 
identified by Lefse. Species associated with healthy samples are shown in green; while 
species associated with swine dysentery samples are shown in red. 
 






LDA score (log 10)
 129 
5.3.6. Antimicrobial resistance genes in faecal samples 
 
Similar AMR genes were found in the faecal sample as the caecal samples. However, a 
greater variety of AMR genes from the following classes were detected than in caecal 
samples sulphonamide, aminoglycoside, streptomycin, and trimethoprim (Table 5.3.5.). 
Like the caecal samples, the majority of AMR genes are tetracycline resistance genes, 
with the most common AMR gene being tet(W), followed by macrolide resistance genes 
and the lincomycin resistance gene lnu(C) also common. lnu(C) has recently been 
linked to lincomycin resistance in B. hyodysenteriae, and the MTnSag1 transposon that 
has been associated with lincomycin resistance in B. hyodysenteriae was detected in all 
samples that contained lnu(C). This transposon appears to be common, so it is possible 
that in the future more B. hyodysenteriae isolates will be identified that contain this 
transposon [124]. Although all healthy samples originated from the same farm and were 
collected at the same time, there were variations in the AMR genes detected. This could 
reflect differences in the total number of reads in each sample, but it may also reflect 
variation in the microbiome between individual pigs.  
 
There was a lot of variation in AMR gene carriage between swine dysentery samples, 
probably because swine dysentery samples have come from a wide geographical area 
and were collected in different years. There was no clear difference between healthy 




Table 5.3.5: AMR genes detected in faecal samples 
AMR genes have been normalised to parts per million. This was done for all samples 
and was done to ensure higher AMR genes detected was not due to a greater depth of 
sequencing in a sample. Numbers represent the reads per million total reads. Only genes 
with a depth of coverage of 15 or greater have been included. 
 
Sample 123 14 161 168 174 26 100 103 55 8 69 
Health 
status SD SD SD SD SD SD H H H H H 
aad6_b 0 0 11.46 0 0 0 0 0 0 0 4.3 
aadA1
b 0 0 0 0 0 6.07 0 0 0 7.57 0 
ant3-
1a 0 0 0 0 0 6.38 0 0 0 7.99 0 
aph3-
Ib 0 0 0 0 0 7.46 0 0 0 7.18 0 
aph3-
IIIa 0 0 0 0 5.71 0 0 0 0 0 0 
aph6-
Id 0 0 0 0 0 8.88 0 0 0 9.4 0 
cfxA-3 0 0 0 0 5.26 0 3.85 0 0 0 0 
ermB 25.2 4.23 0 0 6.47 13 0.42 0 0 0 0 
ermF 0 0 0 0 3.5 0 0.32 0 0 0 0 
ermG 3.4 0 0 0 4.29 0 0.46 0 0 0 0 
lnuA 67.39 0 0 0 0 0 0 0 0 0 0 
lnuC 3.51 7.43 20.56 0 20.13 0 4.6 0 5.83 0 5.06 
mefA 3.27 4.22 0 0 7.68 5.71 6.23 0 0 0 0 
sat4A 0 0 0 0 3.28 0 0 0 0 0 0 
sul2 0 0 0 0 0 0 0 0 11.53 22.09 4.3 
tet39 0 0 0 0 0 0 0 0 0 0 0 
tet43 0 0 25.94 0 6.24 0 1.18 0 10.03 10.31 15.06 
tetO 13.56 8.72 0 0 38.77 9.31 28.93 0 6.38 0 5.82 
tetQ 13.56 8.72 0 0 38.77 9.31 28.93 0 6.38 0 5.82 
tetW 25.86 
11.9





In this study, two aspects of the gut microbiome were examined: the bacterial species 
present in the microbiome and the presence of AMR genes. Similar AMR gene classes 
were detected in caecal and faecal samples, although there was a greater variety of 
AMR genes detected in faecal samples. A higher number of species was also detected in 
faecal samples compared to caecal samples; this has been found previously in two pig 
breeds (Bamaxiang a Chinese micro-pig breed and Erhualian another indigenous 
Chinese pig breed), and may reflect  a more varied microbiota in faeces [332]. In both 
faecal and caecal samples, the most common AMR genes were tetracycline and 
macrolide resistance genes. This has been found in previous studies investigating pigs, 
where there was a high prevalence of tetracycline resistance genes [32, 333]. erm, genes 
and tet genes have been found in a diverse range of anaerobic bacteria including 
Lactobacilli, Prevotella, and Bacteroides species; species that were identified in the 
faecal and caecal samples. [334]. In Bacteroides species, tet(Q) was most abundantly, 
and this may have contributed to the high level of tet genes identified [335]. 
 
There were several genes found at high prevalence in pigs from France, Denmark, and 
China that were not detected in this study; for example, cephalosporin resistance genes 
[33]. It may be that these genes are only present at low levels, and are below the 
detection limit, or a reduction in the levels of cephalosporin use on farms has led to a 
reduction in the presence of the cephalosporin resistance genes in the pig microbiota 
[292]. In a previous study, E. coli containing mcr-1 was isolated from faecal samples 
from the same holding by microbiological culture and PCR, as the faecal samples used 
in this study [264]. Neither E. coli nor mcr-1 was detected in this study. It is likely that 
the level at which they are present are below the detection levels for this study. 
Although some AMR genes may be below our detection level, it was still possible to 
identify some important AMR genes, and compare AMR carriage between healthy and 
swine dysentery positive samples, where there appeared to be little difference. 
 
For speciation of both caecal and faecal samples, few reads were mapped to the RefSeq 
database when Sigma was used. In part, this may be due to the presence of host DNA  
in our samples [336]. The database, and the program used, are also likely to have a large 
impact. Sigma was used because after reads have been mapped to reference sequences 
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in the database Sigma calculates which species are most likely to be present in the 
sample [321]. However, unlike Kraken [240] it does not come with a pre-built database. 
Therefore, one had to be provided; in this study, the RefSeq database (2014) [337] was 
used as it was a curated database. At the time this study was conducted this appeared to 
be the most appropriate methodology. Kraken could have been used, but there is no 
probabilistic analysis after species are identified to determine which species are 
correctly identified, therefore false positives might be identified. As an aim of this study 
was to successfully detect B. hyodysenteriae in swine dysentery positive faecal samples 
it was important to avoid false positives, therefore Sigma was used instead of Kraken. 
However, there are issues with the use of the RefSeq database reference database; 
previously a low percentage mapping has previously been found in human metagenomic 
samples where the majority of sequenced reads did not map to the Genbank database 
[338]. The Genbank and the RefSeq databases are composed of genomes published on 
NCBI and contain species isolated from a diverse range of environments [274, 339]. In 
addition, some species are sequenced disproportionally highly due to their importance 
in human health, for example, the most abundant clade in RefSeq is Escherichia-
Shigella [337, 340]. If this analysis were repeated a recently produced pig metagenomic 
catalogue would be used, this might have improved the analysis. In addition, new 
programs have been produced that would enhance the analysis. Braken uses Bayesian 
statistics to analyse the Kraken output and reclassifies species based on the species most 
probably to be there [341]. The use of Kraken either with the pre-existing database, or 
the pig metagenomic catalogue, would be able to speciate more reads, and Braken 
would enable correct identification of species.  
 
When the caecum was speciated, genera that had previously been detected in the caecal 
microbiome were identified, including Prevotella and Lactobacilli [33, 342-347]. Only 
a small number of previous studies have investigated the caecal microbiome using 
shotgun metagenomics [33, 342]. The caecum has been more extensively studied using 
16S analysis [343-347]. However, comparison to previous studies is complicated by the 
different diets used, the breed of pig and the antibiotic use, all of which impact the 
microbiome [32, 33]. Nevertheless, previously there was an agreement at the phylum 
level that the caecum was dominated by Firmicutes and Bacteroidetes, and this was also 
found in our study [342-347].  At the genus and species level, some differences arose 
between all studies, and between individuals in the same study [342]. Prevotella is a 
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genus that is often found to be present at high levels in the caecum [346]. The samples 
used in this study were collected at slaughter and are older than many pigs investigated. 
The abundance of Prevotella has been found to decline with age and is present at lower 
levels in older pigs [35, 342]. An increase in Lactobacilli has been observed with age 
[35]. As species identified in this study using older pigs were similar to previous 
research, it is likely that they accurately reflect a healthy ceacal microbiome. 
  
Further analysis by PCA did not indicate any difference between the microbiome of 
caecal samples from pigs from different regions of England. There did appear to be a 
small difference between different production types. This could be due to the inflow of 
new weaner pigs onto a farm, introducing new strains of different species, which could 
lead to a more dynamic microbiome, especially if weaner pigs are supplied from 
multiple herds, than seen on breeder-finish herds, which are closed systems [14]. 
MSG07P2 is a farrow-to-finish farm that appeared as an outlier. This farm had seven 
vehicles coming into the farm per week, and it is possible that they may introduce new 
species onto the farm in a similar way to new pigs. Further investigation with LDA 
identified a number of species that were differentially abundant between groups, but 
only one that could reflect a difference between the groups. This was P. 
melaninogenica, this species is typically found in the oral microbiome and is likely a 
related Prevtella species [348]. An increase in Prevotella may reflect the feeder diet 
used, or it may reflect the small number of finisher herds samples. It would be necessary 
to sequence more caecal samples from finisher herds to investigate this further. Few 
significant differences were detected between regions or production types and may 
reflect a shared microbiome between pig herds. This appears consistent with previously 
published studies where there appeared to be a core microbiome, with the same phylum 
and genus evident in multiple studies, albeit at differing abundances [33, 342-347].  
 
It does not appear likely that differences between healthy and swine dysentery positive 
pigs are due to these factors, and may be due to environmental changes that occur 
during SD. When swine dysentery positive faeces were sequenced, it was possible to 
identify B. hyodysenteriae in all samples. For faecal sample 14, it was also possible to 
identify the ST and the most closely related isolates. However, this was only possible as 
B. hyodysenteriae was present in high abundance in this sample. Typical abundance can 
be as low as 0.006% in colonic luminal contents [319], and the median abundance in 
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our study was 2.02%. Therefore, it is likely that to get clinically relevant data from 
metagenomics it would be necessary to either enrich the sample, or sequence to a higher 
depth. Enrichment in pyruvate media and the addition of acriflavin, cefsulodin and 
vancomycin were previously used to enrich spinach spiked with Shiga toxin-producing 
E. coli. Reads mapping to E.coli in spinach spiked with 10 CFU/ml rose from 0.01% 
pre-enrichment to 49.73% after a 23-hour enrichment [349]; a similar method might be 
useful for B. hyodysenteriae enrichment. Although this would increase the time taken it 
would still likely be faster than culturing B. hyodysenteriae and performing biochemical 
tests.  
 
A variety of other species were also detected in sequenced faecal samples, with most 
species being present in both groups. One of the main species detected in both groups 
was Lactobacillus species. Previously, Lactobacillus has been associated with healthy 
samples; differences in the current study may be due to differences in the experimental 
design. In the previous study, pigs were grown at the Swine Nutrition Farm at Iowa 
State University and euthanised at nine weeks of age [226, 319]. The swine dysentery 
positive samples in our study came from clinical submissions to the APHA from 
different farms, and, although for three samples the age was unknown the other samples 
were aged between 14 and 17 weeks. Healthy samples were also 17 weeks of age. 
Variations in diet were also likely to have an impact on Lactobacilli abundance as has 
age, where there is an increase in abundance as pigs age [35, 350]. This could have 
resulted in the higher levels of Lactobacilli being observed in our samples. 
 
 
Faecal samples from swine dysentery positive pigs and healthy pigs appeared to cluster 
separately by PCA. This was supported by LDA, where four species that were 
associated with different disease states were detected. E. coli, C. coli and B. 
hyodysenteriae were associated with swine dysentery isolates, while R. bromii and T. 
succinifaciens was associated with healthy pigs. However, the samples from healthy 
pigs came from one farm, and therefore the difference could be due to variation between 
farms. T. succinifaciens has previously identified in pigs and appears to be commensal, 
and has not previously identified in metagenomic analysis of swine dysentery pigs [319, 
351, 352]. R. bromii is important in the degradation of resistant starch in humans; 
resistant starch along with non-starch polysaccharides have been previously linked with 
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an increased risk of swine dysentery [219, 353]. It is possible that the degradation of 
resistant starch by R. bromii might have a protective effect. Previous analysis of swine 
dysentery microbiome also found the Ruminococcus genus to be associated with healthy 
pigs [319].  
 
 
C. coli is commonly identified in pigs and has previously been associated with swine 
dysentery [319, 354, 355]. It is likely that there is an important relationship between 
these two species as C. coli has had a long association with SD, but this has not been 
explored in detail [355]. Unlike C. coli an increase of E. coli in swine dysentery has not 
previously been identified. E. coli is a part of the healthy gut microbiota and are present 
throughout the life of the pig, although there is a turnover of E. coli strains present 
[356]. As no ETEC genes were identified it is possible the E. coli are commensal strains 
that can take advantage of the conditions created by B. hyodysenteriae or belong to 
other pathotypes. Commensal E. coli are non-motile and have been found to be 
associated with the mucosa in the large intestine where they multiply rapidly in excess 
of the turnover rate of mucin [357-359]. In the mucosa, there can be increased 
expression of ferric iron uptake genes by E. coli and increased production of 
enterobactin, compared to the lumen [359]. This suggests that a limiting factor for E. 
coli is ferric iron in the mucosa. During swine dysentery, bloody diarrhoea is produced 
which would lead to a more plentiful supply of ferric iron in the gut lumen. This could 
result in increased growth of E. coli. In previous studies, other commensal species have 
been found at higher relative abundance in swine dysentery including Mogibacterium 
and a potential opportunistic pathogen Anaerotruncus [319, 360, 361]. It is likely that 
there are a range of different commensals that can multiply in the environment created 
during SD. 
 
In this study, it was demonstrated that it is possible to sequence B. hyodysenteriae 
directly from clinical samples. Whilst this may not be a practical diagnostic technique 
currently, with continued decreases in the cost of sequencing, and enrichment of 
samples, it may become one in the future. The time for diagnosis would also go down as 
expertise develops in this area. In addition, an association between B. hyodysenteriae 
and E. coli during infection, which has not been reported previously, was identified. 
Further research will be needed to elucidate the details of this.  
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Chapter 6. Conclusion 
 
To our knowledge, this has been the largest study performed to date using WGS data for 
analysis of B. hyodysenteriae an important pig pathogen. The data provides a valuable 
set of sequenced samples for subsequent B. hyodysenteriae surveillance in the UK, 
which can be used in future enabling rapid detection of clonal expansion of an isolate 
across regions or farms and the acquisition of SNPs or AMR genes which results in 
antimicrobial resistance. The phylogenetic analysis of B. hyodysenteriae (Chapter 3) has 
indicated differences between the core genome present in B. hyodysenteriae globally. In 
addition, potential differences between pig production systems in different NUTS 1 
regions in England were revealed that may have led to different populations of B. 
hyodysenteriae persisting in these regions. The sequencing of 84 clinical isolates of B. 
hyodysenteriae will enable more in-depth swine dysentery outbreak investigation, as it 
will be possible to trace isolates to specific regions, or potentially holdings, in the UK 
where the sequence type may have persisted. 
 
Antimicrobial susceptibility testing of 47 isolates using MICs (Chapter 4) indicated a 
low level of clinical resistance in the UK, but a significant increase in the number of 
intermediate isolates from 2004 to 2010. This may reflect a long-term trend toward 
decreased pleuromutilin sensitivity and is likely to have been caused by historic, and 
current, antibiotic usage. Also, a newly identified gene tva(A), was detected in isolates 
with an intermediate and resistant tiamulin phenotype. This improved the correlation 
between phenotype (identified by broth dilution susceptibility testing) and genotype 
(based on the presence of tva(A)) substantially, allowing prediction of B. hyodysenteriae 
isolates with decreased sensitivity to tiamulin or valnemulin. tva(A) was further 
analysed by induction of clinical tiamulin and valnemulin resistance in a sensitive 
isolate that contained tva(A) (js27), and a sensitive isolate without tva(A) (js17), by 
repeat subculturing in sublethal concentrations of tiamulin or valnemulin. Tiamulin and 
valnemulin sensitivity of both isolates had decreased after 20 subcultures, but clinical 
resistance only occurred in js27. It appears tva(A) does contribute to pleuromutilin 
resistance and confers resistance to both tiamulin and valnemulin. It is possible that 
multiple genes, including tva(A), could be involved in pleuromutilin resistance in 
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clinical isolates, whole genome sequencing provides a mechanism of identifying these 
new resistance genes.  
 
Using shotgun metagenomic sequencing of swine dysentery positive samples, it was 
possible to gather epidemiologically useful information on B. hyodysenteriae (Chapter 
5). A comparison of the microbiome of healthy and swine dysentery positive faecal 
samples indicated that a number of species may be associated with swine dysentery. 
These were E. coli and C. coli; these species may cause secondary infections 
complicating the treatment of swine dysentery and requires further verification in 
future. Secondary infections could be further exasperated by the acquisition of AMR 
genes, making treatment more difficult, for example in E. coli commensal isolates have 
been found to readily accept some antibiotic resistance plasmids [362].  
 
This study has highlighted the value of WGS for the study of B. hyodysenteriae. At 
present there are few published B. hyodysenteriae genomes limiting the potential of 
WGS for the study of B. hyodysenteriae but the numbers are likely to increase as the 
technique becomes more widely adopted, costs decrease, and analysis methods become 
more standardised. WGS has advantages over existing techniques currently used to 
study B. hyodysenteriae. Currently, MLST is used to investigate the population 
structure. This has enabled quick comparison to other studies and increased the 
understanding of the global population structure of B. hyodysenteriae [52, 60, 73, 93-
95, 121-125]. As demonstrated in this study WGS has the potential to enhance the 
investigation of the population structure of B. hyodysenteriae globally by providing a 
greater depth of resolution that enables identification of differences between STs. In 
addition, the bioinformatics tools available for the analysis of sequences are developing 
rapidly. This has led to the development of powerful analytical programs that have 
enabled new avenues of investigation to be conducted. For example, in this study, 
SCOTTI was used to predict the transmission of B. hyodysenteriae between regions of 
England and Wales. The results generated provide a hypothesis of how B. 
hyodysenteriae has spread, which highlighted regional differences. Although this is only 
a prediction and may not completely reflect the historical transmission events that 
occurred, it may provide new tools for the analysis of outbreaks increasing the accuracy 
of the analysis this may provide valuable information useful for biosecurity and control. 
As well as powerful analytical programs, there has also been a trend in bioinformatics 
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towards more intuitive programs. For example, Nullabor provides a pipeline designed 
for WGS diagnostics that automates assembly, annotation and analysis of clinical 
sequences and provides an easily understandable output [237].  
 
WGS has enhanced the analysis of antibiotic resistance in B. hyodysenteriae by 
enabling the analysis of all genes in the genome. Previously, tiamulin resistant SNPs 
were detected by sequencing the 23S rRNA gene and rplC [159, 163-165, 167]. This 
identified a number of SNPs that may have contributed to tiamulin resistance; but there 
have been discrepancies between a tiamulin resistance phenotype and the genotype, 
with resistant isolates not always harbouring SNPs conferring tiamulin resistance [159, 
167]. In this study, examination of the whole genome confirmed the recent 
identification of tva(A) in a larger set of UK isolates. Sequencing of several Italian 
isolates also revealed a lincomycin resistance gene (lnu(C)) that had previously not been 
reported in B. hyodysenteriae [165]. Previously, only a SNP at position 2058 in the 23S 
rRNA gene was associated with lincomycin resistance in B. hyodysenteriae [165]. In 
this study another SNP was identified in the 23S rRNA G2062T, that may have caused 
lincomycin and pleuromutilin resistance. It is likely that as more samples are sequenced 
more resistance genes, and new SNP variants will be identified. In addition, the recent 
identification of a transposon (MTnSag1) by WGS, suggests that horizontal gene 
transfer in B. hyodysenteriae might be more common than previously expected [165].   
 
Diagnosis of swine dysentery is a slow process complicated by the need to culture B. 
hyodysenteriae. Although WGS provides valuable comparison of clonal isolates 
identifying potentially new virulence and AMR genes, it would not be considerably 
faster than existing techniques for rapid clinical diagnosis, due to the need to purify B. 
hyodysenteriae from clinical specimens. Direct sequencing of faeces by shotgun 
sequencing would be more rapid for diagnosis, and it was demonstrated in this study to 
identify the closest related sequenced clinical isolates. The techniques used to extract 
reads, and identify the most closely related clinical isolates could be automated into a 
pipeline similar to Nullabor that would allow replication by non-experts [237]. This 
could also be used to detect other important pathogens quickly. The results obtained 
could be improved by using an alternative database that includes species more 
representative of the pig; this would result in more reads mapping and better 
identification of species. However, for routine diagnostic, it would be necessary to 
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curate the database to avoid false positive identification of pathogenic species. 
Metagenomic sequencing is currently too expensive for routine diagnostics, but this 
study has shown it is a possible alternative that can be used for rapid, and as sequencing 
costs continue to decline it may become a technique that be used for routine diagnosis 
of swine dysentery.   
 
Metagenomic sequencing is also likely to prove useful for surveillance of AMR genes. 
Increased surveillance of is a key priority of government antibiotic resistance strategy 
and has also been included in highly influential reviews [149]. The use of genetic 
techniques has been suggested as an important component of antibiotic surveillance in 
the UK government 5-year antibiotic resistance strategy, and metagenomics can 
complement other genetic based techniques [150].  For example, PCR enables rapid 
identification of AMR genes, but it cannot provide the total number of AMR genes in a 
sample. With metagenomic sequencing, this could be possible.  
 
There were a number of results from this study that could be continued. There are other 
B. hyodysenteriae isolates have been sequenced at the APHA, some of these have 
recently published [293]. Analysis of all B. hyodysenteriae isolates sequenced by the 
APHA would provide greater information on the population structure of B. 
hyodysenteriae in the UK. It would also be possible to predict the spread of B. 
hyodysenteriae between regions of the UK, this may reveal more regional differences or 
could highlight important nodes where B. hyodysenteriae eradication programs would 
be most effective. Also, the metagenomic analysis presented here could be used to 
investigate speciation in other bacterial infections. However, it would be necessary to 
first improve the percentage of reads identified; this would improve species 
identification resulting in greater quantification of the microbiome.  
 
The pig industry is undergoing substantial structural changes with increased 
industrialisation of pig farming [13], this could lead to an increased need for antibiotics 
as more pigs are kept on the same holding [9]. In addition, growing resistance to 
specific antibiotics, for example, tylosin, has led to a reduction in the variety antibiotics 
available to treat swine dysentery, and if AMR continues to develop treatment options 
could be reduced further [282]. The continued need for antibiotic treatment, and the 
continued acquisition of resistance to new antibiotics are likely to have an impact on the 
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development of B. hyodysenteriae in the future. This could result in tiamulin and 
valnemulin being used more frequently. This, in turn, could result in increased 
resistance, creating a significant challenge to the pig industry that will be difficult to 
resolve. In future, surveillance of B. hyodysenteriae could enable rapid detection of the 
spread of multi-drug resistance B. hyodysenteriae, whereupon control measures could 
be used to limit the spread. WGS offers a useful technique that will strengthen 
surveillance by enabling more in-depth analysis of clinical isolates. For WGS to be 
implemented as effectively as possible, it will be important for data to be shared 
publically, this will enable rapid identification of outbreak strains and their location of 
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Table of uncertainties in MLST assignment by SRST2. 
Edge refers to coverage over the first, or last 2 bases of the gene. 
Isolate SNP Edge 
js02   gdh-5/edge2.0 
js05 glpK-15/51snp,2indel,37holes; thi-19/62snp thi-19/edge2.0 
js15 est-7/1snp; glpK-23/1snp   
js16   gdh-5/edge1.0 
js43   gdh-12/edge2.0 
js48   gdh-1/edge2.0 




Appendix 2  
Phylogenetic tree of B. hyodysenteriae isolates grown in sub-lethal concentrations 
of tiamulin and valnemulin sequenced in this study and other isolates previously 
sequenced (chapter 3).  
Isogenic parent strain and the isolates after 20 subcultures of tiamulin and valnemulin 
are shown in red boxes. 1000 bootstraps were conducted, and bootstrap support above 
70 is shown. 
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Appendix 3  
Relative abundance of sequenced caecal samples.  
Abbreviations: BG: Farrow-to-finish, F: Finisher, M: Midlands, Y: Yorkshire, SW: South West, 44: MSG44P2, 07: MSG07P2, 16: 
MSG16P2, 20: MSG20P2, 54.2: MSG54P2, 54.3: MSG54P3, 54.4: MSG54P4, 54.5: MSG54P5, 15: MSG15P2, 38: MSG38P2, 11: 
MSG11P2, 12: MSG12P2,06: MSG06P2,14: MSG14P2 
 
Sample 44 7 16 20 22 54.2 45.3 54.4 54.5 15 38 11 12 6 14 
Farm Type BF BF BF BF BF BF BF BF BF BF F BF BF F F 
Location M Y Y M Y M M M M SW SW SW SW SW SW 
Acidaminococcus  
fermentans 0 0 1.37 0 0 0 0 0 0 0 0 0 0 0 0 
Bacteroides  
fragilis 4.03 8.11 9.7 1.43 15.48 4.8 3.47 3.44 4.47 5.7 12.68 4.73 6.17 0.67 2.46 
Bacteroides  
salanitronis 0 0 1.55 0 2.96 0 0.99 0 0 0 0 0 1.77 0 0.76 
Bacteroides  
thetaiotaomicron 2.31 1.99 4.65 1.11 4.04 0 2.89 1.61 2.28 2.03 3.01 0.86 4.11 0 1.05 
Bacteroides  
xylanisolvens 0 0 0 0 0 2.2 0.99 0 0 0 0 0 0 0 0 
Butyrate producing  
bacterium 0 0 1.4 0 0 0 0 0 0 0 0 0 0 0 0 
Clostridium cf  
saccharolyticum 1.48 2.07 2.95 1.25 5.42 3.98 1.69 2.75 2.59 4.04 5.37   3.56 3.06 2.11 
Clostridium  
difficile 0 0 0 0 0 0 0 0 0 0 0 0 0 0.45 0 
Coprococcus ART55 0 0 0 0.72 0 1.94 3.73 2.54 0 0 0 0 1.66 0 0 
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Sample 44 7 16 20 22 54.2 45.3 54.4 54.5 15 38 11 12 6 14 
Farm Type BF BF BF BF BF BF BF BF BF BF F BF BF F F 
Location M Y Y M Y M M M M SW SW SW SW SW SW 
Coprococcus  
catus 1.15 0 0 0.63 0 2.07 1.64 2.39 0 2.72 0 0 0 8.46 0.98 
Enterococcus  
faecalis 0 0 0 0 0 0 0 0 0 0 0 0 2.25 0.42 0 
Escherichia  
coli 0 0 0 2.76 0 0 0 0 0 0 0 0 0 0 0 
Eubacterium  
eligens 0 0 1.84 0 0 2.56 1.81 1.51 2.37 0 0 4.53 1.44 0 0 
Eubacterium  
rectale 5.97 0 0 6.87 14.89 27.27 25.97 46.66 40.95 13.44 0 1.77 17.97 1.8 2.94 
Eubacterium  
siraeum 0 0 0 0 0 0 0 0 0 0 0 0 0 0.55 0 
Faecalibacterium  
prausnitzii 0 0 5.37 2.21 0 6.62 13.39 12.37 10.16 7.01 0 3.23 9.85 1.52 0.88 
Lactobacillus  
acidophilus 16.67 13.6 0 0.69 0 0 1.34 0 0 0 3.13 15.24 0 69.08 10.83 
Lactobacillus  
amylovorus 39.59 30.91 0 0.57 0 0 0.85 0 0 0 0 35.87 0 0 23 
Lactobacillus  
johnsonii 0 0 0 43.09 0 4.75 3.99 0 0 0 0 0 3.11 0 16.33 
Lactobacillus  
reuteri 0 1.71 1.5 8.81 0 0 2.23 0 0 4.9 3.13 1.15 0 1.04 11.84 
Lactobacillus  
salivarius 0 0 0 1.15 0 0 0 0 0 0 0 0 0 0 0 
Megasphaera  
elsdenii 6.98 10.28 23.1 6.12 0 0 0 0 0 4.09 0 0 8.9 0 8.76 
Methanobrevibacter  
smithii 0 0 0 0 0 0 0 0 0 0 10.92 18.43 0 2.41 0 
 167 
Sample 44 7 16 20 22 54.2 45.3 54.4 54.5 15 38 11 12 6 14 
Farm Type BF BF BF BF BF BF BF BF BF BF F BF BF F F 
Location M Y Y M Y M M M M SW SW SW SW SW SW 
Prevotella  
dentalis 0 0 3.76 1.31 0 0 1.34 0 0 0 0 0 1.35 0 0 
Prevotella  
denticola 0 0 0 0 0 0 1.29 0 0 0 0 0 0 0 0 
Prevotella  
melaninogenica 2.39 0 4.74 1.81 3.2 2.73 4.11 1.98 0 1.92 0 0.97 3.33 0 0.8 
Prevotella  
ruminicola 0 0 0 0 0 0 0.98 0 0 0 0 0 0 0 0 
Roseburia  
hominis 1.1 0 2.47 1.15 4.71 2.9 1.87 1.78 3.27 3.39 3.88 0.99 3.36 2.39 1.73 
Roseburia  
intestinalis 2.19 0 1.77 2.21 5.3 4.55 3.17 4.95 5.38 2.78 4.01 1.22 4.31 1.13 1.81 
Ruminococcus 0 0 3.06 0 0 0 1.01 0 0 1.61 0 0 0 0.32 0 
Ruminoccus  
bromii 0 0 2.23 0 0 0 1.51 0 0 0 0 0 0 0 0 
Ruminococcus  
obeum 0 0 1.7 0.55 0 0 1.48 0 0 3.01 0 0 1.3 1.09 0.69 
Ruminococcus  
torques 0 0 0 0 0 0 0 0 0 3.14 0 0 0 0 0 
Streptococcus  
gallolyticus 0 0 0 0 0 0 0 0 0 2.59 0 0 0 0 0 
Streptococcus  
lutetiensis 0 0 0 0.87 0 0 0 0 0 4.17 0 0 0 0 0 
Streptococcus  
macedonicus 0 0 0 0 0 0 0 0 0 1.42 0 0 0 0 0 
Streptococcus  
suis 0 0 0 0 0 0 0 0 0 0 0 0 0 0.35 0 
Treponema  





Relative abundance of sequenced faecal samples.  
Abbreviations: H: Healthy, SD: swine dysentery positive. 
 
Isolate 100 103 55 69 8 123 14 174 26 168 161 
Health H H H H H SD SD SD SD SD SD 
archaeon Mx1201 0 0 0 0 0 0 0.99 0.27 0 0 0 
Achromobacter  
xylosoxidans 0 0 0 0 0.95 0 0 0 0 0 0 
Acholeplasma  
brassicae 0 0 0 0 0 0 0 0 0.71 0 0 
Acidaminococcus  
fermentans 1.86 4.74 0 0 0 0 0 1.09 0 0 0 
Acinetobacter  
baumannii 0 0 0 0 0 0 0.8 0 2.92 0 0 
Bacteroides  
fragilis 3.78 2.89 1.87 0 0 0.23 27.5 55.17 7.22 0 0 
Bacteroides  
salanitronis 0 0 0 0 0 0 0.23 0 0 0 0 
Bacteroides  
thetaiotaomicron 1.81 0 0 0 0 0.1 0 0.31 0 0 0 
Bacteroides  
vulgatus 0 0 0 0 0 0.3 0 1 0 0 0 
Bacteroides  
xylanisolvens 0 0 0 0 0 0.05 0 0 0 0 0 
Brachyspira  
hyodysenteriae 0 0 0 0 0 0.15 15.89 1.51 3.87 0.77 3.81 
Campylobacter  
coli 0 0 0 0 0 0.46 0.58 0.39 0 0 1.94 
 169 
Isolate 100 103 55 69 8 123 14 174 26 168 161 
Health H H H H H SD SD SD SD SD SD 
Clostridium cf  
saccharolyticum 1.84 4.36 2.37 1.98 0 0.12 0.48 1.53 0 0 4.05 
Clostridium  
difficile 0 0 3.07 1.21 1.85 0.06 0 0.95 0 0 7.47 
Clostridium  
perfringens 0 0 0 0 0 0 0 1.04 0 0 5.31 
Coprococcus  
catus 0 0 0 0 0 0 0.29 0 1.1 0 0 
Enterobacter  
cloacae 0 0 0 0 1.02 0 0 0 0 0 0 
Enterococcus  
faecalis 0 0 0 0 1.75 0 0 0.4 0 0 0 
Enterococcus  
faecium 0 0 5.48 1.24 5.17 0 0.59 0 0 0 1.69 
Escherichia  
coli 0 0 0 0 0 0.19 27.77 16.34 14 0.22 7.84 
Escherichia  
fergusonii 0 3.98 0 0 0 0.21 0 0.41 0 0 0 
Eubacterium  
rectale 12.44 6.05 0 0 0 0 0.23 0 0 0 0 
Eubacterium  
siraeum 0 0 0 1.08 0 0.13 0 1.79 0 0 7.17 
Faecalibacterium  
prausnitzii 8.5 3.46 0 0.83 0 0 0.7 1.12 0.55 0 2.67 
Lactobacillus  
acidophilus 8.07 6.01 0 3.48 8.98 28.51 8.41 0.54 15.1 26.79 2.99 
Lactobacillus  
amylovorus 17.28 11.91 0 7.11 20.64 63.77 3.65 0.73 32.95 60.43 5.34 
Lactobacillus  
crispatus 0 0 0 0 0 0.23 0 0 0 0.24 0 
Lactobacillus  
helveticus 0 0 0 0 0 0.55 0 0 0 0 0 
 170 
Isolate 100 103 55 69 8 123 14 174 26 168 161 
Health H H H H H SD SD SD SD SD SD 
Lactobacillus  
johnsonii 0 0 0 0 0 0.23 0 1.85 0 0.35 0 
Lactobacillus  
kefiranofaciens 0 0 0 0 0 0.18 0 0 0 0 0 
Lactobacillus  
reuteri 3.48 0 0 1.57 3.16 1.3 1.89 1.95 5.82 4.26 1.2 
Megamonas  
hypermegale 1.92 0 0 0 0 0 0 0 0 0 0 
Megasphaera  
elsdenii 5.71 6.38 0 0.94 0 0 0.27 1.53 0.83 0 0 
Methanobrevibacter  
AbM4 0 0 0 0 0 0 0 0 0 3.97 0 
Methanobrevibacter  
smithii 0 0 50.48 58.13 15.74 0.64 0 0.83 0 0 18.14 
Methanosphaera  
stadtmanae 0 0 0 0.77 1.14 0 0 0 0 0 0 
Prevotella  
melaninogenica 3.08 0 0 0 0 0 0 0 0 0 0 
Psychrobacter  
arcticus 0 0 0 0 2.04 0.07 0 0 0 0 0 
Psychrobacter  
cryohalolentis 0 0 0 0 4.82 0.21 0 0 0 0 0 
Psychrobacter G 0 0 0 0 2.63 0.13 0 0 0 0 0 
Psychrobacter PRwf 0 0 0 0 3.92 0.13 0 0 0 0 0 
Roseburia hominis 1.71 3.92 0 1.43 0 0.12 0.9 1.42 0 0 4.22 
Roseburia intestinalis 0 0 0 0 0 0.08 0.45 0.3 0 0 0 
Ruminococcus 1.68 3.13 0 0 0.99 0 0 0 0 0.28 0 
Ruminococcus bromii 4.83 2.85 2.78 2.2 1.85 0 0.23 0.29 0.52 0 0 
Ruminococcus obeum 0 0 0 0 0 0 0 1.09 0 0 3.9 
 171 
Isolate 100 103 55 69 8 123 14 174 26 168 161 
Health H H H H H SD SD SD SD SD SD 
Ruminococcus torques 0 0 0 0 1.14 0 0 0 0 0 0 
Shigella flexneri 0 0 0 0 2.22 0 0 0 0 0 0 
Shigella sonnei 0 0 0 0 0 0.12 0 0 0 0 0 
Solibacillus silvestris 0 0 0 5.25 0 0 0 0 0 0 0 
Streptococcus  
lutetiensis 0 0 0 0 0 0 0 0 0 0 0 
Streptococcus  
lutetiensis 0 0 0 0 0 0.06 0 0 0 0 0 
Treponema  
succinifaciens 2.1 14.63 3.42 3.48 0 0 0.62 0.24 1.74 0 0 
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